<SEC-DOCUMENT>0001493152-23-029511.txt : 20230821
<SEC-HEADER>0001493152-23-029511.hdr.sgml : 20230821
<ACCEPTANCE-DATETIME>20230821080239
ACCESSION NUMBER:		0001493152-23-029511
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230814
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230821
DATE AS OF CHANGE:		20230821

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jupiter Wellness, Inc.
		CENTRAL INDEX KEY:			0001760903
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				832455880
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39569
		FILM NUMBER:		231187376

	BUSINESS ADDRESS:	
		STREET 1:		1061 E. INDIANTOWN RD.
		STREET 2:		STE. 110
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477
		BUSINESS PHONE:		561-325-0482

	MAIL ADDRESS:	
		STREET 1:		1061 E. INDIANTOWN RD.
		STREET 2:		STE. 110
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CBD Brands, Inc.
		DATE OF NAME CHANGE:	20181206
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:jupw="http://jupiterwellness.com/20230814">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_jupw_jupiterwellness.com_20230814 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230814_20230814 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001760903 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityCentralIndexKey">0001760903</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="jupw-20230814.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-08-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-14</xbrli:startDate>
        <xbrli:endDate>2023-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-142023-08-14_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-14</xbrli:startDate>
        <xbrli:endDate>2023-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jupw:WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-14</xbrli:startDate>
        <xbrli:endDate>2023-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C., 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20230814__20230814_zGLvSnEf3IO"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_90F_edei--DocumentPeriodEndDate_c20230814__20230814_zjZOZbW8STPf"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 14, 2023</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_908_edei--EntityRegistrantName_c20230814__20230814_zFguYZNi7JM8"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityRegistrantName">JUPITER
WELLNESS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20230814__20230814_zSN8bR639Rl4"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityFileNumber_c20230814__20230814_z0dlo68bJ6Pg"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityFileNumber">001-39569</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20230814__20230814_zClipKfaypHf"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityTaxIdentificationNumber">83-2455880</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20230814__20230814_zcSMCKdavsp5"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityAddressAddressLine1">1061
E. Indiantown Rd.</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20230814__20230814_zRemRn5Qg5Ee"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityAddressAddressLine2">Ste. 110</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCityOrTown_c20230814__20230814_zvQ1zCVuf0kd"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityAddressCityOrTown">Jupiter</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20230814__20230814_zuUmMiz4FUde"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_90D_edei--EntityAddressPostalZipCode_c20230814__20230814_z6CkWvHPZbJ3"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:EntityAddressPostalZipCode">33477</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--CityAreaCode_c20230814__20230814_zC4dpWFyAk68"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:CityAreaCode">(561)</ix:nonNumeric></span>
<span id="xdx_903_edei--LocalPhoneNumber_c20230814__20230814_zAQSHytQTRbb"><ix:nonNumeric contextRef="AsOf2023-08-14" name="dei:LocalPhoneNumber">462-2700</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>Not
Applicable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (<span style="text-decoration: underline">see</span> General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--WrittenCommunications_c20230814__20230814_zUS7yuRTJiD3"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SolicitingMaterial_c20230814__20230814_zskbzWxHK05g"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20230814__20230814_zYvgE6bS2hJj"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20230814__20230814_z00ZSm8W26Xd"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20230814__20230814__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_z6pm5tct8RL4"><ix:nonNumeric contextRef="From2023-08-142023-08-14_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--TradingSymbol_c20230814__20230814__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zPA4inaN2E2j"><ix:nonNumeric contextRef="From2023-08-142023-08-14_us-gaap_CommonStockMember" name="dei:TradingSymbol">JUPW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_90B_edei--SecurityExchangeName_c20230814__20230814__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zpZpdycipBBb"><ix:nonNumeric contextRef="From2023-08-142023-08-14_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(The
    Nasdaq Capital Market)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20230814__20230814__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_zXHZmKQ5FQI3"><ix:nonNumeric contextRef="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" name="dei:Security12bTitle">Warrants,
    each exercisable for one share of Common Stock at $8.50 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20230814__20230814__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_z9KEnsVwA9e7"><ix:nonNumeric contextRef="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" name="dei:TradingSymbol">JUPWW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_909_edei--SecurityExchangeName_c20230814__20230814__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_zNZabgjqpnQf"><ix:nonNumeric contextRef="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(The
    Nasdaq Capital Market)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&#160;<span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20230814__20230814_zgI8v2bdOHgj"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span id="xdx_900_edei--EntityExTransitionPeriod_c20230814__20230814_zXLRxy8EWA79"><ix:nonNumeric contextRef="AsOf2023-08-14" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 14, 2023, <span style="background-color: white">Jupiter Wellness, Inc. (the &#8220;Company&#8221;) along with </span>SRM Entertainment,
Inc., a Nevada corporation (&#8220;SRM&#8221;)<span style="background-color: white">, entered into an Underwriting Agreement (the &#8220;Underwriting
Agreement&#8221;), with EF Hutton, division of Benchmark Investments, LLC, the representative of the underwriters (the &#8220;Representative&#8221;),
in connection with SRM&#8217;s initial public offering (the &#8220;IPO&#8221;). Pursuant to the Underwriting Agreement, on August 14,
2023, SRM announced the pricing of its IPO of 1,250,000 shares of common stock, par value $0.0001 (the &#8220;Common Stock&#8221;) for
a price of $5.00 per share, less certain underwriting discounts and commissions. </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 9, 2022, the Company entered into the Exchange Agreement (the &#8220;Exchange Agreement&#8221;) with SRM to govern the separation
of our business from SRM. On May 26, 2023, we amended the Exchange Agreement (the &#8220;Amended and Restated Exchange Agreement&#8221;)
to include additional information regarding the distribution and the separation of our business from SRM. On August 14, 2023, we consummated
the separation contemplated by the Amended and Restated Exchange Agreement. From this date forward, SRM will operate as a separate public
company. Jupiter will no longer consolidate the numbers of SRM in its financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
August 14, 2023, the Company distributed 2,000,000 shares of Common Stock owned by the Company to its stockholders and holders of certain
warrants based on the record date of July 7, 2023. Following the distribution, the Company is the largest shareholder of
SRM, owning 4,500,000 shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 3, 2023, the Company and SRM entered into an Assignment and Assumption Agreement (the &#8220;McKinnon Assignment&#8221;), pursuant
to which SRM assumed the employment agreement, between Douglas McKinnon and the Company. The McKinnon Assignment became effective on
August 14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collectively,
the McKinnon Assignment, the Exchange Agreement, the <span style="background-color: white">Amended and Restated Exchange Agreement and
the Underwriting Agreement are the &#8220;Agreements&#8221;</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of each of the Agreements does not purport to be complete and are qualified in their entirety by the text of the
Agreements which are filed as Exhibit 10.1. 10.2, 10.3 and 10.4, and are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the McKinnon Assignment on August 14, 2023, Douglas McKinnon resigned from his position as the CFO of the Company. Mr. McKinnon did
not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2023, the board of directors (the &#8220;Board&#8221;) of the Company appointed Markita L. Russell as the Chief Financial
Officer of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Ms.
Russell, has over 20 years of experience in accounting. From June 2017 to August 2019, Ms. Russell served as controller at Quantum Admin
Services / Beachway Therapy Center, LLC. From September 2019 to March 2020, Ms. Russell served as acting controller and consultant of
Nautical Ventures Group, Inc. From April 2020 to August 2021, Ms. Russell served as the Staff Accountant for Stem Holdings Inc. Since
August 2021, Ms. Russell has served as the controller for SRM, performing accounting functions for SRM&#8212;from accounts receivable
and accounts payable management to inventory and fixed asset management, cash management and financial reporting utilized for the Company&#8217;s
Form 10-Q and Form 10-K filings with the U.S. Securities and Exchange Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">There are no arrangements or understandings between
the Company and the newly appointed executive officer or director and any other person or persons pursuant to which each executive officer
or director was appointed and there is no family relationship between or among any director or executive officer of the Company or any
person nominated or chosen by the Company to become a director or executive officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no transactions between the Company and any newly appointed executive officer or director that are reportable pursuant to Item 404(a)
of Regulation SK. The Company did not enter into or materially amend any material plan, contract or arrangement with any newly appointed
executive officer or director in connection with his or her appointment as a director or executive officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the distribution, the exercise price of an aggregate of 8,631,754 warrants issued in January 2023 was reduced from $1.00
per share to $0.932 per share and the amount of warrants increased from 8,631,754 to 9,260,554 warrants. The change is a result of the
anti-dilution features contained in those warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 0pt"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated August 14, 2023, by and between <span style="background-color: white">EF Hutton, division of Benchmark Investments, LLC, Jupiter Wellness, Inc. and SRM Entertainment, Inc. </span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 0pt"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Agreement, dated December 9, 2022, between <span style="background-color: white">Jupiter Wellness, Inc. and SRM Entertainment, Inc.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 0pt"><a href="ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Exchange Agreement, dated <span style="background-color: white">May 26, 2023</span>, between <span style="background-color: white">Jupiter Wellness, Inc. and SRM Entertainment, Inc.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 0pt"><a href="ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Assignment and Assumption Agreement, dated August 3, 2023, between <span style="background-color: white">Jupiter Wellness, Inc. and SRM Entertainment, Inc.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded with the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 37.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
August 21, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JUPITER
    WELLNESS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Brian John</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Brian
    John</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kEFuwjAQRU/AHUZRlxE4qahodjQCVBUKAtR264RJsUg80dhQOFJvWcdpBIvWsmRZf/773w6CMJjRVJXI8PG0nsMWq7qUFmGNBTLqHN1E+vySgDvX+KmMZamtv3bGlJwHnWfYjx4zJ/jRkzK4S0CMBtHDIL4HESVCwGoR9Bo9JV2oHWqrZAlS72DFVLNCK/nSErbyTJqqi496QzaKdAJRX7TyN8QiiuGVTvKL+GBgPk+DXuhXL5gxHesm5mgsVTApsXJZprVet6+S+5nkXXLzMjOR+X5yRs6VkVmJU+Klxs1eMi4L99KK9MZSfhjbUX8oVsheWmCVITtYJGLXa/xbsmOGgI4KeMVCQQykEUxjByqgZYOHg7Rw1/Chdv/rR/5ofNPmn/xbZgf4AdSZluQ= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTION
VERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT<BR>
by and among<BR>
SRM ENTERTAINMENT, INC.,<BR>
JUPITER WELLNESS, INC.<BR>
and<BR>
EF HUTTON,<BR>
division of Benchmark Investments, LLC,<BR>
as Representative of the Several Underwriters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
14, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EF
HUTTON,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">division
of Benchmark Investments, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Representative of the several Underwriters named on Schedule 1 attached hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">590
Madison Avenue, 39th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, SRM Entertainment, Inc., a corporation formed under the laws of the State of Nevada (collectively with its subsidiaries
and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined)
as being subsidiaries or affiliates of SRM Entertainment, Inc., the &ldquo;<B>Company</B>&rdquo;), hereby confirms its agreement (this
&ldquo;<B>Agreement</B>&rdquo;) with EF Hutton, division of Benchmark Investments, LLC (the &ldquo;<B>Representative</B>&rdquo;), and
with the other underwriters named on <U>Schedule 1</U> hereto for which the Representative is acting as representative (the Representative
and such other underwriters being collectively called the &ldquo;<B>Underwriters</B>&rdquo; or, individually, an &ldquo;<B>Underwriter</B>&rdquo;)
as set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a majority-owned subsidiary of Jupiter Wellness, Inc., a Delaware corporation (&ldquo;<B>Parent</B>&rdquo;). Prior to the
date hereof, the Company and Parent entered into an exchange agreement, dated December 9, 2022, as amended and restated on May 26, 2023
(the &ldquo;<B>Exchange Agreement</B>&rdquo;), pursuant to which (i) the Company agreed to issue to Parent 6,500,000 shares of the Company&rsquo;s
common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;), in exchange for all of the issued and outstanding
ordinary shares of S.R.M. Entertainment Limited (&ldquo;<B>SRM Limited</B>&rdquo;), a limited company established under the laws of the
Hong Kong Special Administrative Region of the People&rsquo;s Republic of China and a wholly-owned subsidiary of Parent that operates
the Parent&rsquo;s business segment that creates and sells innovative products for the toy and entertainment industries (the &ldquo;<B>SRM
Business</B>&rdquo;), owned by Parent (the &ldquo;<B>Share Exchange</B>&rdquo;), on the terms and subject to the conditions set forth
in the Exchange Agreement, effective August 14, 2023, to effect a separation of the SRM Business from Parent, pursuant to which, the
SRM Business will be contributed to the Company and all expenses related thereto shall be the responsibility of the Company, in each
case, on the terms and subject to the conditions set forth therein (the &ldquo;<B>Separation</B>&rdquo;); and (ii) Parent agreed to distribute
2,000,000 shares of Common Stock out of the 6,500,000 shares of Common Stock received pursuant to the Share Exchange to holders of its
common stock, par value $0.001 per share, and certain warrant holders (the &ldquo;<B>Distribution</B>&rdquo;), in each case, of record
as of July 7, 2023 as further described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
                                            AND SALE OF SECURITIES.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Firm
                                            Shares.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Nature and Purchase
of Firm Shares.</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the
Company agrees to issue and sell to the several Underwriters, an aggregate of 1,250,000 authorized but unissued shares of Common
Stock (the &ldquo;<B>Firm Shares</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Shares set forth opposite their
respective names on <U>Schedule 1</U> attached hereto and made a part hereof, at a purchase price of $4.60 per Firm Share (92% of
the public offering price for each Firm Share). The Firm Shares are to be offered initially to the public at the offering price set
forth on the cover page of the Prospectus (as defined in Section 2.1.1 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Payment and
Delivery of Firm Shares</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Delivery and payment for the Firm Shares shall be made at 10:00 a.m., Eastern time, on the first (1<SUP>st</SUP>) Business Day
following the date hereof or the second (2<SUP>nd</SUP>) Business Day following the date hereof if the Registration Statement (as
defined in Section 2.1.1 hereof) is declared effective after 4:01 p.m., Eastern time) or at such earlier time as shall be agreed
upon by the Representative and the Company, at the offices of Sullivan &amp; Worcester LLP, 1633 Broadway, New York, NY 10019
(&ldquo;<B>Representative&rsquo;s Counsel</B>&rdquo;), or at such other place (or remotely by email or other electronic
transmission) as shall be agreed upon by the Representative and the Company. The hour and date of delivery and payment for the Firm
Shares is called the &ldquo;<B>Closing Date</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Payment for the Firm Shares shall be made on the Closing Date by wire transfer in U.S. dollars (same day) funds, payable to the
order of the Company upon delivery of the certificates (in form and substance satisfactory to the Underwriters) representing the
Firm Shares (or through the facilities of The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;)) for the account of the
Underwriters. The Firm Shares shall be registered in such name or names and in such authorized denominations as the Representative
may request in writing at least two (2) Business Days prior to the Closing Date. The Company shall not be obligated to sell or
deliver the Firm Shares except upon tender of payment by the Representative for all of the Firm Shares. The term &ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are
authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be
authorized or required by law to remain closed due to &ldquo;stay-at-home,&rdquo; &ldquo;shelter-in-place,&rdquo;
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at
the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of
commercial banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-allotment
                                            Option.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.1 <U>Option
Shares</U>. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Shares, the
Company hereby grants to the Underwriters an option to purchase from the Company up to 187,500 additional shares of Common Stock
(the &ldquo;<B>Option Shares</B>&rdquo;), representing fifteen percent (15%) of the Firm Shares sold in the Offering (the
&ldquo;<B>Over-allotment Option</B>&rdquo;). The purchase price to be paid per Option Share shall be equal to the price per Firm
Share set forth in Section 1.1.1 hereof. The Firm Shares and the Option Shares are hereinafter referred to together as the
&ldquo;<B>Public Securities</B>.&rdquo; The offering and sale of the Public Securities is herein referred to as the
&ldquo;<B>Offering</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.2 <U>Exercise
of Option</U>. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative as to all
(at any time) or any part (from time to time) of the Option Shares within forty-five (45) days after the date of this Agreement. The
Underwriters shall not be under any obligation to purchase any Option Shares prior to the exercise of the Over-allotment Option. The
Over-allotment Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which
must be confirmed in writing by overnight mail or email or other electronic transmission setting forth the number of Option Shares
to be purchased and the date and time for delivery of and payment for the Option Shares (the &ldquo;<B>Option Closing
Date</B>&rdquo;), which shall not be later than two (2) Business Days after the date of the notice or such other time as shall be
agreed upon by the Company and the Representative, at the offices of Representative Counsel or at such other place (including
remotely by email or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery
and payment for the Option Shares does not occur on the Closing Date, the Option Closing Date will be as set forth in the notice.
Upon exercise of the Over-allotment Option with respect to all or any portion of the Option Shares, subject to the terms and
conditions set forth herein, (i) the Company shall become obligated to sell to the Underwriters the number of Option Shares
specified in such notice and (ii) each of the Underwriters, acting severally and not jointly, shall purchase that portion of the
total number of Option Shares then being purchased as set forth in Schedule 1 opposite the name of such Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.3 <U>Payment
and Delivery</U>. Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in U.S. dollars (same day)
funds, payable to the order of the Company upon delivery to the Representative of certificates (in form and substance satisfactory
to the Underwriters) representing the Option Shares (or through the facilities of DTC) for the account of the Underwriters. The
Option Shares shall be registered in such name or names and in such authorized denominations as the Representative may request in
writing at least one (1) Business Day prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the
Option Shares except upon tender of payment by the Representative for applicable Option Shares. The Option Closing Date may be
simultaneous with, but not earlier than, the Closing Date; and in the event that such time and date are simultaneous with the
Closing Date, the term &ldquo;Closing Date&rdquo; shall refer to the time and date of delivery of the Firm Shares and Option
Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representative&rsquo;s
                                            Warrants.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.1
<U>Purchase Warrants</U>. The Company hereby agrees to issue to the Representative (and/or its designees) on the Closing Date or the
Option Closing Date, as applicable, one or more warrants for the purchase of an aggregate of up to 57,500 shares of Common Stock, representing
4% of the number of Firm Shares and Option Shares sold on the Closing Date or the Option Closing Date, as applicable, in the form attached
hereto as Exhibit A (the &ldquo;<B>Representative&rsquo;s Warrants</B>&rdquo;), shall be exercisable, in whole or in part, commencing
on a date which is six (6) months after the Effective Date and expiring on the five-year anniversary of the Effective Date at an initial
exercise price per share of Common Stock of $6.00, which is equal to 120% of the initial public offering price of the Firm Shares. The
Representative&rsquo;s Warrants and the shares of Common Stock issuable upon exercise thereof are hereinafter referred to together as
the &ldquo;<B>Representative&rsquo;s Securities</B>.&rdquo; The Representative understands and agrees that there are significant restrictions
pursuant to FINRA Rule 5110 against transferring the Representative&rsquo;s Warrants and the underlying shares of Common Stock during
the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer,
assign, pledge or hypothecate the Representative&rsquo;s Warrants, or any portion thereof, or be the subject of any hedging, short sale,
derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred
eighty (180) days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering,
or (ii) a bona fide officer or partner of the Representative or of any such Underwriter or selected dealer; and only if any such transferee
agrees to the foregoing lock-up restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.2 <U>Delivery</U>.
Delivery of the Representative&rsquo;s Warrants shall be made on the Closing Date or the Option Closing Date(s), as applicable, and
shall be issued in the name or names and in such authorized denominations as the Representative may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Accountable
                                            Expenses.</B> The Company further agrees that, in addition to the expenses payable pursuant
                                            to Section 3.10 hereof, on the Closing Date it shall pay to the Representative, by deduction
                                            from the net proceeds of the Offering contemplated herein, a non-accountable expense allowance
                                            equal to one percent (1.0%) of the aggregate gross proceeds raised in the Offering; provided,
                                            however, that in the event that the Offering is terminated, the Company agrees to reimburse
                                            the Underwriters pursuant to Section 8.3 hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
                                            AND WARRANTIES OF THE COMPANY.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, SRM Limited and Parent (together, the &ldquo;<B>Company Group</B>&rdquo;) each, severally and not jointly, represent and warrant
to the Underwriters as of the Applicable Time (as defined in Section 2.1.1 below), as of the Closing Date and as of the Option Closing
Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
                                            of Registration Statement.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1
<U>Pursuant to the Securities Act</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
a registration statement, and an amendment or amendments thereto, on Form S-1 (File No. 333-272250), including any related prospectus
or prospectuses, for the registration of the Public Securities and the Representative&rsquo;s Securities under the Securities Act of
1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), which registration statement and amendment or amendments have been prepared
by the Company in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the
Commission under the Securities Act (the &ldquo;<B>Securities Act Regulations</B>&rdquo;) and contains and will contain all material
statements that are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations. Except as
the context may otherwise require, such registration statement, as amended, on file with the Commission at the time the registration
statement became effective (including the Preliminary Prospectus included in the registration statement, financial statements, schedules,
exhibits and all other documents filed as a part thereof or incorporated therein and all information deemed to be a part thereof as of
the effective date of the Registration Statement (the &ldquo;<B>Effective Date</B>&rdquo;) pursuant to paragraph (b) of Rule 430A of
the Securities Act Regulations (the &ldquo;<B>Rule 430A Information</B>&rdquo;)), is referred to herein as the &ldquo;<B>Registration
Statement</B>.&rdquo; If the Company files any registration statement pursuant to Rule 462(b) of the Securities Act Regulations, then
after such filing, the term &ldquo;<B>Registration Statement</B>&rdquo; shall include such registration statement filed pursuant to Rule
462(b). The Registration Statement has been declared effective by the Commission on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
prospectus used prior to the effectiveness of the Registration Statement, and each prospectus that omitted the Rule 430A Information
that was used after such effectiveness and prior to the execution and delivery of this Agreement, is herein called a &ldquo;<B>Preliminary
Prospectus</B>.&rdquo; The Preliminary Prospectus, subject to completion, dated August 14, 2023, that was included in the Registration
Statement immediately prior to the Applicable Time is hereinafter called the &ldquo;<B>Pricing Prospectus</B>.&rdquo; The final prospectus
in the form first furnished to the Underwriters for use in the Offering, that includes the Rule 430A Information, is hereinafter called
the &ldquo;<B>Prospectus</B>&rdquo;. Any reference to the &ldquo;most recent Preliminary Prospectus&rdquo; shall be deemed to refer to
the latest Preliminary Prospectus included in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Time</B>&rdquo; means 5:00 p.m., Eastern time, on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
Free Writing Prospectus</B>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Securities Act
Regulations (&ldquo;<B>Rule 433</B>&rdquo;), including without limitation any &ldquo;free writing prospectus&rdquo; (as defined in Rule
405 of the Securities Act Regulations) relating to the Public Securities that is (i) required to be filed with the Commission by the
Company, (ii) a &ldquo;road show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i), whether or not required
to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a
description of the Public Securities or of the Offering that does not reflect the final terms, in each case in the form filed or required
to be filed with the Commission or, if not required to be filed, in the form retained in the Company&rsquo;s records pursuant to Rule
433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
General Use Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to
prospective investors (other than a &ldquo;<I>bona fide</I> electronic road show,&rdquo; as defined in Rule 433 (the &ldquo;<B>Bona Fide
Electronic Road Show</B>&rdquo;)), as evidenced by its being specified in <U>Schedule 2-B</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
Limited Use Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing
Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Pricing
Disclosure Package</B>&rdquo; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Pricing
Prospectus and the information included on <U>Schedule 2-A</U> hereto, all considered together.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2 <U>Pursuant
to the Exchange Act</U>. The Company has filed with the Commission a Form 8-A (File Number 001-41768) providing for the registration
of the Common Stock pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;). The registration of the Common Stock under the Exchange Act has been declared effective by the Commission on or
prior to the date hereof. The Company has taken no action designed to, or likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act, nor has the Company received any notification that the Commission is contemplating
terminating such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                            Exchange Listing</B>. The shares of Common Stock have been approved for listing on The Nasdaq
                                            Stock Market LLC (the &ldquo;<B>Exchange</B>&rdquo;), subject only to official notice of
                                            issuance, and the Company has taken no action designed to, or likely to have the effect of,
                                            delisting the shares of Common Stock from the Exchange, nor has the Company received any
                                            notification that the Exchange is contemplating terminating such listing except as described
                                            in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Stop Orders, etc</B>. Neither the Commission nor, to the Company&rsquo;s knowledge, any state
                                            regulatory authority has issued any order preventing or suspending the use of the Registration
                                            Statement, any Preliminary Prospectus or the Prospectus or has instituted or, to the Company&rsquo;s
                                            knowledge, threatened to institute, any proceedings with respect to such an order. The Company
                                            has complied with each request (if any) from the Commission for additional information.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosures
                                            in Registration Statement.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1 <U>Compliance
with Securities Act and 10b-5 Representation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all
material respects with the requirements of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus,
including the prospectus filed as part of the Registration Statement as originally filed or as part of any amendment or supplement
thereto, and the Prospectus, at the time each was filed with the Commission, complied in all material respects with the requirements
of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in
connection with the Offering and the Prospectus was or will be identical to the electronically transmitted copies thereof filed with
the Commission pursuant to the Commission&rsquo;s EDGAR filing system (&ldquo;<B>EDGAR</B>&rdquo;), except to the extent permitted
by Regulation S-T promulgated under the Securities Act (&ldquo;<B>Regulation S-T</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Neither the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date
or at any Option Closing Date (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits
or will omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Pricing Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does
not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free
Writing Prospectus hereto does not conflict with the information contained in the Registration Statement, any Preliminary
Prospectus, the Pricing Prospectus or the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by
and taken together with the Pricing Prospectus as of the Applicable Time, did not include an untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were
made, not misleading; provided, however, that this representation and warranty shall not apply to statements made or statements
omitted in reliance upon and in conformity with written information furnished to the Company with respect to the Underwriters by the
Representative expressly for use in the Registration Statement, the Pricing Prospectus or the Prospectus or any amendment thereof or
supplement thereto. The parties acknowledge and agree that such information provided by or on behalf of any Underwriter consists
solely of the following disclosure contained in the &ldquo;Underwriting&rdquo; section of the Pricing Prospectus or the Prospectus:
the names of the Underwriters, the information in the table under the subheading titled &ldquo;Over-Allotment Option&rdquo;, the
information under the subheadings titled &ldquo;Price Stabilization, Short Positions and Penalty Bids,&rdquo; &ldquo;Electronic
Distribution,&rdquo; &ldquo;Other Relationships&rdquo; and &ldquo;Selling Restrictions Outside the United States&rdquo; (the
&ldquo;<B>Underwriters&rsquo; Information</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time
of any filing with the Commission pursuant to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or
will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that
this representation and warranty shall not apply to the Underwriters&rsquo; Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2
<U>Disclosure of Agreements</U>. The agreements and documents described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus conform in all material respects to the descriptions thereof contained therein and there are no agreements or other
documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been
so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by
which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, or (ii) is material to the Company&rsquo;s business, has been duly authorized and validly executed by the Company, is
in full force and effect in all material respects and constitute valid and binding agreements of the Company enforceable against the
Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with their respective terms, except (x) as such
enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally,
(y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and
(z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses
and to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments has been
assigned by the Company, and neither the Company nor, to the Company&rsquo;s knowledge, any other party is in default thereunder and,
to the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute
a default thereunder. To the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements or instruments
will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental or regulatory
agency, authority, body, entity or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses
(each, a &ldquo;<B>Governmental Entity</B>&rdquo; and collectively, &ldquo;<B>Governmental Entities</B>&rdquo;), including, without limitation,
those relating to environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3
<U>Regulations</U>. The disclosures in the Registration Statement, the Pricing Disclosure Package and the Prospectus concerning the effects
of federal, state, local and any applicable foreign laws, rules and regulations relating to the Offering and the Company&rsquo;s business
as currently conducted or contemplated are correct and complete in all material respects and no other such laws, rules or regulations
are required under the Securities Act and the Securities Act Regulations to be disclosed in the Registration Statement, the Pricing Disclosure
Package and the Prospectus which are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4
<U>No Other Distribution of Offering Materials</U>. The Company has not, directly or indirectly, distributed and will not distribute
any offering material in connection with the Offering other than any Preliminary Prospectus, any Issuer Free Writing Prospectus, the
Prospectus and other materials, if any, permitted under the Securities Act and consistent with Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5
<U>Prior Securities Transactions</U>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration
Statement, the Pricing Disclosure Package and the Preliminary Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.5</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
                                            After Dates in Registration Statement.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.1
<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse change
in the financial position or results of operations of the Company, nor any change or development that, singularly or in the aggregate,
would reasonably be expected to result in a material adverse change, in or affecting the condition (financial or otherwise), results
of operations, business, assets or prospects of the Company (a &ldquo;<B>Material Adverse Change</B>&rdquo;); (ii) there has been no
Parent Adverse Change (as defined in Section 2.18.2 below); (iii) there have been no material transactions entered into by the Company,
other than as contemplated pursuant to this Agreement; and (iv) no officer (as defined in Rule 16a-1(f) of the Exchange Act) or director
of the Company has resigned from any position with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.2 <U>Recent
Securities Transactions, etc</U>. Subsequent to the respective dates as of which information is given in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has not: (i) issued any securities or
incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any
other distribution on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.6</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reserved.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.7</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Independent
                                            Accountants</B>. M&amp;K CPAs, PLLC (the &ldquo;<B>Auditor</B>&rdquo;), whose reports are
                                            filed with the Commission as part of the Registration Statement, the Pricing Disclosure Package
                                            and the Prospectus, is an independent registered public accounting firm as required by the
                                            Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight
                                            Board. The Auditor has not, during the periods covered by the financial statements included
                                            in the Registration Statement, the Pricing Disclosure Package and the Prospectus, provided
                                            to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange
                                            Act.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.8</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                            Statements, etc</B>. The financial statements, including the notes thereto and supporting
                                            schedules included in the Registration Statement, the Pricing Disclosure Package and the
                                            Prospectus, fairly present the financial position and the results of operations of the Company
                                            at the dates and for the periods to which they apply; and such financial statements have
                                            been prepared in conformity with U.S. generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;),
                                            consistently applied throughout the periods involved (provided that unaudited interim financial
                                            statements are subject to year-end audit adjustments that are not expected to be material
                                            in the aggregate and do not contain all footnotes required by GAAP); and the supporting schedules
                                            included in the Registration Statement present fairly the information required to be stated
                                            therein. Except as included therein, no historical or pro forma financial statements are
                                            required to be included in the Registration Statement, the Pricing Disclosure Package or
                                            the Prospectus under the Securities Act or the Securities Act Regulations. The pro forma
                                            and pro forma as adjusted financial information and the related notes, if any, included in
                                            the Registration Statement, the Pricing Disclosure Package and the Prospectus have been properly
                                            compiled and prepared in accordance with the applicable requirements of the Securities Act
                                            and the Securities Act Regulations and present fairly the information shown therein, and
                                            the assumptions used in the preparation thereof are reasonable and the adjustments used therein
                                            are appropriate to give effect to the transactions and circumstances referred to therein.
                                            All disclosures contained in the Registration Statement, the Pricing Disclosure Package or
                                            the Prospectus regarding &ldquo;non-GAAP financial measures&rdquo; (as such term is defined
                                            by the rules and regulations of the Commission), if any, comply with Regulation G of the
                                            Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable.
                                            Each of the Registration Statement, the Pricing Disclosure Package and the Prospectus discloses
                                            all material off-balance sheet transactions, arrangements, obligations (including contingent
                                            obligations), and other relationships of the Company with unconsolidated entities or other
                                            persons, if any, that may have a material current or future effect on the Company&rsquo;s
                                            financial condition, changes in financial condition, results of operations, liquidity, capital
                                            expenditures, capital resources, or significant components of revenues or expenses. Except
                                            as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
                                            (a) since the date of the last balance sheet included in the Registration Statement, the
                                            Pricing Disclosure Package and the Prospectus, neither the Company nor any of its direct
                                            and indirect subsidiaries, including each entity disclosed or described in the Registration
                                            Statement, the Pricing Disclosure Package and the Prospectus as being a subsidiary of the
                                            Company (each, a &ldquo;<B>Subsidiary</B>&rdquo; and, collectively, the &ldquo;<B>Subsidiaries</B>&rdquo;)
                                            has incurred any material liabilities or obligations, direct or contingent, or entered into
                                            any material transactions other than in the ordinary course of business, (b) the Company
                                            has not declared or paid any dividends or made any distribution of any kind with respect
                                            to its capital stock, (c) there has not been any change in the capital stock of the Company
                                            or any of its Subsidiaries, or, other than in the course of business, any grants under any
                                            stock compensation plan, and (d) there has not been any material adverse change in the Company&rsquo;s
                                            long-term or short-term debt. The Company represents that it has no direct or indirect Subsidiaries
                                            other than those listed in Exhibit 21.1 to the Registration Statement.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.9</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
                                            Capital; Options, etc</B>. The Company had, at the date or dates indicated in the Registration
                                            Statement, the Pricing Disclosure Package and the Prospectus, the duly authorized, issued
                                            and outstanding capitalization as set forth therein. Based on the assumptions stated in the
                                            Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company will
                                            have on the Closing Date the adjusted capitalization set forth therein. Except as set forth
                                            in, or contemplated by, the Registration Statement, the Pricing Disclosure Package and the
                                            Prospectus, on the Effective Date, as of the Applicable Time and on the Closing Date and
                                            any Option Closing Date, there will be no stock options, warrants, or other rights to purchase
                                            or otherwise acquire any authorized, but unissued shares of Common Stock or any security
                                            convertible or exercisable into shares of Common Stock, or any contracts or commitments to
                                            issue or sell shares of Common Stock or any such options, warrants, rights or convertible
                                            securities.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.10</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Valid
                                            Issuance of Securities, etc.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.1
<U>Outstanding Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by
this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights
of rescission or the ability to force the Company to repurchase such securities with respect thereto, and are not subject to personal
liability by reason of being such holders; and none of such securities were issued in violation of the preemptive rights, rights of first
refusal or rights of participation of any holders of any security of the Company or similar contractual rights granted by the Company.
The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. The offers and sales of the outstanding shares of Common Stock, options,
warrants and other outstanding securities convertible into or exercisable for shares of Common Stock, were at all relevant times either
registered under the Securities Act and the applicable state securities or &ldquo;blue sky&rdquo; laws or, based in part on the representations
and warranties of the purchasers of such securities, exempt from such registration requirements. The description of the Company&rsquo;s
stock option, restricted stock awards and other related plans or arrangements, and options and/or other rights granted thereunder, as
described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, accurately and fairly present, in all material
respects, the information required to be shown with respect to such plans, arrangements, options and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.2
<U>Securities Sold Pursuant to this Agreement</U>. The Public Securities and the Representative&rsquo;s Securities have been duly authorized
for issuance and sale and, when issued and paid for pursuant to the terms of this Agreement, will be validly issued, fully paid and non-assessable;
the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Public Securities and
the Representative&rsquo;s Securities are and will be free from all preemptive rights of any holders of any security of the Company,
or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and
sale of the Public Securities and the Representative&rsquo;s Securities has been duly and validly taken. The Representative&rsquo;s Warrants,
when issued and paid for pursuant to this Agreement, will constitute valid and binding obligations of the Company, enforceable against
the Company in accordance with their terms, and no further action is required by the Company, the Company&rsquo;s board of directors
(&ldquo;<B>Board of Directors</B>&rdquo;) or the Company&rsquo;s stockholders in connection therewith. The Public Securities and the
Representative&rsquo;s Securities conform in all material respects to all statements with respect thereto contained in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. The shares of Common Stock issuable upon exercise of the Representative&rsquo;s
Warrants have been duly authorized and reserved for issuance by all necessary corporate action on the part of the Company and when paid
for and issued in accordance with the Representative&rsquo;s Warrants, such shares of Common Stock will be validly issued, fully paid
and nonassessable; the holders thereof are not and will not be subject to personal liability by reason of being such holders; and such
shares of Common Stock are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar
contractual rights granted by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.11</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
                                            Rights of Third Parties</B>. Except as set forth in the Registration Statement, the Pricing
                                            Disclosure Package and the Prospectus, no holders of any securities of the Company or any
                                            options, warrants, rights or other securities exercisable for or convertible or exchangeable
                                            into securities of the Company have the right to require the Company to register any such
                                            securities of the Company under the Securities Act or to include any such securities in the
                                            Registration Statement or any other registration statement to be filed by the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.12</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Validity
                                            and Binding Effect of Agreements</B>. The execution, delivery and performance of this Agreement,
                                            the Exchange Agreement and the Representative&rsquo;s Warrants have been duly and validly
                                            authorized by the Company and/or Parent, as applicable, and constitute, the valid and binding
                                            agreements of the Company and/or Parent, as applicable, in accordance with their respective
                                            terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization
                                            or similar laws affecting creditors&rsquo; rights generally; (ii) as enforceability of any
                                            indemnification or contribution provision may be limited under the federal and state securities
                                            laws; and (iii) that the remedy of specific performance and injunctive and other forms of
                                            equitable relief may be subject to the equitable defenses and to the discretion of the court
                                            before which any proceeding therefor may be brought.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.13</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Conflicts, etc</B>. The execution, delivery and performance by the Company and Parent of
                                            this Agreement, the Exchange Agreement, the Representative&rsquo;s Warrants and all ancillary
                                            documents, the consummation by the Company of the transactions herein and therein contemplated
                                            and the compliance by each member of the Company Group, as applicable with the terms hereof
                                            and thereof do not and will not, with or without the giving of notice or the lapse of time
                                            or both: (i) result in a breach of, or conflict with any of the terms and provisions of,
                                            or constitute a default under, or result in the creation, modification, termination or imposition
                                            of any lien, charge, mortgage, pledge, security interest, claim, equity, trust or other encumbrance,
                                            preferential arrangement, defect or restriction of any kind whatsoever upon any property
                                            or assets of the Company pursuant to the terms of any indenture, mortgage, deed of trust,
                                            note, lease, loan agreement or any other agreement or instrument, license or permit to which
                                            the Company is a party or as to which any property of the Company is a party; (ii) result
                                            in any violation of the provisions of the Company&rsquo;s articles of incorporation or Parent&rsquo;s
                                            second amended and restated certificate of incorporation (as each may be amended and/or restated
                                            from time to time, the &ldquo;<B>Charter</B>&rdquo;) or the amended bylaws of the Company
                                            or Parent&rsquo;s amended and restated bylaws (as each may be amended or restated from time
                                            to time, the &ldquo;<B>Bylaws</B>&rdquo;); or (iii) violate any existing applicable law,
                                            rule, regulation, judgment, order or decree of any Governmental Entity as of the date hereof
                                            having jurisdiction over the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.14</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Defaults; Violations</B>. No material default exists in the due performance and observance
                                            of any term, covenant or condition of any license, contract, indenture, mortgage, deed of
                                            trust, note, loan or credit agreement, or any other agreement or instrument evidencing an
                                            obligation for borrowed money, or any other agreement or instrument to which any member of
                                            the Company Group is a party or by which the Company may be bound or to which any of the
                                            properties or assets of the Company is subject. Each member of the Company Group is not in
                                            violation of any term or provision of its Charter or Bylaws, or in violation of any franchise,
                                            license, permit, applicable law, rule, regulation, judgment or decree of any Governmental
                                            Entity.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.15</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
                                            Power; Licenses; Consents.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.1
<U>Conduct of Business</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, each
member of the Company Group and the Subsidiaries has all requisite corporate power and authority, and has all consents, authorizations,
approvals, licenses, certificates, clearances, permits and orders and supplements and amendments thereto (each an &ldquo;<B>Authorization</B>&rdquo;,
and collectively, &ldquo;<B>Authorizations</B>&rdquo;) of and from all Governmental Entities that it needs as of the date hereof to conduct
its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.2
<U>Transactions Contemplated Herein</U>. The Company and Parent have all corporate power and authority to enter into this Agreement and
the Representative&rsquo;s Warrants, as applicable, and to carry out the provisions and conditions hereof and thereof, and all Authorizations
required in connection therewith have been obtained. No Authorization of, and no filing with, any Governmental Entity or another body
is required for the valid issuance, sale and delivery of the Public Securities and the Representative&rsquo;s Securities and the consummation
of the transactions and agreements contemplated by this Agreement, the Representative&rsquo;s Warrants and as contemplated by the Registration
Statement, the Pricing Disclosure Package and the Prospectus, except with respect to applicable Securities Act and Securities Act Regulations,
the necessary filings and approvals from the Exchange to list the shares of Common Stock, state or foreign securities laws and the rules
and regulations of the Financial Industry Regulatory Authority, Inc. (&ldquo;<B>FINRA</B>&rdquo;), such consents and approvals as having
been obtained and are in full force and effect, and such consents, approvals, orders, authorizations and filings the failure of which
to make or obtain is not reasonably likely to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.16</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D&amp;O
                                            Questionnaires</B>. All information contained in the questionnaires (the &ldquo;<B>Questionnaires</B>&rdquo;)
                                            completed by each of the Company&rsquo;s directors and officers immediately prior to the
                                            Offering (the &ldquo;<B>Insiders</B>&rdquo;) as supplemented by all information concerning
                                            the Insiders as described in the Registration Statement, the Pricing Disclosure Package and
                                            the Prospectus, as well as in the Lock-Up Agreement (as defined in Section 2.25 below), provided
                                            to the Underwriters, is true and correct in all material respects and the Company has not
                                            become aware of any information which would cause the information disclosed in the Questionnaires
                                            to become materially inaccurate and incorrect.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.17</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Litigation;
                                            Governmental Proceedings</B>. There is no action, suit, proceeding, inquiry, arbitration,
                                            investigation, litigation or governmental proceeding pending or, to the Company&rsquo;s knowledge,
                                            threatened against, or involving the Company or, to the Company&rsquo;s knowledge, any executive
                                            officer or director which has not been disclosed in the Registration Statement, the Pricing
                                            Disclosure Package and the Prospectus, or in connection with the Company&rsquo;s listing
                                            application for the listing of the shares of Common Stock on the Exchange. There is no action,
                                            suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding
                                            pending or, to any member of the Company Group&rsquo;s knowledge, threatened against, or
                                            involving any member of the Company Group or, to the Company Group&rsquo;s knowledge, any
                                            executive officer or director thereof which would reasonably be expected to result in a Material
                                            Adverse Change, which has not been disclosed in the Registration Statement, the Pricing Disclosure
                                            Package and the Prospectus or in connection with the Company&rsquo;s listing application
                                            for the listing of the shares of Common Stock on the Exchange.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.18</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Good
                                            Standing.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18.1.
The Company has been duly incorporated and is validly existing as a corporation and is in good standing under the laws of the State of
Nevada as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction in which its ownership
or lease of property or the conduct of business requires such qualification, except where the failure to qualify, singularly or in the
aggregate, would not have or reasonably be expected to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18.2.
Parent has been duly incorporated and is validly existing as a corporation and is in good standing under the laws of the State of Delaware
as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction in which its ownership
or lease of property or the conduct of business requires such qualification, except where the failure to qualify, singularly or in the
aggregate, would not have or reasonably be expected to result in a material adverse change in the financial position or results of operations
of Parent, nor any change or development that, singularly or in the aggregate, would have or reasonably be expected to result in a material
adverse change, in or affecting the condition (financial or otherwise), results of operations, business, assets or prospects of Parent
(a &ldquo;<B>Parent Adverse Change</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.19</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance</B>.
                                            Each of the Company and the Subsidiaries carries or is entitled to the benefits of insurance
                                            (including, without limitation, as to directors and officers insurance coverage), with reputable
                                            insurers, in such amounts and covering such risks which the Company and/or the respective
                                            Subsidiary believes is adequate as is customary for companies engaged in similar business,
                                            and to the Company&rsquo;s knowledge, all such insurance is in full force and effect. Each
                                            of the Company and the Subsidiaries has no reason to believe that it will not be able (i)
                                            to renew its existing insurance coverage as and when such policies expire or (ii) to obtain
                                            comparable coverage from similar institutions as may be necessary or appropriate to conduct
                                            its business as now conducted and at a cost that would not reasonably be expected to result
                                            in a Material Adverse Change.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.20</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transactions
                                            Affecting Disclosure to FINRA.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.1
<U>Finder&rsquo;s Fees</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there
are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder&rsquo;s, consulting or origination
fee by any member of the Company Group or any Insider with respect to the sale of the Public Securities hereunder or any other arrangements,
agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders that may affect the Underwriters&rsquo;
compensation, as determined by FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.2
<U>Payments Within Twelve (12) Months</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s
fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons
who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation
or association with any FINRA member, within the twelve (12) months prior to the Effective Date, other than the payment to the Underwriters
as provided hereunder in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.3
<U>Use of Proceeds</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its
affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.4
<U>FINRA Affiliation</U>. There is no (i) officer or director of the Company, (ii) beneficial owner of ten percent (10%) or more of any
class of the Company&rsquo;s securities or (iii) beneficial owner of the Company&rsquo;s unregistered equity securities which were acquired
during the 180-day period immediately preceding the filing of the Registration Statement that is an affiliate or associated person of
a FINRA member participating in the Offering (as determined in accordance with the rules and regulations of FINRA). Except as disclosed
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company (i) does not have any material lending
or other relationship with any bank or lending affiliate of any Underwriter and (ii) does not intend to use any of the proceeds from
the sale of the Public Securities to repay any outstanding debt owed to any affiliate of any Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.5
<U>Information</U>. All information provided by the Company in its FINRA questionnaire and, to the Company&rsquo;s knowledge, all the
information provided by the Insiders in their FINRA questionnaires to Representative Counsel specifically for use by Representative Counsel
in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all material
respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.21</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
                                            Corrupt Practices Act</B>. Each member of the Company Group and their Subsidiaries has taken
                                            reasonable steps to ensure that its accounting controls and procedures are sufficient to
                                            cause the Company to comply in all material respects with the Foreign Corrupt Practices Act
                                            of 1977, as amended, and the rules and regulations thereunder (collectively, the &ldquo;<B>FCPA</B>&rdquo;).
                                            None of the Company, any member of the Company Group and its Subsidiaries or, to the knowledge
                                            of each member of the Company Group and Subsidiary, any director, officer, agent, employee
                                            or affiliate of a member of the Company Group and its Subsidiaries or any other person acting
                                            on behalf of, and with authority from, a member of the Company Group and its Subsidiaries,
                                            has, directly or indirectly, given or agreed to give any unlawful money, gift or similar
                                            benefit (other than legal price concessions to customers in the ordinary course of business)
                                            to any customer, supplier, employee or agent of a customer or supplier, or official or employee
                                            of any Governmental Entity (domestic or foreign) or any political party or candidate for
                                            office (domestic or foreign) or other person who was, is, or may be in a position to help
                                            or hinder the business of a member of the Company Group or a Subsidiary (or assist it in
                                            connection with any actual or proposed transaction) that could reasonably be expected to
                                            (i) subject any member of the Company Group or any Subsidiary to any damage or penalty in
                                            any civil, criminal or governmental litigation or proceeding, (ii) if not given in the past,
                                            have had a Material Adverse Change or Parent Material Adverse Change or (iii) if not continued
                                            in the future, adversely affect the assets, business, operations or prospects of any member
                                            of the Company Group, (iv) violated or is in violation of any provision of the FCPA or any
                                            applicable non-U.S. anti-bribery statute or regulation, (v) made any bribe, rebate, payoff,
                                            influence payment, kickback or other unlawful payment, or (vi) received notice of any investigation,
                                            proceeding or inquiry by any Governmental Entity regarding any of the matters in clauses
                                            (i)-(v) above; and any member of the Company Group and, to the knowledge of any member of
                                            the Company Group, the Company Group&rsquo;s affiliates have conducted their respective businesses
                                            in compliance with the FCPA and have instituted and maintain policies and procedures designed
                                            to ensure, and which are reasonably expected to continue to ensure, continued compliance
                                            therewith.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.22</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance
                                            with OFAC</B>. None of the members of the Company Group and its Subsidiaries or, to the members
                                            of the Company Group&rsquo;s knowledge, any director, officer, agent, employee or affiliate
                                            of any member of the Company Group and its Subsidiaries or any other person acting on behalf
                                            of, and with authority from, a member of the Company Group and its Subsidiaries, is currently
                                            subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the
                                            U.S. Department of the Treasury (&ldquo;<B>OFAC</B>&rdquo;), and any member of the Company
                                            Group will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend,
                                            contribute or otherwise make available such proceeds to any subsidiary, joint venture partner
                                            or other person or entity, for the purpose of financing the activities of any person currently
                                            subject to any U.S. sanctions administered by OFAC.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.23</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Money
                                            Laundering Laws</B>. The operations of any member of the Company Group and its Subsidiaries
                                            are and have been conducted at all times in compliance with applicable financial recordkeeping
                                            and reporting requirements, including those of the Currency and Foreign Transactions Reporting
                                            Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where
                                            the Company or any of its Subsidiaries conducts business, the rules and regulations thereunder
                                            and any related or similar rules, regulations or guidelines issued, administered or enforced
                                            by any Governmental Entity (collectively, the &ldquo;<B>Anti-Money Laundering Laws</B>&rdquo;);
                                            and no action, suit or proceeding by or before any Governmental Entity involving any member
                                            of the Company Group with respect to the Anti-Money Laundering Laws is pending or, to the
                                            knowledge of the members of the Company Group, threatened.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.24</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Officers&rsquo;
                                            Certificate</B>. Any certificate signed by any duly authorized officer of the Company and
                                            Parent and delivered to the Representative or to Representative Counsel on the Closing Date
                                            or on the Option Closing Date shall be deemed a representation and warranty by the Company
                                            or Parent, as applicable, to the Underwriters as to the matters covered thereby.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.25</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
                                            Agreements</B>. Schedule 3 hereto contains a complete and accurate list of the Company&rsquo;s
                                            and Parent&rsquo;s officers (as defined in Rule 16a-1(f) of the Exchange Act), directors
                                            and all owners of record of the Company&rsquo;s outstanding shares of Common Stock (or securities
                                            convertible or exercisable into shares of Common Stock) who will be subject to the Lock-Up
                                            Agreement (as defined below) (collectively, the &ldquo;<B>Lock-Up Parties</B>&rdquo;). The
                                            Company has caused each of the Lock-Up Parties to deliver to the Representative an executed
                                            Lock-Up Agreement, in the form attached hereto as Exhibit B (the &ldquo;<B>Lock-Up Agreement</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.26</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiaries</B>.
                                            All direct and indirect Subsidiaries of the Company are duly organized and in good standing
                                            under the laws of the place of organization or incorporation, and each Subsidiary is in good
                                            standing in each jurisdiction in which its ownership or lease of property or the conduct
                                            of business requires such qualification, except where the failure to qualify would not have
                                            a Material Adverse Change on the Company taken as a whole. The Company&rsquo;s ownership
                                            and control of each Subsidiary is as described in the Registration Statement, the Pricing
                                            Disclosure Package and the Prospectus.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.27</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
                                            Party Transactions.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27.1
<U>Business Relationships</U>. There are no business relationships or related party transactions involving the Company (within the scope
of Item 404 of Regulation S-K) or any other person required to be described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus that have not been described as required under the Securities Act and the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27.2
<U>No Unconsolidated Entities</U>. There are no transactions, arrangements or other relationships between and/or among the Company, any
of its affiliates (as such term is defined in Rule 405 of the Securities Act) and any unconsolidated entity, including, but not limited
to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company&rsquo;s
liquidity or the availability of or requirements for its capital resources required to be described in the Registration Statement, the
Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27.3 <U>No
Loans or Advances to Affiliates</U>. There are no outstanding loans, advances (except normal advances for business expenses in the
ordinary course of business) or guarantees or indebtedness by the Company to or for the benefit of (i) any of the officers or
directors of the Company, (ii) any other affiliates of the Company or (iii) any of their respective family members, except as
disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, which are, in the case of clauses (ii)
and (iii), required to be disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.28</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
                                            of Directors</B>. The Board of Directors is comprised of the persons set forth under the
                                            heading of the Pricing Prospectus and the Prospectus captioned &ldquo;Management.&rdquo;
                                            The qualifications of the persons serving as board members and the overall composition of
                                            the board comply with the Exchange Act, the rules and regulations of the Commission promulgated
                                            thereunder (the &ldquo;<B>Exchange Act Regulations</B>&rdquo;), the Sarbanes- Oxley Act of
                                            2002 and the rules promulgated thereunder (the &ldquo;<B>Sarbanes-Oxley Act</B>&rdquo;) applicable
                                            to the Company and the listing rules of the Exchange. At least one member of the Audit Committee
                                            of the Board of Directors qualifies as an &ldquo;audit committee financial expert,&rdquo;
                                            as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition,
                                            at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent,&rdquo;
                                            as defined under the listing rules of the Exchange.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.29</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sarbanes-Oxley
                                            Compliance.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.1
<U>Disclosure Controls</U>. The Company has designed and currently maintains a system of &ldquo;disclosure controls and procedures&rdquo;
(as defined in Rule 13a-15(e) under the Exchange Act Regulations) that will comply with the requirements of the Exchange Act within the
time period required and has been designed to ensure that information required to be disclosed by the Company in reports that it files
or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&rsquo;s
rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&rsquo;s
management as appropriate to allow timely decisions regarding required disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.2
<U>Compliance</U>. The Company is and at the Applicable Time and on the Closing Date will be, in material compliance with the provisions
of the Sarbanes-Oxley Act that are then in effect and with which the Company is required to comply with as of the Applicable Time or
on the Closing Date, and has taken reasonable steps to ensure the Company&rsquo;s future compliance (not later than the relevant statutory
and regulatory deadlines therefor) with all of the material provisions of the Sarbanes-Oxley Act then applicable to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.30</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting
                                            Controls</B>. The Company maintains systems of &ldquo;internal control over financial reporting&rdquo;
                                            (as defined under Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that comply
                                            with the requirements of the Exchange Act and have been designed by, or under the supervision
                                            of, its principal executive and principal financial officers, or persons performing similar
                                            functions, to provide reasonable assurance regarding the reliability of financial reporting
                                            and the preparation of financial statements for external purposes in accordance with GAAP,
                                            including, but not limited to, internal accounting controls sufficient to provide reasonable
                                            assurance that (i) transactions are executed in accordance with management&rsquo;s general
                                            or specific authorizations; (ii) transactions are recorded as necessary to permit preparation
                                            of financial statements in conformity with GAAP and to maintain asset accountability; (iii)
                                            access to assets is permitted only in accordance with management&rsquo;s general or specific
                                            authorization; and (iv) the recorded accountability for assets is compared with the existing
                                            assets at reasonable intervals and appropriate action is taken with respect to any differences.
                                            Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the
                                            Prospectus, the Company is not aware of any material weaknesses in its internal controls.
                                            The Auditor and the Audit Committee of the Board of Directors have been advised of: (i) all
                                            significant deficiencies and material weaknesses in the design or operation of internal controls
                                            over financial reporting which are known to the Company&rsquo;s management and that have
                                            adversely affected or are reasonably likely to adversely affect the Company&rsquo;s ability
                                            to record, process, summarize and report financial information; and (ii) any fraud known
                                            to the Company&rsquo;s management, whether or not material, that involves management or other
                                            employees who have a significant role in the Company&rsquo;s internal controls over financial
                                            reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.31</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Investment Company Status</B>. The Company is not and, after giving effect to the Offering
                                            and the application of the proceeds thereof as described in the Registration Statement, the
                                            Pricing Disclosure Package and the Prospectus, will not be, required to register as an &ldquo;investment
                                            company,&rdquo; as defined in the Investment Company Act of 1940, as amended.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.32</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Labor Disputes</B>. No labor dispute with the employees of the Company or any of its Subsidiaries
                                            exists or, to the knowledge of the Company, is imminent. The Company is not aware that any
                                            officer, key employee or significant group of employees of the Company or any Subsidiary
                                            plans to terminate employment with the Company or any Subsidiary, as applicable.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.33</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
                                            Property Rights</B>. The Company and each of its Subsidiaries owns or possesses or has valid
                                            rights to use all patents, patent applications, trademarks, service marks, trade names, trademark
                                            registrations, service mark registrations, copyrights, licenses, inventions, trade secrets
                                            and similar rights (&ldquo;<B>Intellectual Property Rights</B>&rdquo;) necessary for the
                                            conduct of the business of the Company and its Subsidiaries as currently carried on and as
                                            described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
                                            To the knowledge of the Company, no action or use by the Company or any of its Subsidiaries
                                            necessary for the conduct of its business as currently carried on and as described in the
                                            Registration Statement and the Prospectus will or would reasonably be expected to involve
                                            or give rise to any infringement of, or license or similar fees for, any Intellectual Property
                                            Rights of others. Neither the Company nor any of its Subsidiaries has received any notice
                                            alleging any such infringement, fee or conflict with asserted Intellectual Property Rights
                                            of others. Except as would not reasonably be expected to result, individually or in the aggregate,
                                            in a Material Adverse Change: (A) to the knowledge of the Company, there is no infringement,
                                            misappropriation or violation by third parties of any of the Intellectual Property Rights
                                            owned by the Company; (B) there is no pending or, to the knowledge of the Company, threatened
                                            action, suit, proceeding or claim by others challenging the rights of the Company in or to
                                            any such Intellectual Property Rights, and the Company is unaware of any facts which would
                                            form a reasonable basis for any such claim; (C) the Intellectual Property Rights owned by
                                            the Company and, to the knowledge of the Company, the Intellectual Property Rights licensed
                                            to the Company have not been adjudged by a court of competent jurisdiction invalid or unenforceable,
                                            in whole or in part, and there is no pending or, to the Company&rsquo;s knowledge, threatened
                                            action, suit, proceeding or claim by others challenging the validity or scope of any such
                                            Intellectual Property Rights, and the Company is unaware of any facts which would form a
                                            reasonable basis for any such claim; (D) there is no pending or, to the Company&rsquo;s knowledge,
                                            threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates
                                            or otherwise violates any Intellectual Property Rights or other proprietary rights of others,
                                            the Company has not received any written notice of such claim and the Company is unaware
                                            of any other facts which would form a reasonable basis for any such claim; and (E) to the
                                            Company&rsquo;s knowledge, no employee of the Company is in or has ever been in violation
                                            in any material respect of any term of any employment contract, patent disclosure agreement,
                                            invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure
                                            agreement or any restrictive covenant to or with a former employer where the basis of such
                                            violation relates to such employee&rsquo;s employment with the Company, or actions undertaken
                                            by the employee while employed with the Company. To the Company&rsquo;s knowledge, all material
                                            technical information developed by and belonging to the Company which has not been patented
                                            or disclosed in a patent application has been kept confidential. The Company is not a party
                                            to or bound by any options, licenses or agreements with respect to the Intellectual Property
                                            Rights of any other person or entity that are required to be set forth in the Registration
                                            Statement, the Pricing Disclosure Package and the Prospectus and are not described therein.
                                            The Registration Statement, the Pricing Disclosure Package and the Prospectus contain in
                                            all material respects the same description of the matters set forth in the preceding sentence.
                                            None of the technology employed by the Company has been obtained or is being used by the
                                            Company in violation of any contractual obligation binding on the Company or, to the Company&rsquo;s
                                            knowledge, any of its officers, directors or employees, or otherwise in violation of the
                                            rights of any persons.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.34</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes</B>.
                                            Each of the Company and its Subsidiaries has filed all returns (as hereinafter defined) required
                                            to be filed with taxing authorities prior to the date hereof or has duly obtained extensions
                                            of time for the filing thereof. Each of the Company and its Subsidiaries has paid all taxes
                                            (as hereinafter defined) shown as due on such returns that were filed and has paid all taxes
                                            imposed on or assessed against the Company or such respective Subsidiary, except those that
                                            are being contested in good faith or as would not have, individually or in the aggregate,
                                            result in a Material Adverse Change. The provisions for taxes payable, if any, shown on the
                                            financial statements filed with or as part of the Registration Statement are sufficient for
                                            all accrued and unpaid taxes, whether or not disputed, and for all periods to and including
                                            the dates of such consolidated financial statements. Except as disclosed in writing to the
                                            Underwriters, (i) no issues have been raised (and are currently pending) by any taxing authority
                                            in connection with any of the returns or taxes asserted as due from the Company or its Subsidiaries,
                                            and (ii) no waivers of statutes of limitation with respect to the returns or collection of
                                            taxes have been given by or requested from the Company or its Subsidiaries. To the Company&rsquo;s
                                            knowledge, there are no tax liens against the assets, properties or business of the Company.
                                            The term &ldquo;<B>taxes</B>&rdquo; means all federal, state, local, foreign and other net
                                            income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits,
                                            license, lease, service, service use, withholding, payroll, employment, excise, severance,
                                            stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees,
                                            assessments or charges of any kind whatever, together with any interest and any penalties,
                                            additions to tax or additional amounts with respect thereto. The term &ldquo;<B>returns</B>&rdquo;
                                            means all returns, declarations, reports, statements and other documents required to be filed
                                            in respect to taxes.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.35</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ERISA
                                            Compliance</B>. The Company and any &ldquo;employee benefit plan&rdquo; (as defined under
                                            the Employee Retirement Income Security Act of 1974, as amended, and the regulations and
                                            published interpretations thereunder (collectively, &ldquo;<B>ERISA</B>&rdquo;)) established
                                            or maintained by the Company or its &ldquo;ERISA Affiliates&rdquo; (as defined below) are
                                            in compliance in all material respects with ERISA. &ldquo;<B>ERISA Affiliate</B>&rdquo; means,
                                            with respect to the Company, any member of any group of organizations described in Sections
                                            414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations
                                            and published interpretations thereunder (the &ldquo;<B>Code</B>&rdquo;) of which the Company
                                            is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or is
                                            reasonably expected to occur with respect to any &ldquo;employee benefit plan&rdquo; established
                                            or maintained by the Company or any of its ERISA Affiliates. No &ldquo;employee benefit plan&rdquo;
                                            established or maintained by the Company or any of its ERISA Affiliates, if such &ldquo;employee
                                            benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo;
                                            (as defined under ERISA). Neither the Company nor any of its ERISA Affiliates has incurred
                                            or reasonably expects to incur any material liability under (i) Title IV of ERISA with respect
                                            to termination of, or withdrawal from, any &ldquo;employee benefit plan&rdquo; or (ii) Sections
                                            412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established
                                            or maintained by the Company or any of its ERISA Affiliates that is intended to be qualified
                                            under Section 401(a) of the Code is so qualified and, to the knowledge of the Company, nothing
                                            has occurred, whether by action or failure to act, which would or reasonably be expected
                                            to cause the loss of such qualification.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.36</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compliance
                                            with Laws</B>. Each of the Company and its Subsidiaries: (A) is and at all times has been
                                            in compliance with all statutes, rules, or regulations applicable to the business of the
                                            Company as currently conducted (&ldquo;<B>Applicable Laws</B>&rdquo;), except as could not,
                                            individually or in the aggregate, reasonably be expected to have a Material Adverse Change;
                                            (B) has not received any warning letter, untitled letter or other correspondence or written
                                            notice from any Governmental Entity alleging or asserting noncompliance with any Applicable
                                            Laws or any Authorizations; (C) possesses all Authorizations and such Authorizations are
                                            valid and in full force and effect and are not in violation of any term of any such Authorizations;
                                            (D) has not received written notice of any claim, action, suit, proceeding, hearing, enforcement,
                                            investigation, arbitration or other action from any Governmental Entity or third party alleging
                                            that any activity conducted by the Company is in violation of any Applicable Laws or Authorizations
                                            and has no knowledge that any such Governmental Entity or third party is considering any
                                            such claim, litigation, arbitration, action, suit, investigation or proceeding, nor, to the
                                            Company&rsquo;s knowledge, has there been any material noncompliance with or violation of
                                            any Applicable Laws by the Company that could reasonably be expected to require the issuance
                                            of any such communication or result in an investigation, corrective action, or enforcement
                                            action by any Governmental Entity; (E) has not received written notice that any Governmental
                                            Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke
                                            any Authorizations and has no knowledge that any such Governmental Entity is considering
                                            such action; and (F) has filed, obtained, maintained or submitted all reports, documents,
                                            forms, notices, applications, records, claims, submissions and supplements or amendments
                                            as required by any Applicable Laws or Authorizations and that all such reports, documents,
                                            forms, notices, applications, records, claims, submissions and supplements or amendments
                                            were complete and correct on the date filed (or were corrected or supplemented by a subsequent
                                            submission), except where the failure to be so in compliance would not, individually or in
                                            the aggregate, result in or reasonably be expected to have a Material Adverse Change.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.37</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Emerging
                                            Growth Company</B>. From the time of the initial confidential submission of the Registration
                                            Statement to the Commission (or, if earlier, the first date on which the Company engaged
                                            directly in or through any Person authorized to act on its behalf in any Testing-the Waters
                                            Communication) through the date hereof, the Company has been and is an &ldquo;emerging growth
                                            company,&rdquo; as defined in Section 2(a) of the Securities Act. &ldquo;Testing-the-Waters
                                            Communication&rdquo; means any oral or written communication with potential investors undertaken
                                            in reliance on Section 5(d) of the Securities Act.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.38</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Environmental
                                            Laws</B>. Each of the Company and its Subsidiaries is in compliance with all foreign, federal,
                                            state and local rules, laws and regulations relating to the use, treatment, storage and disposal
                                            of hazardous or toxic substances or waste and protection of health and safety or the environment
                                            which are applicable to their businesses (&ldquo;<B>Environmental Laws</B>&rdquo;), except
                                            where the failure to comply would not, singularly or in the aggregate, result in a Material
                                            Adverse Change. There has been no storage, generation, transportation, handling, treatment,
                                            disposal, discharge, emission, or other release of any kind of toxic or other wastes or other
                                            hazardous substances by, due to, or caused by the Company or any of its Subsidiaries (or,
                                            to the knowledge of the members of the Company Group, any other entity for whose acts or
                                            omissions the Company or any of its Subsidiaries is or may otherwise be liable) upon any
                                            of the property now or previously owned or leased by the Company or any of its Subsidiaries,
                                            or upon any other property, in violation of any law, statute, ordinance, rule, regulation,
                                            order, judgment, decree or permit or which would, under any law, statute, ordinance, rule
                                            (including rule of common law), regulation, order, judgment, decree or permit, give rise
                                            to any liability, except for any violation or liability which would not have, singularly
                                            or in the aggregate with all such violations and liabilities, a Material Adverse Change;
                                            and there has been no disposal, discharge, emission or other release of any kind onto such
                                            property or into the environment surrounding such property of any toxic or other wastes or
                                            other hazardous substances with respect to which any member of the Company Group has knowledge,
                                            except for any such disposal, discharge, emission, or other release of any kind which would
                                            not have, singularly or in the aggregate with all such discharges and other releases, a Material
                                            Adverse Change. In the ordinary course of business, Parent, the Company and each of the Subsidiaries
                                            conduct periodic reviews of the effect of Environmental Laws on their respective business
                                            and assets, in the course of which they identify and evaluate associated costs and liabilities
                                            (including, without limitation, any capital or operating expenditures required for clean-up,
                                            closure of properties or compliance with Environmental Laws or governmental permits issued
                                            thereunder, any related constraints on operating activities and any potential liabilities
                                            to third parties). On the basis of such reviews, Parent, the Company and each of the Subsidiaries
                                            have reasonably concluded that such associated costs and liabilities would not have, singularly
                                            or in the aggregate, a Material Adverse Change.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.39</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
                                            to Property</B>. Except as set forth in the Registration Statement, the Pricing Disclosure
                                            Package and the Prospectus, the Company and its Subsidiaries have good and marketable title
                                            in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal
                                            property which are material to the business of the Company and each of its Subsidiaries taken
                                            as a whole, in each case free and clear of all liens, encumbrances, security interests, claims
                                            and defects that do not, singly or in the aggregate, materially affect the value of such
                                            property and do not interfere with the use made and proposed to be made of such property
                                            by the Company or any of its Subsidiaries; and all of the leases and subleases material to
                                            the business of the Company and its Subsidiaries, considered as one enterprise, and under
                                            which the Company or any of its Subsidiaries holds properties described in the Registration
                                            Statement, the Pricing Disclosure Package and the Prospectus, are in full force and effect,
                                            and neither the Company nor any of its Subsidiaries has received any notice of any material
                                            claim of any sort that has been asserted by anyone adverse to the rights of the Company or
                                            any Subsidiary under any of the leases or subleases mentioned above, or affecting or questioning
                                            the rights of the Company any such Subsidiary to the continued possession of the leased or
                                            subleased premises under any such lease or sublease.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.40</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contracts
                                            Affecting Capital</B>. There are no transactions, arrangements or other relationships between
                                            and/or among the Company, any of its affiliates (as such term is defined in Rule 405 of the
                                            Securities Act Regulations) and any unconsolidated entity, including, but not limited to,
                                            any structured finance, special purpose or limited purpose entity that could reasonably be
                                            expected to materially affect the Company&rsquo;s liquidity or the availability of or requirements
                                            for its capital resources required to be described or incorporated by reference in the Registration
                                            Statement, the Pricing Disclosure Package and the Prospectus which have not been described
                                            or incorporated by reference as required.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.41</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loans
                                            to Directors or Officers</B>. There are no outstanding loans, advances (except normal advances
                                            for business expenses in the ordinary course of business) or guarantees or indebtedness by
                                            the Company or its Subsidiaries to or for the benefit of any of the officers or directors
                                            of the Company, its Subsidiaries or any of their respective family members, except as disclosed
                                            in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.42</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ineligible
                                            Issuer</B>. At the time of filing the Registration Statement and any post-effective amendment
                                            thereto, at the Effective Date and at the time of any amendment thereto, at the earliest
                                            time thereafter that the Company or another offering participant made a bona fide offer (within
                                            the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public Securities
                                            and at the Effective Date, the Company was not and is not an &ldquo;ineligible issuer,&rdquo;
                                            as defined in Rule 405, without taking account of any determination by the Commission pursuant
                                            to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.43</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Smaller
                                            Reporting Company</B>. As of the time of filing of the Registration Statement, the Company
                                            was a &ldquo;smaller reporting company,&rdquo; as defined in Rule 12b-2 of the Exchange Act
                                            Regulations.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.44</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Industry
                                            Data</B>. The statistical and market-related data included in each of the Registration Statement,
                                            the Pricing Disclosure Package and the Prospectus are based on or derived from sources that
                                            the Company reasonably and in good faith believes are reliable and accurate or represent
                                            the Company&rsquo;s good faith estimates that are made on the basis of data derived from
                                            such sources.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.45</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
                                            Road Show</B>. The Company has made available a Bona Fide Electronic Road Show in compliance
                                            with Rule 433(d)(8)(ii) of the Securities Act Regulations such that no filing of any &ldquo;road
                                            show&rdquo; (as defined in Rule 433(h) of the Securities Act Regulations) is required in
                                            connection with the Offering.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.46</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Margin
                                            Securities</B>. The Company owns no &ldquo;margin securities&rdquo; as that term is defined
                                            in Regulation U of the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal
                                            Reserve Board</B>&rdquo;), and none of the proceeds of Offering will be used, directly or
                                            indirectly, for the purpose of purchasing or carrying any margin security, for the purpose
                                            of reducing or retiring any indebtedness which was originally incurred to purchase or carry
                                            any margin security or for any other purpose which might cause any of the Public Securities
                                            to be considered a &ldquo;purpose credit&rdquo; within the meanings of Regulation T, U or
                                            X of the Federal Reserve Board.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.47</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
                                            Statements</B>. No forward-looking statement (within the meaning of Section 27A of the Securities
                                            Act and Section 21E of the Exchange Act) contained in the Registration Statement, the Pricing
                                            Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis
                                            or has been disclosed other than in good faith.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.48</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Integration</B>.
                                            Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf
                                            has, directly or indirectly, made any offers or sales of any security or solicited any offers
                                            to buy any security, under circumstances that would cause the Offering to be integrated with
                                            prior offerings by the Company for purposes of the Securities Act that would require the
                                            registration of any such securities issued in such prior offerings under the Securities Act.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.49</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidentiality
                                            and Non-Competition</B>. No director, officer, key employee or consultant of the Company
                                            is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation
                                            agreement with any employer (other than the Company) or prior employer that could materially
                                            affect his or her ability to be and act in his or her respective capacity of the Company
                                            or be reasonable expected to result in a Material Adverse Change.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.50</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
                                            Records</B>. The minute books of Parent, the Company and each of the Subsidiaries have been
                                            made available to the Representative and Representative Counsel and such books (i) contain
                                            minutes of all material meetings and actions of the board of directors (including each board
                                            committee) and stockholders of Parent, the Company and each of the Subsidiaries, and (ii)
                                            reflect all material transactions referred to in such minutes.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.51</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Diligence
                                            Materials</B>. Parent, the Company and each of the Subsidiaries have provided to the Representative
                                            and Representative Counsel all materials required or necessary to respond in all material
                                            respects to the diligence request submitted to the Company or Company Counsel by the Representative.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.52</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stabilization</B>.
                                            Neither the Company nor, to its knowledge, any of its employees, directors or stockholders
                                            (without the consent of the Representative) has taken, directly or indirectly, any action
                                            designed to or that has constituted or that might reasonably be expected to cause or result
                                            in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of
                                            the price of any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.53</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Testing-the-Waters
                                            Communications</B>. The Company has filed publicly on EDGAR, at least fifteen (15) calendar
                                            days prior to any &ldquo;road show&rdquo; (as defined in Rule 433 under the Securities Act),
                                            any confidentially submitted registration statement and registration statement amendments
                                            relating to the offer and sale of the Securities. The Company has not (i) alone engaged in
                                            any Testing-the-Waters Communications, other than Testing-the-Waters Communications with
                                            the written consent of the Representative and with entities that are qualified institutional
                                            buyers within the meaning of Rule 144A under the Securities Act or institutions that are
                                            accredited investors within the meaning of Rule 501 under the Securities Act and (ii) authorized
                                            anyone other than the Representative to engage in Testing-the-Waters Communications. The
                                            Company confirms that the Representative has been authorized to act on its behalf in undertaking
                                            Testing-the-Waters Communications. The Company has not distributed any Written Testing-the-Waters
                                            Communications other than those listed on Schedule 2-C hereto. Each Written Testing-the-Waters
                                            Communications did not, as of the Effective Date, and at all times through the completion
                                            of the public offer and sale of the Public Securities will not, include any information that
                                            conflicted, conflicts or will conflict with the information contained in the Registration
                                            Statement, the Pricing Disclosure Package or the Prospectus. Each Written Testing-the-Waters
                                            Communication did not, as of the Effective Date, when taken together with the General Disclosure
                                            Package, contain an untrue statement of a material fact or omit to state a material fact
                                            necessary in order to make the statements therein, in the light of the circumstances under
                                            which they were made, not misleading , and at all times through the completion of the offer
                                            and sale of the Public Securities will not, include any information that conflicted, conflicts
                                            or will conflict with the information contained in the Registration Statement, the Pricing
                                            Disclosure Package and the Prospectus. &ldquo;<B>Written Testing-the-Waters Communication</B>&rdquo;
                                            means any Testing-the-Waters Communication that is a written communication within the meaning
                                            of Rule 405 under the Securities Act.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.54</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sanctions</B>.
                                            None of the Company, any of its Subsidiaries, their directors or officers or, to the knowledge
                                            of the Company, any agent, employee, affiliate or other person acting on behalf of the Company
                                            or any of its Subsidiaries has engaged in any activities sanctionable under the Comprehensive
                                            Iran Sanctions, Accountability, and Divestment Act of 2010, the Iran Sanctions Act of 1996,
                                            the National Defense Authorization Act for Fiscal Year 2012, the Iran Threat Reduction and
                                            Syria Human Rights Act of 2012 or any Executive Order relating to any of the foregoing (collectively,
                                            and as each may be amended from time to time, the &ldquo;<B>Iran Sanctions</B>&rdquo;); and
                                            the Company will not directly or indirectly use the proceeds of the Offering, or lend, contribute
                                            or otherwise make available such proceeds to any subsidiary, joint venture partner or other
                                            person or entity, for the purpose of engaging in any activities sanctionable under the Iran
                                            Sanctions.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.55</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IT
                                            Systems</B>. Except as would not, individually or in the aggregate, result in a Material
                                            Adverse Change, the Company reasonably believes that (i) each of the Company and the Subsidiaries
                                            owns or has a valid right to access and use all computer systems, networks, hardware, software,
                                            databases, websites, and equipment used to process, store, maintain and operate data, information,
                                            and functions used in connection with the business of the Company and the Subsidiaries (the
                                            &ldquo;<B>Company IT Systems</B>&rdquo;), (ii) the Company IT Systems are adequate for, and
                                            operate and perform as required in connection with, the operation of the business of the
                                            Company as currently conducted and (iii) each of the Company and the Subsidiaries has implemented
                                            reasonable backup, security and disaster recovery technology consistent with applicable regulatory
                                            standards.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.56</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cybersecurity</B>.
                                            There has been no security breach or other compromise of or relating to any of the Company&rsquo;s
                                            or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware,
                                            software, data (including the data of its respective customers, employees, suppliers, vendors
                                            and any third party data maintained by or on behalf of it), equipment or technology (collectively,
                                            &ldquo;<B>IT Systems and Data</B>&rdquo;), except as would not, individually or in the aggregate,
                                            result in a Material Adverse Change, and (y) the Company and the Subsidiaries have not been
                                            notified of, and has no knowledge of any event or condition that would reasonably be expected
                                            to result in, any security breach or other compromise to its IT Systems and Data; (ii) the
                                            Company and the Subsidiaries are presently in compliance with all applicable laws or statutes
                                            and all judgments, orders, rules and regulations of any court or arbitrator or governmental
                                            or regulatory authority, internal policies and contractual obligations relating to the privacy
                                            and security of IT Systems and Data and to the protection of such IT Systems and Data from
                                            unauthorized use, access, misappropriation or modification, except as would not, individually
                                            or in the aggregate, result in a Material Adverse Change; (iii) the Company and the Subsidiaries
                                            have implemented and maintained commercially reasonable safeguards to maintain and protect
                                            its material confidential information and the integrity, continuous operation, redundancy
                                            and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented
                                            backup and disaster recovery technology consistent with industry standards and practices.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.57</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>U.S.
                                            Real Property Holding Corporation</B>. The Company is not and has never been a U.S. real
                                            property holding corporation within the meaning of Section 897 of the Internal Revenue Code
                                            of 1986, as amended, and the Company shall so certify upon the Representative&rsquo;s request.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.58</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bank
                                            Holding Company Act</B>. Neither the Company nor any of its Subsidiaries or affiliates is
                                            subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;)
                                            and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal
                                            Reserve</B>&rdquo;). Neither the Company nor any of its Subsidiaries or affiliates owns or
                                            controls, directly or indirectly, five percent (5%) or more of the outstanding shares of
                                            any class of voting securities or twenty-five percent (25%) or more of the total equity of
                                            a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.
                                            Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence
                                            over the management or policies of a bank or any entity that is subject to the BHCA and to
                                            regulation by the Federal Reserve.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.59</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Solvency</B>.
                                            Based on the consolidated financial condition of the Company as of the Closing Date, after
                                            giving effect to the receipt by the Company of the proceeds from the sale of the Securities
                                            hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that
                                            will be required to be paid on or in respect of the Company&rsquo;s existing debts and other
                                            liabilities (including known contingent liabilities) as they mature, (ii) the Company&rsquo;s
                                            assets do not constitute unreasonably small capital to carry on its business as now conducted
                                            and as proposed to be conducted including its capital needs taking into account the particular
                                            capital requirements of the business conducted by the Company, consolidated and projected
                                            capital requirements and capital availability thereof, and (iii) the current cash flow of
                                            the Company, together with the proceeds the Company would receive, were it to liquidate all
                                            of its assets, after taking into account all anticipated uses of the cash, would be sufficient
                                            to pay all amounts on or in respect of its liabilities when such amounts are required to
                                            be paid. The Company does not intend to incur debts beyond its ability to pay such debts
                                            as they mature (taking into account the timing and amounts of cash to be payable on or in
                                            respect of its debt). The Company has no knowledge of any facts or circumstances which lead
                                            it to believe that it will file for reorganization or liquidation under the bankruptcy or
                                            reorganization laws of any jurisdiction within one year from the Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.60</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
                                            of Takeover Protections</B>. The Company and the Board of Directors have taken all necessary
                                            action, if any, in order to render inapplicable any control share acquisition, business combination,
                                            poison pill (including any distribution under a rights agreement) or other similar anti-takeover
                                            provision under the Charter or the laws of its state of incorporation that is or could become
                                            applicable as a result of the Underwriters and the Company fulfilling their obligations or
                                            exercising their rights under this Agreement, the Exchange Agreement, the Lock-Up Agreements,
                                            and any other documents or agreements executed in connection with the transactions contemplated
                                            hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COVENANTS
                                            OF THE COMPANY.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendments
                                            to Registration Statement</B>. The Company shall deliver to the Representative, at least
                                            one (1) Business Day (or such shorter time mutually agreed by the parties hereto) prior to
                                            filing, any amendment or supplement to the Registration Statement or Prospectus proposed
                                            to be filed after the Effective Date and not file any such amendment or supplement to which
                                            the Representative shall reasonably object in writing.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Federal
                                            Securities Laws.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1
<U>Compliance</U>. The Company, subject to Section 3.2.2 hereof, shall comply with the requirements of Rule 430A of the Securities Act
Regulations, and will, during the period required to permit the completion of the distribution of the Public Securities as contemplated
in this Agreement and in the Registration Statement, the Pricing Disclosure Package and the Prospectus, notify the Representative promptly,
and confirm the notice in writing, (i) when any post-effective amendment to the Registration Statement shall become effective or any
amendment or supplement to the Prospectus shall have been filed; (ii) of its receipt of any comments from the Commission; (iii) of any
request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or for additional
information; (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any
post-effective amendment or of any order preventing or suspending the use of any Preliminary Prospectus or the Prospectus, or of the
suspension of the qualification of the Public Securities and the Representative&rsquo;s Securities for offering or sale in any jurisdiction,
or of the initiation or threatening of any proceedings for any of such purposes or of any examination pursuant to Section 8(d) or 8(e)
of the Securities Act concerning the Registration Statement; and (v) if the Company becomes the subject of a proceeding under Section
8A of the Securities Act in connection with the Offering of the Public Securities and the Representative&rsquo;s Securities. The Company
shall effect all filings required under Rule 424(b) of the Securities Act Regulations, in the manner and within the time period required
by Rule 424(b) (without reliance on Rule 424(b)(8)), and shall take such steps as it deems necessary to ascertain promptly whether the
form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not,
it will promptly file such prospectus. The Company shall use its best efforts to prevent the issuance of any stop order, prevention or
suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2
<U>Continued Compliance</U>. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the
Exchange Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement
and in the Registration Statement, the Pricing Disclosure Package and the Prospectus. If at any time when a prospectus relating to the
Public Securities is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations (&ldquo;<B>Rule 172</B>&rdquo;),
would be) required by the Securities Act to be delivered in connection with sales of the Public Securities, any event shall occur or
condition shall exist as a result of which it is necessary, in the opinion of Representative Counsel or Company Counsel, to (i) amend
the Registration Statement in order that the Registration Statement will not include an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) amend or supplement
the Pricing Disclosure Package or the Prospectus in order that the Pricing Disclosure Package or the Prospectus, as the case may be,
will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein
not misleading in the light of the circumstances existing at the time it is delivered to a purchaser; or (iii) amend the Registration
Statement or amend or supplement the Pricing Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements
of the Securities Act or the Securities Act Regulations, the Company will promptly (A) give the Representative notice of such event;
(B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement,
the Pricing Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed
filing or use, furnish the Representative with copies of any such amendment or supplement; and (C) file with the Commission any such
amendment or supplement; provided that the Company shall not file or use any such amendment or supplement to which the Representative
or Representative Counsel shall reasonably object. The Company will furnish to the Underwriters such number of copies of such amendment
or supplement as the Underwriters may reasonably request. The Company has given the Representative notice of any filings made pursuant
to the Exchange Act or the Exchange Act Regulations within 48 hours prior to the Applicable Time. The Company shall give the Representative
notice of its intention to make any such filing from the Applicable Time until the later of the Closing Date and the exercise in full
or expiration of the Over-allotment Option specified in Section 1.2 hereof and will furnish the Representative with copies of the related
document(s) a reasonable amount of time prior to such proposed filing, as the case may be, and will not file or use any such document
to which the Representative or Representative Counsel shall reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3 <U>Exchange
Act Registration</U>. Until the later of (i) three (3) years after the date of this Agreement and (ii) the expiration date of the
Representative&rsquo;s Warrants (or the date that all of the Representative&rsquo;s Warrants have been exercised, if earlier), the
Company shall use its best efforts to maintain the registration of the Common Stock under the Exchange Act. The Company shall not
deregister the Common Stock under the Exchange Act without the prior written consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.4
<U>Free Writing Prospectuses</U>. The Company agrees that, unless it obtains the prior written consent of the Representative, it shall
not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a &ldquo;free writing prospectus,&rdquo; or a portion thereof, required to be filed by the Company with the Commission or
retained by the Company under Rule 433; provided that the Representative shall be deemed to have consented to each Issuer General Use
Free Writing Prospectus set forth in Schedule 2-B. The Company represents that it has treated or agrees that it will treat each such
free writing prospectus consented to, or deemed consented to, by the Representative as an &ldquo;issuer free writing prospectus,&rdquo;
as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including
timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing
Prospectus, the Company has knowledge that there has occurred or is occurring an event or development as a result of which such Issuer
Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement or included or would
include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representative
and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict,
untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.5 <U>Testing-the-Waters
Communications</U>. If at any time following the distribution of any Written Testing-the-Waters Communication, the Company has
knowledge that there occurred or is occurring an event or development as a result of which such Written Testing-the-Waters
Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not
misleading, the Company shall promptly notify the Representative and shall promptly amend or supplement, at its own expense, such
Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delivery
                                            to the Underwriters of Registration Statements</B>. The Company has delivered or made available
                                            or shall deliver or make available to the Representative and Representative Counsel, without
                                            charge, conformed copies of the Registration Statement as originally filed and each amendment
                                            thereto (including exhibits filed therewith) and signed copies of all consents and certificates
                                            of experts, and will also deliver to each Underwriter, without charge, a conformed copy of
                                            the Registration Statement as originally filed and each amendment thereto (without exhibits)
                                            upon receipt of a written request for each Underwriter. The copies of the Registration Statement
                                            and each amendment thereto furnished to the Underwriters will be identical to the electronically
                                            transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent
                                            permitted by Regulation S-T.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delivery
                                            to the Underwriters of Prospectuses</B>. The Company has delivered or made available or will
                                            deliver or make available to each Underwriter, without charge, as many copies of each Preliminary
                                            Prospectus as such Underwriter reasonably requested, and the Company hereby consents to the
                                            use of such copies for purposes permitted by the Securities Act. The Company will furnish
                                            to each Underwriter, without charge, during the period when a prospectus relating to the
                                            Public Securities is (or, but for the exception afforded by Rule 172 of the Securities Act
                                            Regulations, would be) required to be delivered under the Securities Act, such number of
                                            copies of the Prospectus (as amended or supplemented) as such Underwriter may reasonably
                                            request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters
                                            will be identical to the electronically transmitted copies thereof filed with the Commission
                                            pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effectiveness
                                            and Events Requiring Notice to the Representative</B>. The Company shall use its best efforts
                                            to cause the Registration Statement to remain effective with a current prospectus for through
                                            and including the expiration date of the Representative&rsquo;s Warrants (or the date that
                                            all of the Representative&rsquo;s Warrants have been exercised, if earlier), and shall notify
                                            the Representative immediately and confirm the notice in writing: (i) of the effectiveness
                                            of the Registration Statement and any amendment thereto; (ii) of the issuance by the Commission
                                            of any stop order or of the initiation, or the threatening, of any proceeding for that purpose;
                                            (iii) of the issuance by any state securities commission of any proceedings for the suspension
                                            of the qualification of the Public Securities or the Representative&rsquo;s Securities, as
                                            applicable, for offering or sale in any jurisdiction or of the initiation, or the threatening,
                                            of any proceeding for that purpose; (iv) of the mailing and delivery to the Commission for
                                            filing of any amendment or supplement to the Registration Statement or Prospectus; (v) of
                                            the receipt of any comments or request for any additional information from the Commission;
                                            and (vi) of the happening of any event during the period described in this Section 3.5 that,
                                            in the judgment of the Company, makes any statement of a material fact made in the Registration
                                            Statement, the Pricing Disclosure Package or the Prospectus untrue or that requires the making
                                            of any changes in (a) the Registration Statement in order to make the statements therein
                                            not misleading, or (b) in the Pricing Disclosure Package or the Prospectus in order to make
                                            the statements therein, in light of the circumstances under which they were made, not misleading.
                                            If the Commission or any state securities commission shall enter a stop order or suspend
                                            such qualification at any time, the Company shall use its reasonable best efforts to obtain
                                            promptly the lifting of such order.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.6</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Review
                                            of Financial Statements</B>. For a period of three (3) years after the date of this Agreement,
                                            the Company, at its expense, shall cause its regularly engaged independent registered public
                                            accounting firm to review (but not audit) the Company&rsquo;s financial statements for each
                                            of the three fiscal quarters immediately preceding the announcement of any quarterly financial
                                            information.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.7</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B>.
                                            The Company shall use its best efforts to maintain the listing of the shares of Common Stock
                                            on the Exchange for at least three (3) years from the Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.8</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                            Public Relations</B>. As of the Effective Date, the Company shall have retained a financial
                                            public relations firm reasonably acceptable to the Representative, which firm shall be experienced
                                            in assisting issuers in initial public offerings of securities and in their relations with
                                            their security holders, and shall retain such firm or another firm reasonably acceptable
                                            to the Representative for a period of not less than two (2) years after the Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.9</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reports
                                            to the Representative.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.1
<U>Periodic Reports, etc</U>. For a period of three (3) years after the date of this Agreement, the Company shall furnish or make available
to the Representative copies of such financial statements and other periodic and special reports as the Company from time to time furnishes
generally to holders of any class of its securities and also promptly furnish to the Representative: (i) a copy of each periodic report
the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations; (ii) a copy of every
press release and every news item and article with respect to the Company or its affairs which was released by the Company; (iii) a copy
of each Form 8-K prepared and filed by the Company; (iv) a copy of each registration statement filed by the Company under the Securities
Act; (v) a copy of each report or other communication furnished to stockholders and (vi) such additional documents and information with
respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably
request. Documents filed with the Commission pursuant to its EDGAR system or press releases shall be deemed to have been delivered to
the Representative pursuant to this Section 3.9.1. Any documents not filed with the Commission pursuant to its EDGAR system shall be
delivered to jrallo@efhuttongroup.com, with a copy to dboral@efhuttongroup.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.2 <U>Transfer
Agent; Transfer Sheets</U>. For a period of three (3) years after the date of this Agreement, the Company shall retain a transfer
agent and registrar acceptable to the Representative (the &ldquo;<B>Transfer Agent</B>&rdquo;) and shall furnish to the
Representative at the Company&rsquo;s sole cost and expense such transfer sheets of the Company&rsquo;s securities as the
Representative may reasonably request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and DTC.
VStock Transfer, LLC is acceptable to the Representative to act as Transfer Agent for the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.3
<U>Trading Reports</U>. During such time as any of the Public Securities are listed on the Exchange, the Company shall provide to the
Representative, at the Company&rsquo;s expense, such reports published by the Exchange relating to price trading of the Public Securities,
as the Representative shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.10</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment
                                            of Expenses</B><FONT STYLE="font-weight: normal">. The Company hereby agrees to pay on each
                                            of the Closing Date and the Option Closing Date, if any, to the extent not paid at the Closing
                                            Date, all expenses related to the Offering or otherwise incident to the performance of the
                                            obligations of the Company under this Agreement, including, but not limited to: (a) all filing
                                            fees and communication expenses relating to the registration of the Public Securities and
                                            the Representative&rsquo;s Securities with the Commission; (b) all Public Filing System filing
                                            fees associated with the review of the Offering by FINRA; (c) all fees and expenses relating
                                            to the listing of the shares of Common Stock on the Exchange and such other stock exchanges
                                            as the Company and the Representative together determine, including any fees charged by DTC;
                                            (d) all fees, expenses and disbursements relating to background checks of the Company&rsquo;s
                                            officers and directors; (e) all fees, expenses and disbursements relating to the registration
                                            or qualification of the Public Securities under the &ldquo;blue sky&rdquo; securities laws
                                            of such states and other jurisdictions as the Representative may reasonably designate (including,
                                            without limitation, all filing and registration fees, and the reasonable fees and disbursements
                                            of the Company&rsquo;s &ldquo;blue sky&rdquo; counsel, which will be Representative Counsel)
                                            unless such filings are not required in connection with the Company&rsquo;s proposed listing
                                            on the Exchange; (f) all fees, expenses and disbursements relating to the registration, qualification
                                            or exemption of the Public Securities under the securities laws of such foreign jurisdictions
                                            as the Representative may reasonably designate; (g) the costs of all mailing and printing
                                            of the underwriting documents (including, without limitation, the Underwriting Agreement,
                                            any Blue Sky Surveys and, if appropriate, any agreement among Underwriters, Selected Dealers&rsquo;
                                            Agreement, Underwriters&rsquo; Questionnaire and Power of Attorney), Registration Statements,
                                            Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary
                                            and final Prospectuses as the Representative may reasonably deem necessary; (h) the costs
                                            and expenses of a public relations firm; (i) the costs of preparing, printing and delivering
                                            certificates representing the Public Securities; (j) fees and expenses of the Transfer Agent
                                            for the shares of Common Stock; (k) stock transfer and/or stamp taxes, if any, payable upon
                                            the transfer of the Public Securities from the Company to the Underwriters; (l) the costs
                                            associated with bound volumes of the public offering materials as well as commemorative mementos
                                            and lucite tombstones in an aggregate amount not to exceed $5,000; (m) the fees and expenses
                                            of the Company&rsquo;s accountants; (n) the fees and expenses of the Company&rsquo;s legal
                                            counsel and other agents and representatives; (o) the fees and expenses of Representative
                                            Counsel in an amount not to exceed $175,000 in the event of a Closing of the Offering and
                                            a maximum of $50,000 in the event there is not a Closing; (p) the $29,500 cost associated
                                            with the Underwriters&rsquo; use of Ipreo&rsquo;s book- building, prospectus tracking and
                                            compliance software for the Offering; (q) to the extent approved by the Company in writing,
                                            the costs associated with post-Closing advertising of the Offering in the national editions
                                            of the Wall Street Journal and New York Times; (r) up to $20,000 of the Representative&rsquo;s
                                            actual accountable &ldquo;road show&rdquo; expenses for the Offering; and (s) the Underwriters&rsquo;
                                            actual accountable expenses for the Offering. The Representative may deduct from the net
                                            proceeds of the Offering payable to the Company on the Closing Date, or the Option Closing
                                            Date, if any, the expenses set forth herein to be paid by the Company to the Underwriters,
                                            less the Advance (as such term is defined in Section 8.3 hereof). The Company further agrees
                                            that, on the Closing Date it shall pay to the Representative, by deduction from the net proceeds
                                            of the Offering contemplated herein, a non-accountable expense allowance equal to one percent
                                            (1%) of the gross proceeds received by the Company from the sale of the Public Securities,
                                            less the Advance; provided, however, that in the event that the Offering is terminated, the
                                            Company agrees to reimburse the Representative pursuant to Section 8.3 hereof.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.11</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
                                            of Net Proceeds</B>. The Company shall apply the net proceeds from the Offering received
                                            by it in a manner consistent with the application thereof described under the caption &ldquo;Use
                                            of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure Package and the
                                            Prospectus.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.12</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delivery
                                            of Earnings Statements to Security Holders</B>. The Company shall make generally available
                                            to its security holders as soon as practicable, but not later than the first day of the fifteenth
                                            (15<SUP>th</SUP>) full calendar month following the date of this Agreement, an earnings statement
                                            (which need not be certified by an independent registered public accounting firm unless required
                                            by the Securities Act or the Securities Act Regulations, but which shall satisfy the provisions
                                            of Rule 158(a) under Section 11(a) of the Securities Act) covering a period of at least twelve
                                            (12) consecutive months beginning after the date of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.13</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stabilization</B>.
                                            Neither the Company nor, to its knowledge, any of its employees, directors or stockholders
                                            has taken or shall take, directly or indirectly, any action designed to or that has constituted
                                            or that might reasonably be expected to cause or result in, under Regulation M of the Exchange
                                            Act, or otherwise, stabilization or manipulation of the price of any security of the Company
                                            to facilitate the sale or resale of the Public Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.14</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Internal
                                            Controls</B>. The Company shall maintain a system of internal accounting controls sufficient
                                            to provide reasonable assurances that: (i) transactions are executed in accordance with management&rsquo;s
                                            general or specific authorization; (ii) transactions are recorded as necessary in order to
                                            permit preparation of financial statements in accordance with GAAP and to maintain accountability
                                            for assets; (iii) access to assets is permitted only in accordance with management&rsquo;s
                                            general or specific authorization; and (iv) the recorded accountability for assets is compared
                                            with existing assets at reasonable intervals and appropriate action is taken with respect
                                            to any differences.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.15</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accountants</B>.
                                            As of the date of this Agreement, the Company has retained an independent registered public
                                            accounting firm, as required by the Securities Act and the Securities Act Regulations and
                                            the Public Company Accounting Oversight Board, reasonably acceptable to the Representative,
                                            and the Company shall continue to retain a nationally recognized independent registered public
                                            accounting firm for a period of at least three (3) years after the Closing Date. The Representative
                                            acknowledges that M&amp;K CPAs, PLLC is acceptable to the Representative.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.16</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FINRA</B>.
                                            For a period of ninety (90) days from the later of the Closing Date or the Option Closing
                                            Date, the Company shall advise the Representative (who shall make an appropriate filing with
                                            FINRA) if it is or becomes aware that (i) any officer or director of the Company, (ii) any
                                            beneficial owner of ten percent (10%) or more of any class of the Company&rsquo;s securities
                                            or (iii) any beneficial owner of the Company&rsquo;s unregistered equity securities which
                                            were acquired during the one hundred eighty (180) days immediately preceding the filing of
                                            the Registration Statement is or becomes an affiliate or associated person of a FINRA member
                                            participating in the Offering (as determined in accordance with the rules and regulations
                                            of FINRA).</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.17</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Fiduciary Duties</B>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility
                                            to the Company is solely contractual in nature and that none of the Underwriters or their
                                            affiliates or any selling agent shall be deemed to be acting in a fiduciary capacity, or
                                            otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with
                                            the Offering and the other transactions contemplated by this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.18</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
                                            Lock-Up Agreements</B>. The Company, on behalf of itself and any successor entity, agrees
                                            that, without the prior written consent of the Representative, it will not, for a period
                                            of ninety (90) days after the date of this Agreement (the &ldquo;<B>Lock-Up Period</B>&rdquo;),
                                            (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase
                                            any option or contract to sell, grant any option, right or warrant to purchase, lend, or
                                            otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of
                                            the Company or any securities convertible into or exercisable or exchangeable for shares
                                            of capital stock of the Company; (ii) file or cause to be filed any registration statement
                                            with the Commission relating to the offering of any shares of capital stock of the Company
                                            or any securities convertible into or exercisable or exchangeable for shares of capital stock
                                            of the Company other than a registration statement on Form S-4 or S-8; (iii) complete any
                                            offering of debt securities of the Company, other than entering into a line of credit with
                                            a traditional bank; or (iv) enter into any swap or other arrangement that transfers to another,
                                            in whole or in part, any of the economic consequences of ownership of capital stock of the
                                            Company, whether any such transaction described in clause (i), (ii), (iii), or (iv) above
                                            is to be settled by delivery of shares of capital stock of the Company or such other securities,
                                            in cash or otherwise.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
restrictions contained in this Section 3.18 shall not apply to (i) the Public Securities or the Representative&rsquo;s Securities; (ii)
the issuance by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the conversion of a security,
in each case outstanding on the date hereof, provided that such options, warrants, securities are disclosed in the Registration Statement,
the Pricing Disclosure Package or the Prospectus and have not been amended since the date of this Agreement to increase the number of
such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such
securities, (iii) the issuance of shares of Common Stock issued as part of the purchase price in connection with acquisitions or strategic
transactions, or (iv) the issuance by the Company of any shares of Common Stock or standard options to purchase shares of Common Stock
to directors, officers or employees of the Company in their capacity as such pursuant to an Approved Stock Plan. &ldquo;<B>Approved Stock
Plan</B>&rdquo; means any employee benefit plan which has been approved by the Board of Directors prior to or subsequent to the date
hereof pursuant to which shares of Common Stock and standard options to purchase Common Stock may be issued to any employee, officer
or director for services provided to the Company in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.19</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Release
                                            of D&amp;O Lock-up Period</B>. If the Representative, in its sole discretion, agrees to release
                                            or waive the restrictions set forth in the Lock-Up Agreements described in Section 2.25 hereof
                                            for an officer or director of the Company and provides the Company with notice of the impending
                                            release or waiver at least three (3) Business Days before the effective date of the release
                                            or waiver, the Company agrees to announce the impending release or waiver by a press release
                                            substantially in the form of Exhibit C hereto through a major news service at least two (2)
                                            Business Days before the effective date of the release or waiver.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.20</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Blue
                                            Sky Qualifications</B>. The Company shall use its best efforts, in cooperation with the Underwriters,
                                            if necessary, to qualify the Public Securities for offering and sale under the applicable
                                            securities laws of such states and other jurisdictions (domestic or foreign) as the Representative
                                            may reasonably designate and to maintain such qualifications in effect so long as required
                                            to complete the distribution of the Public Securities; provided, however, that the Company
                                            shall not be obligated to file any general consent to service of process or to qualify as
                                            a foreign corporation or as a dealer in securities in any jurisdiction in which it is not
                                            so qualified or to subject itself to taxation in respect of doing business in any jurisdiction
                                            in which it is not otherwise so subject.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.21</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reporting
                                            Requirements</B>. The Company, during the period when a prospectus relating to the Public
                                            Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered
                                            under the Securities Act, will file all documents required to be filed with the Commission
                                            pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange
                                            Act Regulations. Additionally, the Company shall report the use of proceeds from the issuance
                                            of the Public Securities as may be required under Rule 463 under the Securities Act Regulations.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.22</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Press
                                            Releases</B>. Prior to the Closing Date and any Option Closing Date, the Company shall not
                                            issue any press release or other communication directly or indirectly or hold any press conference
                                            with respect to the Company, its condition, financial or otherwise, or earnings, business
                                            affairs or business prospects (except for routine oral marketing communications in the ordinary
                                            course of business and consistent with the past practices of the Company and of which the
                                            Representative is notified), without the prior written consent of the Representative, which
                                            consent shall not be unreasonably withheld, unless in the judgment of the Company and its
                                            counsel, and after notification to the Representative, such press release or communication
                                            is required by law.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.23</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sarbanes-Oxley</B>.
                                            For a period of one (1) year after the date of this Agreement, the Company shall at all times
                                            comply in all material respects with all applicable provisions of the Sarbanes-Oxley Act
                                            in effect from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.24</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IRS
                                            Forms</B>. If requested by the Representative, the Company shall deliver to each Underwriter
                                            (or its agent), prior to or at the Closing Date, a properly completed and executed Internal
                                            Revenue Service (&ldquo;<B>IRS</B>&rdquo;) Form W-9 or an IRS Form W-8, as appropriate, together
                                            with all required attachments to such form.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.25</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporation
                                            Records Service</B>. For a period of three (3) years from the Closing Date, the Company shall
                                            register and maintain the registration with the Corporation Records Service (including annual
                                            report information) published by Standard &amp; Poor&rsquo;s Corporation.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.26</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Key
                                            Man&rdquo; Life Insurance</B></FONT>. On or prior to Closing, the Company shall procure and
                                            maintain &ldquo;key man&rdquo; life insurance (in the amount customary in the Company&rsquo;s
                                            industry with the Company as the sole beneficiary thereof) with an insurer rated at least
                                            AA or better in the most recent edition of &ldquo;Best&rsquo;s Life Reports&rdquo; on the
                                            lives of officers of the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.27</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D&amp;O
                                            Insurance</B>. The Company has procured and shall maintain directors and officers insurance
                                            for each of the officers and directors of the Company in a manner consistent with the Company&rsquo;s
                                            business and industry standards.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.28</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Emerging
                                            Growth Company Status</B>. The Company shall promptly notify the Representative if the Company
                                            ceases to be an &ldquo;emerging growth company,&rdquo; as defined in Section 2(a) of the
                                            Securities Act, at any time prior to the later of (i) completion of the distribution of the
                                            Public Securities within the meaning of the Securities Act and (ii) fifteen (15) days following
                                            the completion of the Lock-Up Period.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
                                            OF UNDERWRITERS&rsquo; OBLIGATIONS.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Underwriters to purchase and pay for the Public Securities, as provided herein, shall be subject to (i) the continuing
accuracy of the representations and warranties of the Company as of the date hereof and as of each of the Closing Date and the Option
Closing Date, if any; (ii) the accuracy of the statements of officers of the Company made pursuant to the provisions hereof; (iii) the
performance by the Company of its obligations hereunder; and (iv) the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulatory
                                            Matters.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1
<U>Effectiveness of Registration Statement; Rule 430A Information</U>. The Registration Statement has become effective not later than
5:00 p.m., Eastern time, on the date of this Agreement or such later date and time as shall be consented to in writing by the Representative,
and, at each of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of the Registration Statement
or any post-effective amendment thereto shall have been issued under the Securities Act, no order preventing or suspending the use of
any Preliminary Prospectus or the Prospectus shall have been issued and no proceedings for any of those purposes shall have been instituted
or are pending or, to the Company&rsquo;s knowledge, contemplated by the Commission. The Company has complied with each request (if any)
from the Commission for additional information. A prospectus containing the Rule 430A Information shall have been filed with the Commission
in the manner and within the time frame required by Rule 424(b) under the Securities Act Regulations (without reliance on Rule 424(b)(8))
or a post-effective amendment providing such information shall have been filed with, and declared effective by, the Commission in accordance
with the requirements of Rule 430A under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2 <U>FINRA
Clearance</U>. On or before the date of this Agreement, the Representative shall have received clearance from FINRA as to the amount
of compensation allowable or payable to the Underwriters as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3 <U>Exchange
Clearance</U>. On or prior to the Closing Date, the Common Stock shall have been approved for listing on the Exchange, subject only
to official notice of issuance. On the first Option Closing Date (if any), the Company&rsquo;s shares of Common Stock, including the
Option Shares, shall have been approved for listing on the Exchange, subject only to official notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
                                            Counsel Matters.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1 <U>Closing
Date Opinion of Counsel</U>. On the Closing Date, the Representative shall have received the favorable opinion and negative
assurance letter of Sichenzia Ross Ference LLP (&ldquo;<B>Company Counsel</B>&rdquo;), counsel to the Company, dated the Closing
Date and addressed to the Representative, in form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2 <U>Opinion
of Counsel for Parent</U>. On the Closing Date, the Representative shall have received the favorable opinion and negative assurance
letter of Sichenzia Ross Ference LLP, counsel to Parent, dated the Closing Date and addressed to the Representative, substantially
in form and substance reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.3
<U>Option Closing Date Opinions of Counsel</U>. On the Option Closing Date, if any, the Representative shall have received the favorable
opinions and/or negative assurance letters of each counsel listed in Sections 4.2.1 and 4.2.2 hereof, dated the Option Closing Date,
addressed to the Representative and in form and substance reasonably satisfactory to the Representative, confirming as of the Option
Closing Date, the statements made by such counsels in their respective opinions delivered on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4 <U>Reliance</U>.
The opinions of each counsel listed in Sections 4.2.1 and 4.2.2 hereof and any opinion relied upon thereby shall include a statement
to the effect that it may be relied upon by Representative Counsel in its opinion delivered to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comfort
                                            Letters.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1
<U>Comfort Letter</U>. At the time this Agreement is executed, the Representative shall have received a cold comfort letter from the
Auditor containing statements and information of the type customarily included in accountants&rsquo; comfort letters with respect to
the financial statements and certain financial information contained in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, addressed to the Representative and in form and substance satisfactory in all respects to the Representative and to Representative
Counsel, dated as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.2
<U>Bring-down Comfort Letter</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received
from the Auditor a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that the Auditor reaffirms
the statements made in the letter furnished pursuant to Section 4.3.1 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Officers&rsquo;
                                            Certificates.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.1 <U>Officers&rsquo;
Certificate</U>. The Company shall have furnished to the Representative a certificate, dated the Closing Date and any Option Closing
Date (if such date is other than the Closing Date), of its Chief Executive Officer and its Chief Financial Officer certifying that
on behalf of the Company and not in an individual capacity that (i) such officers have carefully examined the Registration
Statement, the Pricing Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and, in their opinion, the
Registration Statement and each amendment thereto, as of the Applicable Time and as of the Closing Date (or any Option Closing Date
if such date is other than the Closing Date) did not include any untrue statement of a material fact and did not omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading, and the Pricing Disclosure
Package, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing
date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option Closing Date if such date is
other than the Closing Date), the Prospectus and each amendment or supplement thereto, as of the respective date thereof and as of
the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances in which they were made, not misleading, (ii) since the
effective date of the Registration Statement, no event has occurred which should have been set forth in a supplement or amendment to
the Registration Statement, the Pricing Disclosure Package or the Prospectus, (iii) to their knowledge after reasonable
investigation, as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the representations
and warranties of the Company in this Agreement are true and correct and the Company has complied with all agreements and satisfied
all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any Option Closing Date if
such date is other than the Closing Date), and (iv) there has not been, subsequent to the date of the most recent audited financial
statements included in the Pricing Disclosure Package, any Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.2
<U>Secretary&rsquo;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have
received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Closing Date, as the
case may be, respectively, certifying on behalf of the Company and not in an individual capacity: (i) that each of the Charter and Bylaws
is true and complete, has not been modified and is in full force and effect; (ii) that the resolutions of the Board of Directors relating
to the Offering are in full force and effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence
between the Company or its counsel and the Commission; and (iv) as to the incumbency of the officers of the Company. The documents referred
to in such certificate shall be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.3
<U>Parent Certificate</U>. Parent shall have furnished to the Representative a certificate, dated the Closing Date and any Option Closing
Date (if such date is other than the Closing Date), of its Chief Executive Officer and its Chief Financial Officer certifying that on
behalf of Parent and not in an individual capacity that (i) such officers have carefully examined the Registration Statement, the Pricing
Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and, in their opinion, the Registration Statement and each
amendment thereto, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing
Date) did not include any untrue statement of a material fact and did not omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading, and the Pricing Disclosure Package, as of the Applicable Time and as of the
Closing Date (or any Option Closing Date if such date is other than the Closing Date), any Issuer Free Writing Prospectus as of its date
and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the Prospectus and each amendment
or supplement thereto, as of the respective date thereof and as of the Closing Date, did not include any untrue statement of a material
fact and did not omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances in
which they were made, not misleading, (ii) since the effective date of the Registration Statement, no event has occurred which should
have been set forth in a supplement or amendment to the Registration Statement, the Pricing Disclosure Package or the Prospectus, (iii)
to their knowledge after reasonable investigation, as of the Closing Date (or any Option Closing Date if such date is other than the
Closing Date), the representations and warranties of Parent in this Agreement are true and correct and Parent has complied with all agreements
and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any Option Closing
Date if such date is other than the Closing Date), and (iv) there has not been, subsequent to the date of the most recent audited financial
statements included in the Pricing Disclosure Package, any Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.5</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Material Changes</B>. Prior to and on each of the Closing Date and each Option Closing Date,
                                            if any: (i) there shall have been no Material Adverse Change in the condition or prospects
                                            or the business activities, financial or otherwise, of any member of the Company Group from
                                            the latest dates as of which such condition is set forth in the Registration Statement, the
                                            Pricing Disclosure Package and the Prospectus; (ii) no action, suit or proceeding, at law
                                            or in equity, shall have been pending or threatened against the Company or any Insider before
                                            or by any court or federal or state commission, board or other administrative agency wherein
                                            an unfavorable decision, ruling or finding may reasonably be expected to cause a Material
                                            Adverse Change, except as set forth in the Registration Statement, the Pricing Disclosure
                                            Package and the Prospectus; (iii) no stop order shall have been issued under the Securities
                                            Act and no proceedings therefor shall have been initiated or threatened by the Commission;
                                            and (iv) no action shall have been taken and no law, statute, rule, regulation or order shall
                                            have been enacted, adopted or issued by any Governmental Entity which would prevent the issuance
                                            or sale of the Public Securities or materially and adversely affect or potentially materially
                                            and adversely affect the business or operations of any member of the Company Group; (v) no
                                            injunction, restraining order or order of any other nature by any federal, state or foreign
                                            court of competent jurisdiction shall have been issued which would prevent the issuance or
                                            sale of the Public Securities or materially and adversely affect or potentially materially
                                            and adversely affect the business or operations of any member of the Company Group; and (vi)
                                            the Registration Statement, the Pricing Disclosure Package and the Prospectus and any amendments
                                            or supplements thereto shall contain all material statements which are required to be stated
                                            therein in accordance with the Securities Act and the Securities Act Regulations and shall
                                            conform in all material respects to the requirements of the Securities Act and the Securities
                                            Act Regulations, and neither the Registration Statement, the Pricing Disclosure Package nor
                                            the Prospectus nor any amendment or supplement thereto shall contain any untrue statement
                                            of a material fact or omit to state any material fact required to be stated therein or necessary
                                            to make the statements therein, in light of the circumstances under which they were made,
                                            not misleading.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.6</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Material Misstatement or Omission</B>. The Underwriters shall not have discovered and disclosed
                                            to the Company on or prior to the Closing Date and any Option Closing Date that the Registration
                                            Statement or any amendment or supplement thereto contains an untrue statement of a fact which,
                                            in the opinion of Representative Counsel, is material or omits to state any fact which, in
                                            the opinion of such counsel, is material and is required to be stated therein or is necessary
                                            to make the statements therein not misleading, or that the Registration Statement, the Pricing
                                            Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus or any amendment
                                            or supplement thereto contains an untrue statement of fact which, in the opinion of Representative
                                            Counsel, is material or omits to state any fact which, in the opinion of Representative Counsel,
                                            is material and is necessary in order to make the statements, in the light of the circumstances
                                            under which they were made, not misleading.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.7</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
                                            Proceedings</B>. All corporate proceedings and other legal matters incident to the authorization,
                                            form and validity of each of this Agreement, the Public Securities, the Representative&rsquo;s
                                            Securities, the Registration Statement, the Pricing Disclosure Package, each Issuer Free
                                            Writing Prospectus, if any, and the Prospectus and all other legal matters relating to this
                                            Agreement, the Representative&rsquo;s Securities and the transactions contemplated hereby
                                            shall be reasonably satisfactory in all material respects to Representative Counsel, and
                                            the Company shall have furnished to such counsel all documents and information that they
                                            may reasonably request to enable them to pass upon such matters.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.8</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
                                            Agreements</B>. On or before the date of this Agreement, the Company shall have delivered
                                            to the Representative executed copies of the Lock-Up Agreements from each of the persons
                                            listed in Schedule 3 hereto.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.9</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
                                            Exchange, Separation and Distribution</B>. On or before the date of this Agreement, the Share
                                            Exchange and the Separation shall have been consummated. On or before the Closing Date, the
                                            Distribution shall have been consummated.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.10</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representative&rsquo;s
                                            Warrants. </B>On the Closing Date and each Option Closing Date (if any), the Company shall
                                            have delivered to the Representative executed copies of the Representative&rsquo;s Warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.11</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
                                            Documents</B>. At the Closing Date and at each Option Closing Date (if any) Representative
                                            Counsel shall have been furnished with such documents and opinions as they may reasonably
                                            require for the purpose of enabling Representative Counsel to deliver an opinion to the Underwriters,
                                            or in order to evidence the accuracy of any of the representations or warranties, or the
                                            fulfillment of any of the conditions, herein contained; and all proceedings taken by the
                                            Company in connection with the issuance and sale of the Public Securities and the Representative&rsquo;s
                                            Securities as herein contemplated shall be reasonably satisfactory in form and substance
                                            to the Representative and Representative Counsel.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNIFICATION.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
                                            of the Underwriters.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1
<U>General</U>. The Company Group shall indemnify and hold harmless each Underwriter, its affiliates and each of its and their respective
directors, officers, members, employees, representatives, partners, shareholders, affiliates, counsel and agents and each person, if
any, who controls any such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively
the &ldquo;<B>Underwriter Indemnified Parties</B>,&rdquo; and each an &ldquo;<B>Underwriter Indemnified Party</B>&rdquo;), against any
and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and all legal or other expenses reasonably
incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising
out of any action between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties
and any third party, or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any
other statute or at common law or otherwise or under the laws of foreign countries, (x) arising out of or based upon any untrue statement
or alleged untrue statement of a material fact contained in (i) the Registration Statement, the Pricing Disclosure Package, the Preliminary
Prospectus, the Prospectus or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication (as from time to time
each may be amended and supplemented); (ii) any materials or information provided to investors by, or with the approval of, the Company
in connection with the marketing of the Offering, including any &ldquo;road show&rdquo; or investor presentations made to investors by
the Company (whether in person or electronically); or (iii) any application or other document or written communication (in this Section
5, collectively called &ldquo;<B>application</B>&rdquo;) executed by the Company or based upon written information furnished by the Company
in any jurisdiction in order to qualify the Public Securities and the Representative&rsquo;s Securities under the securities laws thereof
or filed with the Commission, any state securities commission or agency, the Exchange or any other national securities exchange; or the
omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance
upon, and in conformity with, the Underwriters&rsquo; Information or (y) otherwise arising in connection with or allegedly in connection
with the Offering, including the Share Exchange, Separation and Distribution. With respect to any untrue statement or omission or alleged
untrue statement or omission made in the Pricing Disclosure Package, the indemnity agreement contained in this Section 5.1.1 shall not
inure to the benefit of any Underwriter Indemnified Party to the extent that any loss, liability, claim, damage or expense of such Underwriter
Indemnified Party (a) is based on the Underwriters&rsquo; Information or material omission therefrom, (b) results from the fact that
a copy of the Prospectus was not given or sent to the person asserting any such loss, liability, claim or damage at or prior to the written
confirmation of sale of the Public Securities to such person as required by the Securities Act and the Securities Act Regulations, and
if the untrue statement or omission has been corrected in the Prospectus, unless such failure to deliver the Prospectus was a result
of non-compliance by the Company with its obligations under Section 3.3 hereof, or (c) is found in a final, non-appealable judgment of
a court of competent jurisdiction to have resulted primarily from the willful misconduct or gross negligence of such Underwriter Indemnified
Party. The Company also agrees that it will reimburse each Underwriter Indemnified Party for all reasonable and documented fees and expenses
(including but not limited to any and all reasonable legal or other expenses reasonably incurred in investigating, preparing or defending
against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action between any of the Underwriter
Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties and any third party, or otherwise), and further
agrees wherever and whenever possible to advance payment of such expenses as they are incurred by an Underwriter Indemnified Party in
investigating, preparing, pursuing or defending any Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2
<U>Procedure</U>. If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought against
the Company pursuant to Section 5.1.1 hereof, such Underwriter Indemnified Party shall promptly notify the Company in writing of the
institution of such action and the Company shall be entitled to participate therein and, to the extent that it wishes, jointly with any
other similarly notified indemnifying party, to assume the defense of such action, including the employment and fees of counsel (subject
to the reasonable approval of such Underwriter Indemnified Party) and payment of actual expenses. Such Underwriter Indemnified Party
shall have the right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense
of such Underwriter Indemnified Party unless (i) the employment of such counsel at the expense of the Company shall have been authorized
in writing by the Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have
charge of the defense of such action, or (iii) the action includes both the Company and the indemnified party as defendants and such
indemnified party or parties shall have been advised by its counsel that there may be defenses available to it or them which are different
from or additional to those available to the Company which makes it impossible or inadvisable for the Company and such indemnified party
to be represented in the action by the same counsel (in which case the Company shall not have the right to direct the defense of such
action on behalf of the indemnified party), in any of which events the reasonable fees and expenses of not more than one additional firm
of attorneys selected by the Underwriter Indemnified Parties who are party to such action (in addition to local counsel) shall be borne
by the Company. Notwithstanding anything to the contrary contained herein, if any Underwriter Indemnified Party shall assume the defense
of such action as provided above, the Company shall have the right to approve the terms of any settlement of such action, which approval
shall not be unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
                                            of the Company</B>. Each Underwriter, severally and not jointly, shall indemnify and hold
                                            harmless the Company, its directors, its officers who signed the Registration Statement and
                                            persons who control the Company within the meaning of Section 15 of the Securities Act or
                                            Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense
                                            described in the foregoing indemnity from the Company to the several Underwriters, as incurred,
                                            but only with respect to such losses, liabilities, claims, damages and expenses (or actions
                                            in respect thereof) which arise out of or are based upon untrue statements or omissions made
                                            in the Registration Statement, any Preliminary Prospectus, the Pricing Disclosure Package
                                            or Prospectus or any amendment or supplement thereto or in any application, in reliance upon,
                                            and in strict conformity with, the Underwriters&rsquo; Information. In case any action shall
                                            be brought against the Company or any other person so indemnified based on any Preliminary
                                            Prospectus, the Registration Statement, the Pricing Disclosure Package or Prospectus or any
                                            amendment or supplement thereto or any application, and in respect of which indemnity may
                                            be sought against any Underwriter, such Underwriter shall have the rights and duties given
                                            to the Company, and the Company and each other person so indemnified shall have the rights
                                            and duties given to the several Underwriters by the provisions of Section 5.1.2 hereof. The
                                            Company agrees promptly to notify the Representative of the commencement of any litigation
                                            or proceedings against the Company or any of its officers, directors or any person, if any,
                                            who controls the Company within the meaning of Section 15 of the Securities Act or Section
                                            20 of the Exchange Act, in connection with the issuance and sale of the Public Securities
                                            or in connection with the Registration Statement, the Pricing Disclosure Package, the Prospectus
                                            or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contribution.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1
<U>Contribution Rights</U>. If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient
to hold harmless an indemnified party under Section 5.1 or 5.2 hereof in respect of any loss, claim, damage or liability, or any action
in respect thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute
to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof,
(i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand, and each of
the Underwriters, on the other hand, from the Offering, or (ii) if the allocation provided by clause (i) above is not permitted by applicable
law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative
fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that resulted
in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations. The relative
benefits received by the Company, on the one hand, and the Underwriters, on the other, with respect to such Offering shall be deemed
to be in the same proportion as the total proceeds from the Offering (before deducting expenses) received by the Company bear to the
total underwriting discount and commissions received by the Underwriters in connection with the Offering, in each case as set forth in
the table on the cover page of the Prospectus. The relative fault of the Company, on the one hand, and the Underwriters, on the other,
shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission
or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the Underwriters, on
the other, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue
statement, omission, act or failure to act; provided that the parties hereto agree that the written information furnished to the Company
through the Representative by or on behalf of any Underwriter for use in any Preliminary Prospectus, any Registration Statement or the
Prospectus, or in any amendment or supplement thereto, consists solely of the Underwriters&rsquo; Information and any material information
that was omitted therefrom. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant
to this Section 5.3.1 were to be determined by pro rata allocation or by any other method of allocation that does not take into account
the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage,
expense, liability, action, investigation or proceeding referred to above in this Section 5.3.1 shall be deemed to include, for purposes
of this Section 5.3.1, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating, preparing
to defend or defending against or appearing as a third party witness in respect of, or otherwise incurred in connection with, any such
loss, claim, damage, expense, liability, action, investigation or proceeding. Notwithstanding the provisions of this Section 5.3.1 no
Underwriter shall be required to contribute any amount in excess of the total discount and commission received by such Underwriter in
connection with the Offering less the amount of any damages which such Underwriter has otherwise paid or becomes liable to pay by reason
of any untrue or alleged untrue statement, omission or alleged omission, act or alleged act or failure to act or alleged failure to act.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2
<U>Contribution Procedure</U>. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice
of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made
against another party (&ldquo;<B>contributing party</B>&rdquo;), notify the contributing party of the commencement thereof, but the failure
to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or
its representative of the commencement thereof within the aforesaid fifteen (15) days, the contributing party will be entitled to participate
therein with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable
to any party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
without the written consent of such contributing party. The contribution provisions contained in this Section 5.3.2 are intended to supersede,
to the extent permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available. Each Underwriter&rsquo;s
obligations to contribute as provided in this Section 5.3 are several and in proportion to their respective underwriting obligation,
and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFAULT
                                            BY AN UNDERWRITER.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Default
                                            Not Exceeding 10% of Firm Shares or Option Shares</B>. If any Underwriter or Underwriters
                                            shall default in its or their obligations to purchase the Firm Shares or the Option Shares,
                                            if the Over-allotment Option is exercised hereunder, and if the number of the Firm Shares
                                            or Option Shares with respect to which such default relates does not exceed in the aggregate
                                            10% of the number of Firm Shares or Option Shares that all Underwriters have agreed to purchase
                                            hereunder, then such Firm Shares or Option Shares to which the default relates shall be purchased
                                            by the non-defaulting Underwriters in proportion to their respective commitments hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Default
                                            Exceeding 10% of Firm Shares or Option Shares</B></FONT>. In the event that the default addressed
                                            in Section 6.1 hereof relates to more than 10% of the number of Firm Shares or Option Shares,
                                            the Representative may in its discretion arrange for itself or for another party or parties
                                            to purchase such Firm Shares or Option Shares to which such default relates on the terms
                                            contained herein. If, within one (1) Business Day after such default relating to more than
                                            10% of the number of Firm Shares or Option Shares, the Representative does not arrange for
                                            the purchase of such Firm Shares or Option Shares, then the Company shall be entitled to
                                            a further period of one (1) Business Day within which to procure another party or parties
                                            satisfactory to the Representative to purchase said Firm Shares or Option Shares on such
                                            terms. In the event that neither the Representative nor the Company arrange for the purchase
                                            of the Firm Shares or Option Shares to which a default relates as provided in this Section
                                            6, this Agreement will automatically be terminated by the Representative or the Company without
                                            liability on the part of the Company (except as provided in Sections 3.10 and 5 hereof) or
                                            the several Underwriters (except as provided in Section 5 hereof); provided, however, that
                                            if such default occurs with respect to the Option Shares, this Agreement will not terminate
                                            as to the Firm Shares; and provided, further, that nothing herein shall relieve a defaulting
                                            Underwriter of its liability, if any, to the other Underwriters and to the Company for damages
                                            occasioned by its default hereunder.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Postponement
                                            of Closing Date</B>. In the event that the Firm Shares or Option Shares to which the default
                                            relates are to be purchased by the non-defaulting Underwriters, or are to be purchased by
                                            another party or parties as aforesaid, the Representative or the Company shall have the right
                                            to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any
                                            event exceeding five (5) Business Days, in order to effect whatever changes may thereby be
                                            made necessary in the Registration Statement, the Pricing Disclosure Package or the Prospectus
                                            or in any other documents and arrangements, and the Company agrees to file promptly any amendment
                                            to the Registration Statement, the Pricing Disclosure Package or the Prospectus that in the
                                            reasonable opinion of Representative Counsel may thereby be made necessary. The term &ldquo;<B>Underwriter</B>&rdquo;
                                            as used in this Agreement shall include any party substituted under this Section 6 with like
                                            effect as if it had originally been a party to this Agreement with respect to such Firm Shares
                                            or Option Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADDITIONAL
                                            COVENANTS.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prohibition
                                            on Press Releases and Public Announcements</B>. No member of the Company Group shall issue
                                            press releases or engage in any other publicity, without the Representative&rsquo;s prior
                                            written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1<SUP>st</SUP>)
                                            Business Day following the forty-fifth (45<SUP>th</SUP>) day after the Closing Date, other
                                            than normal and customary releases issued in the ordinary course of the Company&rsquo;s business.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
                                            Composition and Board Designations</B>. The Company shall ensure that: (i) the qualifications
                                            of the persons serving as members of the Board of Directors and the overall composition of
                                            the Board comply with the Sarbanes-Oxley Act, with the Exchange Act and with the listing
                                            rules of the Exchange or any other national securities exchange, as the case may be, in the
                                            event the Company seeks to have its Public Securities listed on another exchange or quoted
                                            on an automated quotation system, and (ii) if applicable, at least one (1) member of the
                                            Audit Committee of the Board of Directors qualifies as an &ldquo;audit committee financial
                                            expert,&rdquo; or , absent meeting such qualification, has &ldquo;accounting or related financial
                                            management expertise&rdquo; or &ldquo;financial sophistication&rdquo; or such term, as applicable,
                                            is defined under Regulation S-K or the listing rules of the Exchange, as applicable.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tail
                                            Period</B>. The Company agrees to pay the Representative a cash fee equal to eight percent
                                            (8.0%) of the gross proceeds received by the Company from the sale of the securities offered
                                            to any investor actually introduced by the Representative to the Company during the Engagement
                                            Period (as defined below) (the &ldquo;<B>Tail Financing</B>&rdquo;), and such Tail Financing
                                            is consummated at any time during the Engagement Period or within the twelve (12) month period
                                            following the expiration of the Engagement Period, provided that such financing is by a party
                                            actually introduced to the Company in an offering in which the Company has direct knowledge
                                            of such party&rsquo;s participation and not a party that the Company can demonstrate was
                                            already known to the Company. In addition, unless (x) the Company terminates this Agreement
                                            for &ldquo;Cause&rdquo; (as defined below), or (y) the Representative fails to provide the
                                            underwriting services provided in this Agreement, upon termination of this Agreement, if
                                            the Company subsequently completes a public or private financing with any investors introduced
                                            to the Company by the Representative during the twelve (12) month period following such termination,
                                            the Representative shall be entitled to receive the same compensation to be paid to the Representative
                                            in connection with the Offering. &ldquo;<B>Cause</B>&rdquo;, for the purpose of this Agreement,
                                            shall mean, as determined by a court of competent jurisdiction, willful misconduct, gross
                                            negligence or a material breach of this Agreement by the Representative. In the event that
                                            the Company believes that the Representative has engaged in conduct constituting Cause, the
                                            Company must first notify the Representative in writing of the facts and circumstances supporting
                                            such an assertion(s), and the Representative shall have twenty (20) days to cure such alleged
                                            conduct. &ldquo;<B>Engagement Period</B>&rdquo; shall mean the period beginning on January
                                            18, 2022, and ending on the earlier of (i) August 7, 2023, (ii) the final Option Closing
                                            Date, if any, of the Offering, or (iii) the date that either party to this Agreement gives
                                            the other party to this Agreement at least thirty (30) days&rsquo; advance written notice
                                            of termination of that certain engagement letter agreement by and between the Company and
                                            the Representative, dated January 18, 2022, as amended on February 7, 2023 (the &ldquo;<B>Engagement
                                            Letter</B>&rdquo;), in accordance with the terms thereof.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Reserved]</B>.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EFFECTIVE
                                            DATE OF THIS AGREEMENT AND TERMINATION THEREOF.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effective
                                            Date</B>. This Agreement shall become effective as of the date hereof once the Company, Parent
                                            and the Representative have executed the same and delivered counterparts of such signatures
                                            to the other parties.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination</B>.
                                            The Representative shall have the right to terminate this Agreement at any time prior to
                                            any Closing Date, (i) if any domestic or international event or act or occurrence has materially
                                            disrupted, or in the Representative&rsquo;s reasonable opinion will in the immediate future
                                            materially disrupt, general securities markets in the United States; or (ii) if trading on
                                            the Exchange or the New York Stock Exchange shall have been suspended or materially limited,
                                            or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices
                                            for securities shall have been required by FINRA or by order of the Commission or any other
                                            government authority having jurisdiction; or (iii) if the United States shall have become
                                            involved in a new war or an increase in major hostilities; or (iv) if a banking moratorium
                                            has been declared by a New York State or federal authority; or (v) if a moratorium on foreign
                                            exchange trading has been declared which materially adversely impacts the United States securities
                                            markets; or (vi) if the Company shall have sustained a material loss by fire, flood, accident,
                                            hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether
                                            or not such loss shall have been insured, will, in the Representative&rsquo;s reasonable
                                            opinion, make it inadvisable to proceed with the delivery of the Firm Shares or Option Shares;
                                            or (vii) if the Company is in material breach of any of its representations, warranties or
                                            covenants hereunder; or (viii) if the Representative shall have become aware after the date
                                            hereof of a Material Adverse Change, or an adverse material change in general market conditions
                                            as in the Representative&rsquo;s judgment would make it impracticable to proceed with the
                                            offering, sale and/or delivery of the Public Securities or to enforce contracts made by the
                                            Underwriters for the sale of the Public Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expenses</B>.
                                            Notwithstanding anything to the contrary in this Agreement, except in the case of a default
                                            by the Underwriters, pursuant to Section 6.2 above, in the event that this Agreement shall
                                            not be carried out for any reason whatsoever, within the time specified herein or any extensions
                                            thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters
                                            their actual and accountable out-of-pocket expenses related to the transactions contemplated
                                            herein then due and payable (including the fees and disbursements of Representative Counsel)
                                            up to $50,000, inclusive of the payments totaling $50,000 in advance for accountable expenses
                                            previously paid by the Company to the Representative (the &ldquo;<B>Advance</B>&rdquo;),
                                            and upon demand the Company shall pay the full amount thereof to the Representative on behalf
                                            of the Underwriters; provided, however, that such expense cap in no way limits or impairs
                                            the indemnification and contribution provisions of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, any advance received by the Representative will be reimbursed to the Company to the extent not actually incurred in compliance
with FINRA Rule 5110(g)(4)(A).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification</B>.
                                            Notwithstanding any contrary provision contained in this Agreement, any election hereunder
                                            or any termination of this Agreement, and whether or not this Agreement is otherwise carried
                                            out, the provisions of Section 5 hereof shall remain in full force and effect and shall not
                                            be in any way affected by, such election or termination or failure to carry out the terms
                                            of this Agreement or any part hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.5</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Representations,
                                            Warranties, Agreements to Survive</B>. All representations, warranties and agreements contained
                                            in this Agreement or in certificates of officers of the Company submitted pursuant hereto,
                                            shall remain operative and in full force and effect regardless of (i) any investigation made
                                            by or on behalf of any Underwriter or its affiliates or selling agents, any person controlling
                                            any Underwriter, its officers or directors or any person controlling the Company or (ii)
                                            delivery of and payment for the Public Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS.</B></FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.1</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Constructive
                                            Knowledge</B>. Whenever a representation or warranty or other statement in this Agreement
                                            (including, without limitation, schedules hereto) is made with respect to a party&rsquo;s
                                            &ldquo;knowledge,&rdquo; such statement refers to the knowledge, after reasonable inquiry,
                                            of such party&rsquo;s employees or agents who were or are responsible for or involved with
                                            the indicated matter.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.2</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B>.
                                            All communications hereunder, except as herein otherwise specifically provided, shall be
                                            in writing and shall be mailed (registered or certified mail, return receipt requested),
                                            personally delivered or sent by email transmission and confirmed and shall be deemed given
                                            when so delivered or emailed and confirmed (which confirmation may be by email transmission)
                                            or if mailed, two (2) days after such mailing.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Representative:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EF
Hutton,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">division
of Benchmark Investments, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">590
Madison Avenue, 39th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Joseph T. Rallo</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>jrallo@efhuttongroupcm.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan
&amp; Worcester LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1633
Broadway</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
David E. Danovitch</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
ddanovitch@sullivanlaw.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRM
Entertainment, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1061
E Indiantown Road, Suite 110</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter,
Florida 33477</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Richard Miller, Chief Executive Officer<BR>
Email: rmiller@jupiterwellness.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Arthur Marcus</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
Amarcus@SRF.LAW</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Parent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter
Wellness, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1061
E. Indiantown Rd., Ste. 110</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter,
FL 33477</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Brian John, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
bjohn@jupiterwellness.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Arthur Marcus</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
Amarcus@SRF.LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.3</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Headings</B>.
                                            The headings contained herein are for the sole purpose of convenience of reference, and shall
                                            not in any way limit or affect the meaning or interpretation of any of the terms or provisions
                                            of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.4</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment</B>.
                                            This Agreement may only be amended by a written instrument executed by each of the parties
                                            hereto.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.5</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entire
                                            Agreement</B>. This Agreement (together with the other agreements and documents being delivered
                                            pursuant to or in connection with this Agreement) constitutes the entire agreement of the
                                            parties hereto with respect to the subject matter hereof and thereof, and supersedes all
                                            prior agreements and understandings of the parties, oral and written, with respect to the
                                            subject matter hereof. Notwithstanding anything to the contrary set forth herein, it is understood
                                            and agreed by the parties hereto that all other terms and conditions of that the Engagement
                                            Letter shall remain in full force and effect.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.6</B></FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Binding
                                            Effect</B>. This Agreement shall inure solely to the benefit of and shall be binding upon
                                            the Representative, the Underwriters, the Company and the controlling persons, directors
                                            and officers referred to in Section 5 hereof, and their respective successors, legal representatives,
                                            heirs and assigns, and no other person shall have or be construed to have any legal or equitable
                                            right, remedy or claim under or in respect of or by virtue of this Agreement or any provisions
                                            herein contained. The term &ldquo;successors and assigns&rdquo; shall not include a purchaser,
                                            in its capacity as such, of securities from any of the Underwriters.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.7</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
                                            Law; Consent to Jurisdiction; Trial by Jury</B>. This Agreement shall be governed by and
                                            construed and enforced in accordance with the laws of the State of New York, without giving
                                            effect to conflict of laws principles thereof to the extent that such principles or rules
                                            would require or permit the application of the laws of any jurisdiction other than those
                                            of the State of New York. The Company hereby agrees that any action, proceeding or claim
                                            against it arising out of, or relating in any way to this Agreement shall be brought and
                                            enforced in the New York Supreme Court, County of New York, or in the United States District
                                            Court for the Southern District of New York, and irrevocably submits to such jurisdiction,
                                            which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive
                                            jurisdiction and that such courts represent an inconvenient forum. Any such process or summons
                                            to be served upon the Company may be served by transmitting a copy thereof by registered
                                            or certified mail, return receipt requested, postage prepaid, addressed to it at the address
                                            set forth in Section 9.1 hereof. Such mailing shall be deemed personal service and shall
                                            be legal and binding upon the Company in any action, proceeding or claim. Each of the Company
                                            and the Underwriters agrees that the prevailing party(ies) in any such action shall be entitled
                                            to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses
                                            relating to such action or proceeding and/or incurred in connection with the preparation
                                            therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf
                                            of its stockholders and affiliates) and each of the Underwriters hereby irrevocably waives,
                                            to the fullest extent permitted by applicable law, any and all right to trial by jury in
                                            any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
                                            hereby.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.8</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Execution
                                            in Counterparts</B>. This Agreement may be executed in one or more counterparts, and by the
                                            different parties hereto in separate counterparts, each of which shall be deemed to be an
                                            original, but all of which taken together shall constitute one and the same agreement, and
                                            shall become effective when one or more counterparts has been signed by each of the parties
                                            hereto and delivered to each of the other parties hereto. Delivery of a signed counterpart
                                            of this Agreement by email/pdf transmission shall constitute valid and sufficient delivery
                                            thereof.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.9</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Waiver,
                                            etc</B>. The failure of any of the parties hereto to at any time enforce any of the provisions
                                            of this Agreement shall not be deemed or construed to be a waiver of any such provision,
                                            nor to in any way affect the validity of this Agreement or any provision hereof or the right
                                            of any of the parties hereto to thereafter enforce each and every provision of this Agreement.
                                            No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this
                                            Agreement shall be effective unless set forth in a written instrument executed by the party
                                            or parties against whom or which enforcement of such waiver is sought; and no waiver of any
                                            such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver
                                            of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page Follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the understanding between the Underwriters, the Company and Parent, please so indicate in the space
provided below for that purpose, whereupon this letter shall constitute a binding agreement between us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SRM
    ENTERTAINMENT, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Richard Miller </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Miller</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JUPITER
    WELLNESS, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian S. John</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    S. John </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
of the date first written above mentioned, on behalf of itself and as Representative of the several Underwriters named on <U>Schedule
1</U> hereto:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EF
    HUTTON,</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>division
    of Benchmark Investments, LLC</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Sam Fleischman</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam
    Fleischman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supervisory
    Principal </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
1</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <BR> Number<BR> of Firm Shares<BR> to be<BR> Purchased</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <BR> Additional <BR> Option Shares to be<BR> Purchased if the <BR> Over-Allotment<BR> Option<BR> is Fully<BR> Exercised</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">EF Hutton, division of Benchmark Investments, LLC</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">1,195,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">179,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dominari Securities LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Westpark Capital, Inc.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">750</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">TOTAL</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,250,000</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">187,500</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
2-A</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Firm Shares: 1,250,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Option Shares: 187,500</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Firm Share: $5.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Option Share: $5.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Discount per Firm Share: $0.40</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Discount per Option Share: $0.40</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Firm Share (before expenses): $4.60</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Option Share (before expenses): $4.60</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
2-B</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer
General Use Free Writing Prospectuses</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
2-C</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
Testing-the-Waters Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
3</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>List
of Lock-Up Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
and Executive Officers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    Miller</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    McKinnon</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taft
    Flittner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deborah
    McDaniel-Hand</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    John</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Herman</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Melton</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hans
    Haywood</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Skender Fani</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glynn
    Wilson</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hector
    Alila</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nancy
    Torres Kaufman</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
Stockholders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter
    Wellness, Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
A</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Form
of Representative&rsquo;s Warrant</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-decoration: none">(See
attached.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
B</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Lock-Up Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________,
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EF
HUTTON,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">division
of Benchmark Investments, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
Representative of the Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">590
Madison Avenue, 39th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that EF Hutton, division of Benchmark Investments, LLC (the &ldquo;<B>Representative</B>&rdquo;), proposes to
enter into an Underwriting Agreement (the &ldquo;<B>Underwriting Agreement</B>&rdquo;) with SRM Entertainment, Inc., a Nevada corporation
(the &ldquo;<B>Company</B>&rdquo;), and Jupiter Wellness, Inc., a Delaware corporation (&ldquo;<B>Parent</B>&rdquo;), providing for the
public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of shares of the Company&rsquo;s common stock, par value $0.0001 per share
(the &ldquo;<B>Common Stock</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
induce the Representative to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without
the prior written consent of the Representative, the undersigned will not, during the period commencing on the date hereof and ending
ninety (90) days after the date of the Underwriting Agreement (the &ldquo;<B>Lock-Up Period</B>&rdquo;), (1) offer, pledge, sell, contract
to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible
into or exercisable or exchangeable for shares of Common Stock, whether now owned or hereafter acquired by the undersigned or with respect
to which the undersigned has or hereafter acquires the power of disposition (collectively, the &ldquo;<B>Lock-Up Securities</B>&rdquo;);
(2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Lock-Up Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up
Securities, in cash or otherwise; (3) make any demand for or exercise any right with respect to the registration of any Lock-Up Securities;
or (4) publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge
or other arrangement relating to any Lock-Up Securities. Notwithstanding the foregoing, and subject to the conditions below, the undersigned
may transfer Lock-Up Securities without the prior written consent of the Representative in connection with (a) transactions relating
to Lock-Up Securities acquired in open market transactions after the completion of the Public Offering; provided that no filing under
Section 13 or Section 16(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), or other public
announcement shall be required or shall be voluntarily made during the Lock-Up Period in connection with subsequent sales of Lock-Up
Securities acquired in such open market transactions; (b) transfers of Lock-Up Securities as a bona fide gift, by will or intestacy or
to a family member or trust for the benefit of the undersigned or a family member (for purposes of this lock-up agreement, &ldquo;family
member&rdquo; means any relationship by blood, marriage or adoption, not more remote than first cousin); (c) transfers of Lock-Up Securities
to a charity or educational institution; or (d) if the undersigned, directly or indirectly, controls a corporation, partnership, limited
liability company or other business entity, any transfers of Lock- Up Securities to any shareholder, partner or member of, or owner of
similar equity interests in, the undersigned, as the case may be; provided that in the case of any transfer pursuant to the foregoing
clauses (b), (c) or (d), (i) it shall be a condition to any such transfer that (i) the transferee/donee agrees to be bound by the terms
of this lock-up agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as
if the transferee/donee were a party hereto; (ii) each party (donor, donee, transferor or transferee) shall not be required by law (including
without limitation the disclosure requirements of the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), and
the Exchange Act) to make, and shall agree to not voluntarily make, any filing or public announcement of the transfer or disposition
prior to the expiration of the Lock-Up Period; and (iii) the undersigned notifies the Representative at least two (2) business days prior
to the proposed transfer or disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the foregoing restrictions shall not apply to (i) the exercise or vesting of stock options or other equity awards granted pursuant
to the Company&rsquo;s equity incentive plans; provided that it shall apply to any of the undersigned&rsquo;s shares of Common Stock
issued upon such exercise, (ii) the conversion or exercise of convertible debt or warrants; provided that it shall apply to any of the
undersigned&rsquo;s shares of Common Stock issued upon such exercise, or (iii) the establishment of any new plan (a &ldquo;<B>Plan</B>&rdquo;)
that satisfies all of the requirements of Rule 10b5-1I(1)(i)(B) under the Exchange Act; provided that no sales of the undersigned&rsquo;s
securities of the Company shall be made pursuant to such new Plan prior to the expiration of the Lock-Up Period (as such may have been
extended pursuant to the provisions hereof), and such a Plan may only be established if no public announcement of the establishment or
existence thereof and no filing with the U.S. Securities and Exchange Commission or other regulatory authority in respect thereof or
transactions thereunder or contemplated thereby, by the undersigned, the Company or any other person, shall be required, and no such
announcement or filing is made voluntarily, by the undersigned, the Company or any other person, prior to the expiration of the Lock-Up
Period (as such may have been extended pursuant to the provisions hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned also agrees and consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar
against the transfer of the undersigned&rsquo;s Lock-Up Securities subject to this lock-up agreement except in compliance herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees that, prior to engaging in any transaction or taking any other action that is subject to the terms of this lock-up
agreement during the period from the date hereof to and including the thirty-fourth (34<SUP>th</SUP>) day following the expiration of
the Lock-Up Period, the undersigned will give notice thereof to the Company and will not consummate any such transaction or take any
such action unless it has received written confirmation from the Company that the Lock-Up Period has expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is an officer or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be equally
applicable to any shares of Common Stock that the undersigned may purchase or receive as a distribution in connection with the Public
Offering; (ii) the Representative agrees that, at least three (3) business days before the effective date of any release or waiver of
the foregoing restrictions in connection with a transfer of Lock-Up Securities, the Representative will notify the Company of the impending
release or waiver; and (iii) the Company has agreed in the Underwriting Agreement to announce the impending release or waiver by press
release through a major news service at least two (2) business days before the effective date of the release or waiver. Any release or
waiver granted by the Representative hereunder to any such officer or director shall only be effective two (2) business days after the
publication date of such press release. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely
to permit a transfer of Lock-Up Securities not for consideration and (b) the transferee has agreed in writing to be bound by the same
terms described in this lock-up agreement to the extent and for the duration that such terms remain in effect at the time of such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation
of the Public Offering. The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the
undersigned&rsquo;s heirs, legal representatives, successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the
provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the shares of Common
Stock to be sold thereunder, the undersigned shall be released from all obligations under this lock-up agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
lock-up agreement shall be governed by, and construed in accordance with, the laws of the State of New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
    of Signatory, in the case of entities - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    - Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
C</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Press Release</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SRM
Entertainment, Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Date]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRM
Entertainment, Inc. (the &ldquo;Company&rdquo;) announced today that EF Hutton, division of Benchmark Investments, LLC, acting as representative
for the underwriters in the Company&rsquo;s recent public offering of the Company&rsquo;s common stock, is [waiving] [releasing] a lock-up
restriction with respect to _______________ shares of common stock held by [certain officers or directors] [an officer or director] of
the Company. The [waiver] [release] will take effect on___________, 202__, and such shares of common stock may be sold on or after such
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is
prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration
under the Securities Act of 1933, as amended.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 61; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCK
EXCHANGE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
STOCK EXCHANGE AGREEMENT (the &ldquo;Agreement&rdquo;) is entered into as of December 9, 2022, by and between Jupiter Wellness, Inc.,
a Delaware corporation (the &ldquo;Company&rdquo;) and SRM Entertainment, Inc, a Nevada corporation (&ldquo;SRM NV&rdquo;) formed on
April 24, 2022. Each party to this Agreement is individually referred to herein as a &ldquo;Party&rdquo; and collectively as the &ldquo;Parties.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company is a publicly held corporation organized under the laws of the State of Delaware and listed and traded on the NASDAQ Exchange
under the symbol JUPW;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company owns 100% of the issued and outstanding shares of SRM Entertainment LTD, a Hong Kong Special Administrative Region of the
People&rsquo;s Republic of China limited company (&ldquo;SRM Ltd&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
The Company agrees to acquire 6,500,000 shares of SRM NV&rsquo;s common stock (the &ldquo;SRM NV Common Stock&rdquo;) (representing
79.3% of SRM NV&rsquo;s outstanding common stock) in exchange for all of the issued and outstanding shares of the SRM Ltd common
stock (the &ldquo;SRM Ltd Common Stock&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
it is the intent of the Parties that SRM NV file a registration Statement (SEC Form S-1) to register certain shares of SRM NV as soon
as practicable; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
for Federal income tax purposes, it is intended that the Exchange qualify as a reorganization under the provisions of Section 368(a)
of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, on the stated premises and for and in consideration of the mutual covenants and agreements hereinafter set forth and the
mutual benefits to the parties to be derived therefrom, and intending to be legally bound hereby, it is hereby agreed as follows:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
I &ndash; SHARE EXCHANGE</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1.01 The Exchange</U><FONT STYLE="font-weight: normal">. On the terms and subject to the conditions set forth in this Agreement, on the
Closing Date (as defined below), (i) the Company shall sell, assign, transfer and deliver, free and clear of all liens, pledges, encumbrances,
charges, restrictions or known claims of any kind, nature, or description, all of the shares of SRM Ltd. Common Stock held by the Company
to SRM NV; the objective of such sale (the &ldquo;Exchange&rdquo;) being the acquisition by SRM NV of not less than 100% of the issued
and outstanding shares of SRM Ltd Common Stock. In exchange for the transfer of such securities by the Company, SRM NV shall deliver
to the Company 6,500,000 restricted shares of SRM NV Common Stock at closing (as defined below) (the &ldquo;Consideration Shares&rdquo;).</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
1.02 Closing</U></B>. The closing (&ldquo;Closing&rdquo; or &ldquo;Closing Date&rdquo;) of the transactions contemplated by this Agreement
shall take place at a mutually agreeable time and place and shall close immediately after the effective date of the SEC Form S-1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
II &ndash; TRANSITION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
2.01 Shared Employees.</U></B> Douglas McKinnon and Markita Russell are currently providing services to both the Company and SRM NV and
shall continue to do so during the transition period. For providing these services, Mr. McKinnon and Ms. Russell shall be paid $25,000
per annum directly from SRM NV. The transition period shall be mutually agreed upon by the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
2.02 Office and Facilities</U></B><U>.</U> Currently both the Company and SRM NV share the same office premises and related facilities.
The Company agrees that SRM NV may maintain its presence at the current office location until such time as it is mutually agreed that
SRM NV requires its own office and facilities, or the Parties agree on a monthly sub-lease arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ARTICLE
III &ndash; MISCELLANEOUS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
3.01 Governing Law</U></B>. This Agreement shall be governed by, enforced, and construed under and in accordance with the laws of the
laws of the State of Florida. Venue for all matters shall be in Palm Beach County, Florida, without giving effect to principles of conflicts
of law thereunder. Each of the parties (a) irrevocably consents and agrees that any legal or equitable action or proceedings arising
under or in connection with this Agreement shall be brought exclusively in the federal courts of the United States in the Southern District
of Florida. By execution and delivery of this Agreement, each party hereto irrevocably submits to and accepts, with respect to any such
action or proceeding, generally and unconditionally, the jurisdiction of the aforesaid court, and irrevocably waives any and all rights
such party may now or hereafter have to object to such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
3.02 Notices</U></B>. Any notice or other communications required or permitted hereunder shall be in writing and shall be sufficiently
given if personally delivered to it or sent by telecopy, overnight courier or registered mail or certified mail, postage prepaid, addressed
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to SRM NV to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Richard
Miller</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>1061
E. Indiantown Rd., Ste. 110</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jupiter,
FL 33477</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to JUPW to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Brian S. John</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>1061
E. Indiantown Rd., Ste. 110</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jupiter,
FL 33477</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
such other addresses as shall be furnished in writing by any party in the manner for giving notices hereunder, and any such notice or
communication shall be deemed to have been given (i) upon receipt, if personally delivered, (ii) on the day after dispatch, if sent by
overnight courier, (iii) upon dispatch, if transmitted by telecopy and receipt is confirmed by telephone and (iv) three (3) days after
mailing, if sent by registered or certified mail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
3.03 Attorney&rsquo;s Fees</U></B>. In the event that either party institutes any action or suit to enforce this Agreement or to secure
relief from any default hereunder or breach hereof, the prevailing party shall be reimbursed by the losing party for all costs, including
reasonable attorney&rsquo;s fees, incurred in connection therewith and in enforcing or collecting any judgment rendered therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
3.04 Confidentiality</U></B>. Each party hereto agrees with the other that, unless and until the transactions contemplated by this Agreement
have been consummated, it and its representatives will hold in strict confidence all data and information obtained with respect to another
party or any subsidiary thereof from any representative, officer, director or employee, or from any books or records or from personal
inspection, of such other party, and shall not use such data or information or disclose the same to others, except (i) to the extent
such data or information is published, is a matter of public knowledge, or is required by law to be published; or (ii) to the extent
that such data or information must be used or disclosed in order to consummate the transactions contemplated by this Agreement. In the
event of the termination of this Agreement, each party shall return to the other party all documents and other materials obtained by
it or on its behalf and shall destroy all copies, digests, work papers, abstracts or other materials relating thereto, and each party
will continue to comply with the confidentiality provisions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
2.05 Expenses</U></B>. The Company will bear the expenses, including legal, accounting and professional fees, incurred in connection
with the Exchange or any of the other transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
2.06 Entire Agreement</U></B>. This Agreement represents the entire agreement between the parties relating to the subject matter thereof
and supersedes all prior agreements, understandings and negotiations, written or oral, with respect to such subject matter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JUPITER WELLNESS, INC.:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian John</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
S. John </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/09/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRM ENTERTAINMENT, INC.:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Richard Miller</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
Miller </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/09/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive
    Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDED
AND RESTATED STOCK EXCHANGE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">between<BR>
<BR></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JUPITER
WELLNESS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRM
ENTERTAINMENT, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
as of May 26, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDED
AND RESTATED STOCK EXCHANGE AGREEMENT, dated as of May 26, 2023 between Jupiter Wellness, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and SRM Entertainment, Inc., a Nevada corporation (&ldquo;<U>SRM</U>&rdquo;) (the Company and SRM each a &ldquo;<U>Party</U>&rdquo; and
together, the &ldquo;<U>Parties</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
on December 9, 2022, the Parties entered into a Stock Exchange Agreement (the &ldquo;<U>Original Agreement</U>&rdquo;) whereby SRM agreed
to acquire all of the capital stock of SRM Ltd., as defined below;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company is a publicly held corporation organized under the laws of the State of Delaware and its shares of common stock are listed
and traded on the Nasdaq Stock Market LLC under the symbol JUPW;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company owns 100% of the issued and outstanding ordinary shares of SRM Entertainment LTD, a Hong Kong Special Administrative Region
of the People&rsquo;s Republic of China limited company (&ldquo;<U>SRM Ltd</U>&rdquo;), which currently operates the Company&rsquo;s
business segment that creates and sells innovative products for the toy and entertainment industries (the &ldquo;<U>SRM Business</U>&rdquo;),
and owns all of the assets and liabilities related thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Parties have determined to effect a separation of the SRM Business from the Company (the &ldquo;<U>Separation</U>&rdquo;) whereby
the SRM Business will be contributed to SRM and all expenses related thereto shall be the responsibility of SRM, in each case, on the
terms and subject to the conditions set forth herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
to effect the Separation, the Company desires to acquire 6,500,000 shares of SRM&rsquo;s common stock, par value $0.0001 per share (the
&ldquo;<U>SRM Common Stock</U>&rdquo;), (representing approximately 80.0% of SRM&rsquo;s outstanding common stock post-exchange) in exchange
for all of the issued and outstanding ordinary shares of SRM Ltd owned by the Company (the &ldquo;<U>SRM Ltd Shares</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
SRM intends to file with the Securities and Exchange Commission (&ldquo;<U>SEC</U>&rdquo;) a draft Registration Statement on Form S-1
(the &ldquo;<U>IPO Registration Statement</U>&rdquo;) to register certain shares of SRM Common Stock to be sold in an initial public
offering of SRM (the &ldquo;<U>SRM IPO</U>&rdquo;) and to be distributed to stockholders of the Company as of a record date (the &ldquo;<U>Record
Date</U>&rdquo;) to be determined by the Company (the &ldquo;<U>Distribution</U>&rdquo;), drafts of which have been confidentially submitted
to the SEC; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company and SRM have determined that it is necessary and desirable to amend and restate the Original Agreement in its entirety on
the terms and conditions set forth herein, effective as of the date stated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing premises and the covenants and agreements contained in this Agreement, and intending to
be legally bound hereby, the Parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share
Exchange</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.01.
<U>Share Exchange</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Share Exchange</U>. On the terms and subject to the conditions set forth in this Agreement, at or prior to the effective time of the
IPO Registration Statement (the &ldquo;<U>Effective Time</U>&rdquo;), the Company shall contribute, convey, transfer, assign and deliver
to SRM, as a contribution, all of its right, title and interest in and to the SRM Ltd Shares owned by it, free and clear of all liens
and encumbrances, and in exchange therefor, SRM will accept and agree to assume all obligations with respect to such SRM Ltd Shares,
if any, from and after the Effective Time and shall issue to the Company 6,500,000 shares of SRM Common Stock (the &ldquo;<U>Share Exchange</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Costs and Expenses for Transfer of Assets and Liabilities</U>. Any costs and expenses incurred to effect any assignment, transfer,
conveyance and delivery contemplated by this <U>Section 1.01</U> shall, except as set forth herein, be the responsibility of the Company.
Other than costs and expenses incurred in accordance with the foregoing, nothing in this <U>Section 1.01(b)</U> shall require any Party
to incur any material obligation or grant any material concession for the benefit of any member of the other Party in order to effect
any transaction contemplated by this <U>Section 1.01</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In the event that at any time after the Effective Time, a Party becomes aware that an SRM Asset (as defined below) has not been transferred
pursuant to <U>Section 1.01(a)</U>, the Parties shall cause the prompt transfer of such SRM Asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02.
<U>Vendor and other Contracts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
current contracts pertaining to the SRM Business are in the name of SRM Ltd. In the event that any contract necessary to operate the
business of SRM are in the Company&rsquo;s name, the Company shall obtain the necessary consents to transfer such contracts to SRM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SRM IPO </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01.
<U>Sole and Absolute Discretion; Cooperation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of the underwriting agreement to be entered into between the Company, SRM and the underwriters in the SRM IPO (the &ldquo;<U>Underwriting
Agreement</U>&rdquo;), the Company and SRM shall mutually determine the terms of the SRM IPO, including the form, structure and terms
of any transaction(s) and/or offering(s) to effect the SRM IPO and the timing and conditions to the consummation of the SRM IPO. In addition,
subject to the terms of the Underwriting Agreement, the Company and SRM may, at any time and from time to time until the consummation
of the SRM IPO, modify or change the terms of the SRM IPO, including by accelerating or delaying the timing of the consummation of all
or part of the SRM IPO. SRM shall cooperate with the Company to accomplish the SRM IPO and shall promptly take any and all actions necessary
or desirable to effect the SRM IPO, including, without limitation, the registration under the Securities Act of 1933, as amended (the
Securities Act&rdquo;), shares of SRM Common Stock on an appropriate registration form or forms to be designated by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.02.
<U>Actions Prior to the SRM IPO</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to the conditions specified in this Section 2.02, the Company and SRM shall use their reasonable best efforts to consummate the
SRM IPO. Such actions shall include, but not necessarily be limited to, those specified in this <U>Section 2.02</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Registration Statements. </I>SRM shall prepare and file the IPO Registration Statement, and shall file such amendments or supplements
thereto, and shall use its reasonable best efforts to cause the same to become and remain effective as required by law or by the Underwriting
Agreement, including, but not limited to, filing such amendments to the IPO Registration Statement as may be required by the Underwriting
Agreement, the SEC or federal, state or foreign securities laws. The IPO Registration Statement and any preliminary, final or supplemental
prospectus forming a part of the Registration Statement (each, a &ldquo;<U>Prospectus</U>&rdquo;) shall contain such information as is
required under the Securities Act. The Company and SRM shall also cooperate in preparing, filing with the SEC and causing to become effective
a registration statement registering the SRM Common Stock under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Underwriting Activities. </I>SRM and the Company shall enter into the Underwriting Agreement, in form and substance reasonably satisfactory
to the Company and SRM and shall comply with their obligations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>SRM IPO Consultation. </I>The Company and SRM shall consult with each other and the underwriter in the SRM IPO (the &ldquo;<U>Underwriter</U>&rdquo;)
regarding the timing, pricing and other material matters with respect to the SRM IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<I>Nasdaq Listing. </I>SRM shall prepare, file and use its reasonable best efforts to have the SRM Common Stock approved for listing
on Nasdaq, subject to official notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<I>Preparation of Materials. </I>SRM shall participate in the preparation of materials and presentations as the Underwriter shall deem
necessary or desirable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<I>SRM IPO Costs. </I> SRM shall pay all third-party costs, fees and expenses relating to the SRM IPO, all of the reimbursable expenses
of the Underwriter pursuant to the Underwriting Agreement, all of the costs of producing, printing, mailing and otherwise distributing
the Prospectus, as well as the Underwriter&rsquo;s discount as provided in the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<I>SRM Directors and Officers. </I>On or prior to the Effective Time the Company and SRM shall take all necessary actions so that, as
of such time, the directors and executive officers of SRM shall be those set forth in the IPO Registration Statement, unless otherwise
agreed by the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.03.
<U>Conditions Precedent to Consummation of the SRM IPO</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to <U>Section 2.01</U>, as soon as practicable after the date of this Agreement, the Parties hereto shall use their reasonable
best efforts to satisfy the conditions to the consummation of the SRM IPO set forth in this <U>Section 2.03</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Share Exchange shall have occurred as contemplated by <U>Section 1.01</U> so that by operation of law SRM owns all of the SRM Assets
or has licenses to any assets necessary to operate the SRM Business as conducted by the Company and SRM Ltd immediately prior to the
Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The IPO Registration Statement shall have been filed and declared effective by the SEC, and there shall be no stop-order in effect with
respect thereto, and no proceeding for that purpose shall have been instituted by the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The shares of SRM Common Stock shall have been approved for listing on Nasdaq, subject to official notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
SRM and the Company shall have entered into the Underwriting Agreement, and all conditions to the obligations of SRM, the Company and
the Underwriter shall have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
No order, injunction or decree issued by any court or agency of competent jurisdiction or other legal restraint or prohibition preventing
the consummation of the Separation or the SRM IPO or any of the other transactions contemplated by this Agreement shall be in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
Such other actions as the parties hereto may, based upon the advice of counsel, reasonably requested to be taken prior to the Separation
and the SRM IPO in order to assure the successful completion of the Separation and the SRM IPO and the other transactions contemplated
by this Agreement shall have been taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
This Agreement shall not have been terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
No event or development shall have occurred or exist or be expected to occur that, in the judgment of the Company&rsquo;s Board of Directors,
in its sole discretion, makes it inadvisable to effect the Share Exchange or the SRM IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The foregoing conditions are for the sole benefit of the Company and shall not give rise to or create any duty on the part of the Company
to waive or not waive such conditions or in any way limit the Company&rsquo;s right to terminate this Agreement or alter the consequences
of any such termination from those specified in such Article. Any determination made by the Company&rsquo;s board prior to the entry
into the Underwriting Agreement concerning the satisfaction or waiver of any or all of the conditions set forth in this <U>Section 2.03
</U>shall be conclusive. This Agreement may only be terminated in accordance with <U>Section 9.01</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
DISTRIBUTION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.01.
<U>Sole and Absolute Discretion; Cooperation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall effect the Distribution as promptly as possible following the Effective Time; <U>provided</U>, <U>however</U>, that
prior to the Effective Time, the Company and SRM may determine whether to proceed with, the Distribution. Subject to any restrictions
contained in the Underwriting Agreement, the Company shall have the sole discretion to determine the declaration and payment dates of
the Distribution at any time prior to the Effective Time, and the payment date as so determined by the Company is referred to herein
as the &ldquo;Distribution Date.&rdquo; The Distribution will not take place unless the IPO Registration Statement is declared effective
by the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
SRM shall cooperate with the Company to accomplish the Distribution and shall, at the Company&rsquo;s direction, promptly take any and
all actions necessary or desirable to effect the Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.02.
<U>Actions Prior to the Distribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Distribution Date and subject to the terms and conditions set forth herein, the Parties shall take, or cause to be taken, the
following actions in connection with the Distribution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Securities Law Matters</I>. The Company and SRM shall prepare, prior to the Distribution, for the holders of shares of common stock
of the Company, such information concerning SRM, its business, operations and management, the Distribution and such other matters as
the Company shall reasonably determine and as may be required by law. The Company and SRM will prepare and file with the SEC any such
documentation, which the Company and SRM determine to be necessary or desirable to effectuate the Distribution, and the Company and SRM
shall each use its reasonable best efforts to obtain all necessary approvals from the SEC with respect thereto as soon as practicable.
The IPO Registration Statement shall serve to have satisfied this requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>The Distribution Agent</I>. The Company shall enter into an agreement with VStock Transfer, LLC, the Company&rsquo;s transfer agent
(the &ldquo;Agent&rdquo;), or otherwise provide instructions to the Agent regarding the Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.03
<U>Conditions to the Distribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The consummation of the Distribution will be subject to the satisfaction, or waiver by the Company in its sole and absolute discretion,
of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The actions and filings necessary or appropriate under applicable U.S. federal, U.S. state or other securities laws, including, but not
limited to the Securities Act and the Exchange Act and the rules and regulations promulgated thereunder, in connection with the Distribution
shall have been taken or made, and, where applicable, have become effective or been accepted by the applicable governmental authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
No order, injunction or decree issued by any governmental authority of competent jurisdiction or other legal restraint or prohibition
preventing the consummation of the Distribution or any of the transactions related thereto shall be in effect, and no other event outside
the control of the Company shall have occurred or failed to occur that prevents the consummation of the Distribution or any related transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The shares of SRM Common Stock shall have been approved for listing on Nasdaq, subject to official notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The foregoing conditions are for the sole benefit of the Company and shall not give rise to or create any duty on the part of the Company
or the Company&rsquo;s board to waive or not waive any such condition or in any way limit the Company&rsquo;s right to terminate this
Agreement or alter the consequences of any such termination from those specified herein. Any determination made by the Company&rsquo;s
board prior to the Distribution concerning the satisfaction or waiver of any or all of the conditions set forth in <U>Section 2.03(a)
</U>shall be conclusive and binding on the Parties. The Company&rsquo;s ability to terminate this Agreement shall cease upon the execution
of the IPO Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.04.
<U>The Distribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subject to <U>Section 2.03</U>, on or prior to the Distribution Date, the Company will instruct the Agent to set aside 2,000,000 of the
shares of SRM Common Stock to be issued to the Company in the Separation for the benefit of holders of shares of common stock of the
Company and certain warrants issued in the Company&rsquo;s July 2021 offering (the &ldquo;<U>July Warrants</U>&rdquo;) on a record date
to be determined by the Company (the &ldquo;<U>Record Date</U>&rdquo;) to effect the Distribution, and shall cause the Agent to distribute,
as of the Distribution Date, the appropriate number of whole shares of SRM Common Stock to each such holder (the &ldquo;<U>Record Holder</U>&rdquo;)
or designated transferee or transferees of any Record Holder by way of direct registration in book-entry form. The Distribution shall
be effective as of the Distribution Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Each Record Holder will be entitled to receive in the Distribution a number of whole shares of SRM Common Stock equal to the number of
shares of common stock of the Company or shares of common stock of the Company underlying the July Warrants held by such Record Holder
on the Record Date multiplied by the distribution ratio to be determined by the Company, rounded up to the nearest whole number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Until the shares of SRM Common Stock are duly transferred in accordance with this <U>Section 3.04</U> and applicable law, from and after
the Distribution Date, SRM will regard the individuals or entities entitled to receive such shares of SRM Common Stock in accordance
with this <U>Section 3.04</U> as record holders of shares of SRM Common Stock in accordance with the terms of the Distribution without
requiring any action on the part of such individuals or entities. SRM agrees that, subject to any transfers of such shares, from and
after the Distribution Date, (i) each such holder will be entitled to receive all dividends, if any, payable on, and exercise voting
rights and all other rights and privileges with respect to, the shares of SRM Common Stock then held by such holder, and (ii) each such
holder will be entitled, without any action on the part of such holder, to receive evidence of ownership of the shares of SRM Common
Stock then held by such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY
RELEASE; INDEMNIFICATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.01.
<U>Release of Pre-Separation Claims</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Company Release of SRM. </I>Effective as of the Effective Time, the Company does hereby, for itself and each of its subsidiaries and
their respective successors and assigns, and, to the extent permitted by law, all individuals who at any time prior to the Effective
Time have been stockholders, directors, officers, agents or employees of the Company (in each case, in their respective capacities as
such), remise, release and forever discharge (i) SRM and their respective successors and assigns, including SRM Ltd, and (ii) all stockholders,
directors, officers, agents or employees of SRM or SRM Ltd other than the Company (such persons released in this Section 4.01(a) shall
be referred to as the &ldquo;SRM Persons&rdquo;, in each case, in their respective capacities as such), and their respective heirs, executors,
administrators, successors and assigns, from (A) all of the liabilities of the Company, (B) all liabilities arising from or in connection
with the transactions and all other activities to implement the Separation, the Share Exchange, the SRM IPO and the Distribution and
(C) all damages arising from or in connection with actions, inactions, events, omissions, conditions, facts or circumstances occurring
or existing prior to or following the Effective Time (whether or not such labilities cease being contingent, mature, become known, are
asserted or foreseen, or accrue, in each case before, at or after the Effective Time), in each case to the extent relating to, arising
out of or resulting from the business of the Company or any liability of the Company (the &ldquo;<U>Company Liabilities</U>&rdquo;).
To avoid ambiguity, the Company agrees that in the event that an action is brought against the Company related to the Separation, the
Share Exchange, the SRM IPO or the Distribution, the Company agrees not to bring any claim against SRM or any SRM Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>No Claims. </I> The Company shall not make any claim or demand, or commence any judicial proceeding asserting any claim or demand,
including any claim of contribution or any indemnification, against SRM, or any other SRM Person released pursuant to <U>Section 4.01(b)</U>,
with respect to any SRM Liabilities (as defined below) released pursuant to <U>Section 4.01(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.02.
<U>Indemnification by SRM</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise specifically set forth in this Agreement, to the fullest extent permitted by Law, SRM shall, indemnify, defend and hold
harmless the Company and each stockholder, director, officer, agent or employees of the Company, and each of the heirs, executors, successors
and assigns of any of the foregoing (collectively, the &ldquo;<U>Company Indemnitees</U>&rdquo;), from and against any and all liabilities
of the Company Indemnitees relating to, arising out of or resulting from, directly or indirectly, any of the following items (without
duplication):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any the SRM Business or the SRM Assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any SRM Liability;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
any failure of SRM to pay, perform or otherwise promptly discharge any SRM Liability in accordance with their terms, whether prior to,
on or after the Effective Time; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
any material breach by SRM of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.03.
<U>Indemnification by the Company</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise specifically set forth in this Agreement, to the fullest extent permitted by law, the Company shall, and shall cause the
other members of the Company to, indemnify, defend and hold harmless SRM and each SRM Person or their respective past, present and future
directors, officers, employees or agents, in each case in their respective capacities as such, and each of the heirs, executors, successors
and assigns of any of the foregoing (collectively, the &ldquo;<U>SRM Indemnitees</U>&rdquo;), from and against any and all liabilities
of the SRM Indemnitees relating to, arising out of or resulting from, directly or indirectly, any of the following items (without duplication):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
any Company Liability or the Company&rsquo;s assets or business other than the SRM Business or the SRM Assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
any failure of the Company to pay, perform or otherwise promptly discharge any of the Company Liabilities in accordance with their terms,
whether prior to, on or after the Effective Time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
any breach by the Company of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Company Taxes (as defined below);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
any untrue statement or alleged untrue statement of a material fact or omission or alleged omission to state a material fact required
to be stated therein or necessary to make the statements therein not misleading, with respect to all information (i) contained in the
IPO Registration Statement or any Prospectus (including in any amendments or supplements thereto), (ii) contained in any public filings
made by the Company with the SEC following the date of the SRM IPO, or (iii) provided by the Company to SRM specifically for inclusion
in SRM&rsquo;s annual or quarterly or current reports following the date of the SRM IPO; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
any action brought against SRM relating to the SRM IPO, the Separation, the Share Exchange or the Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.04.
<U>Indemnification Obligations Net of Insurance Proceeds and Other Amounts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Parties intend that any liability subject to indemnification (an &ldquo;<U>Indemnified Liability</U>&rdquo;), contribution or reimbursement
pursuant to this <U>Article IV</U> will be net of any insurance proceeds or other amounts actually recovered (net of any out-of-pocket
costs or expenses incurred in the collection thereof) from any individual or entity by or on behalf of the Indemnitee (as defined below)
in respect of any Indemnifiable Liability pursuant to an insurance policy (an &ldquo;<U>Insurance Policy</U>&rdquo;). Accordingly, the
amount which either Party (an &ldquo;<U>Indemnifying Party</U>&rdquo;) is required to pay to any person entitled to indemnification or
contribution hereunder (an &ldquo;<U>Indemnitee</U>&rdquo;) will be reduced by any insurance proceeds or other amounts actually recovered
(net of any out-of-pocket costs or expenses incurred in the collection thereof) from any person by or on behalf of the Indemnitee in
respect of the related Indemnified Liability. If an Indemnitee receives a payment (an &ldquo;<U>Indemnity Payment</U>&rdquo;) required
by this Agreement from an Indemnifying Party in respect of any Indemnified Liability and subsequently receives any insurance proceeds
or any other amounts in respect of such Indemnified Liability, then within ten (10) calendar days of receipt of such insurance proceeds,
the Indemnitee will pay to the Indemnifying Party an amount equal to the excess of the Indemnity Payment received over the amount of
the Indemnity Payment that would have been due if the insurance proceeds or such other amounts (net of any out-of-pocket costs or expenses
incurred in the collection thereof) had been received, realized or recovered before the Indemnity Payment was made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Parties agree that it is their intent that an insurer that would otherwise be obligated to pay any claim shall not be relieved of
the responsibility with respect thereto or, solely by virtue of any provision contained in this Agreement , have any subrogation rights
with respect thereto, it being understood that no insurer or any other Indemnified Party shall be entitled to a &ldquo;windfall&rdquo;
(<I>i.e.</I>, a benefit they would not be entitled to receive in the absence of the indemnification provisions) by virtue of the indemnification
and contribution provisions hereof. Each Party shall use commercially reasonable efforts (taking into account the probability of success
on the merits and the cost of expending such efforts, including attorneys&rsquo; fees and expenses) to collect or recover any Insurance
Proceeds that may be collectible or recoverable respecting the Indemnified Liabilities for which indemnification or contribution may
be available under this <U>Article IV</U>. Notwithstanding the foregoing, an Indemnifying Party may not delay making any indemnification
payment required under the terms of this Agreement, or otherwise satisfying any indemnification obligation, pending the outcome of any
action to collect or recover insurance proceeds, and an Indemnitee need not attempt to collect any insurance proceeds prior to making
a claim for indemnification or contribution or receiving any Indemnity Payment otherwise owed to it under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.05.
<U>Procedures for Indemnification of Third-Party Claims</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Notice of Claims. </I>If, at or following the Effective Time, an Indemnitee shall receive notice or otherwise learn of the assertion
by an individual or entity who is not themselves an Indemnified Party (including any federal, state or foreign government of government
agency (a &ldquo;Governmental Authority&rdquo;) who is not a subsidiary of the Company of any claim or of the commencement by any such
person of any action (collectively, a &ldquo;<U>Third-Party Claim</U>&rdquo;) with respect to which an Indemnifying Party may be obligated
to provide indemnification to such Indemnitee pursuant to <U>Section 4.02</U> or <U>4.03</U>, or any other Section of this Agreement,
such Indemnitee shall give such Indemnifying Party written notice thereof as soon as practicable, but in any event within fourteen (14)
days (or sooner if the nature of the Third-Party Claim so requires) after becoming aware of such Third-Party Claim. Any such notice shall
describe the Third-Party Claim in reasonable detail, including the facts and circumstances giving rise to such claim for indemnification,
and include copies of all notices and documents (including court papers) received by the Indemnitee relating to the Third-Party Claim.
Notwithstanding the foregoing, the failure of an Indemnitee to provide notice in accordance with this <U>Section 4.05(a)</U> shall not
relieve an Indemnifying Party of its indemnification obligations under this Agreement, except to the extent to which the Indemnifying
Party is actually prejudiced by the Indemnitee&rsquo;s failure to provide notice in accordance with this <U>Section 4.05(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Control of Defense. </I>Subject to any insurer&rsquo;s rights pursuant to an Insurance Policy of either Party, an Indemnifying Party
may elect to defend (and seek to settle or compromise), at its own expense and with its own counsel, any Third-Party Claim; <U>provided</U>,
that, prior to the Indemnifying Party assuming and controlling defense of such Third-Party Claim, it shall first confirm to the Indemnitee
in writing that, assuming the facts presented to the Indemnifying Party by the Indemnitee being true, the Indemnifying Party shall indemnify
the Indemnitee for any such damages to the extent resulting from, or arising out of, such Third-Party Claim. Notwithstanding the foregoing,
if the Indemnifying Party assumes such defense and, in the course of defending such Third-Party Claim, (i) the Indemnifying Party discovers
that the facts presented at the time the Indemnifying Party acknowledged its indemnification obligation in respect of such Third-Party
Claim were not true in all material respects and (ii) such untruth provides a reasonable basis for asserting that the Indemnifying Party
does not have an indemnification obligation in respect of such Third-Party Claim, then (A) the Indemnifying Party shall not be bound
by such acknowledgment, (B) the Indemnifying Party shall promptly thereafter provide the Indemnitee written notice of its assertion that
it does not have an indemnification obligation in respect of such Third-Party Claim and (C) the Indemnitee shall have the right to assume
the defense of such Third-Party Claim. Within thirty (30) days after the receipt of a notice from an Indemnitee in accordance with <U>Section
4.5(a)</U> (or sooner, if the nature of the Third-Party Claim so requires), the Indemnifying Party shall provide written notice to the
Indemnitee indicating whether the Indemnifying Party shall assume responsibility for defending the Third-Party Claim and specifying any
reservations or exceptions to its defense. If an Indemnifying Party elects not to assume responsibility for defending any Third-Party
Claim as provided in this <U>Section 4.5(b)</U> or fails to notify an Indemnitee of its election within thirty (30) days after receipt
of the notice from an Indemnitee as provided in <U>Section 4.5(a)</U>, then the Indemnitee that is the subject of such Third-Party Claim
shall be entitled to continue to conduct and control the defense of such Third-Party Claim. Notwithstanding anything herein to the contrary,
to the extent a Third-Party Claim involves or would reasonably be expected to involve both an SRM Liability and the Company Liability
(collectively, a &ldquo;<U>Shared Third-Party Claim</U>&rdquo;), the Company shall have the sole right to defend and control such portion
of any Action relating to such Third-Party Claim to the extent it relates to a the Company Liability, and SRM shall have the sole right
to defend and control such portion of any Action relating to such Third-Party Claim to the extent it relates to an SRM Liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Allocation of Defense Costs</I>. If an Indemnifying Party has elected to assume the defense of a Third-Party Claim, whether with or
without any reservations or exceptions with respect to such defense, then such Indemnifying Party shall be solely liable for all fees
and expenses incurred by it in connection with the defense of such Third-Party Claim and shall not be entitled to seek any indemnification
or reimbursement from the Indemnitee for any such fees or expenses incurred by the Indemnifying Party during the course of the defense
of such Third-Party Claim by such Indemnifying Party, regardless of any subsequent decision by the Indemnifying Party to reject or otherwise
abandon its assumption of such defense. If an Indemnifying Party elects not to assume responsibility for defending any Third-Party Claim
or fails to notify an Indemnitee of its election within thirty (30) days after receipt of a notice from an Indemnitee as provided in
<U>Section 4.05(a)</U>, and the Indemnitee conducts and controls the defense of such Third-Party Claim and the Indemnifying Party has
an indemnification obligation with respect to such Third-Party Claim, then the Indemnifying Party shall be liable for all reasonable
fees and expenses incurred by the Indemnitee in connection with the defense of such Third-Party Claim. In the event of a Shared Third-Party
Claim, each Party shall be liable for the portion of the fees and expenses incurred by such Party in connection with the defense of such
Shared Third-Party Claim that is equal to the relative portion of such Party&rsquo;s Liability in respect of such Shared Third-Party
Claim, and shall be entitled to seek any indemnification or reimbursement from the other Party for any fees or expenses incurred by such
Party during the course of the defense of such Shared Third-Party Claim in excess of such fees and expenses that are the responsibility
of such Party pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>No Settlement. </I>Neither Party may settle or compromise any Third-Party Claim for which either Party is seeking to be indemnified
hereunder without the prior written consent of the other Party, which consent may not be unreasonably withheld, unless such settlement
or compromise is solely for monetary damages that are fully payable by the settling or compromising Party, does not involve any admission,
finding or determination of wrongdoing or violation of Law or the Indemnitee and provides for a full, unconditional and irrevocable release
of the other Party and the Indemnitee(s) from all Liability in connection with the Third-Party Claim. The Parties hereby agree that if
a Party presents the other Party with a written notice containing a proposal to settle or compromise a Third-Party Claim for which either
Party is seeking to be indemnified hereunder and the Party receiving such proposal does not respond in any manner to the Party presenting
such proposal within thirty (30) days (or within any such shorter time period that may be required by applicable Law or court order)
of receipt of such proposal, then the Party receiving such proposal shall be deemed to have consented to the terms of such proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.06.
<U>Right of Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Contribution. </I>If any right of indemnification contained in <U>Section 4.02</U> or <U>Section 4.03</U> is held unenforceable or
is unavailable for any reason, or is insufficient to hold harmless an Indemnitee in respect of any Indemnified Liability for which such
Indemnitee is entitled to indemnification hereunder, then the Indemnifying Party shall contribute to the amounts paid or payable by the
Indemnitees as a result of such Indemnified Liability (or actions in respect thereof) in such proportion as is appropriate to reflect
the relative fault of the Indemnifying Party, on the one hand, and the Indemnitee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.07.
<U>Limitation of an Indemnified Liability</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification includes all liabilities and expenses incurred in connection with a matter resulting in the right to indemnification,
including without limitation, any reasonable fees for independent legal counsel and accountants. No Indemnitee shall be entitled to indemnification
for any special, punitive or exemplary damages, except to the extent such damages are finally awarded and actually paid by the Indemnitee
to a third party in connection with a Third Party Claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.08.
<U>Survival of Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification provisions in this Article IV shall survive until the expiration of the applicable statute of limitations, plus sixty
days. The right to indemnification with respect to claims of which notice was given prior to the expiration of the applicable survival
period shall survive such expiration until such claim is finally resolved and any obligations with respect thereto are fully satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCESS
TO INFORMATION; PRIVILEGE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.01. <U>Financial Statements and Accounting</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each of SRM and the Company agrees to provide the other Party and its auditors reasonable assistance and reasonable access to the properties,
books and records, other information and personnel of each Party or any of its subsidiaries set forth in this <U>Section 5.01</U>, from
the Effective Time until the completion of each Party&rsquo;s respective audit for the fiscal year ending December 31, 2023, (i) in connection
with the preparation and audit of each Party&rsquo;s respective quarterly and annual financial statements for the fiscal year ended December
31, 2023, and (ii) to the extent reasonably necessary to respond (and for the limited purpose of responding) to any written request or
official comment from a Governmental Authority;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
SRM shall authorize and request its auditors to make reasonably available to the Company&rsquo;s auditors the personnel performing its
annual audits and work papers related thereto (subject to the execution of any reasonable and customary access letters that such party&rsquo;s
auditors may require in connection with such review of such work papers), in all cases within a reasonable time prior to the Company&rsquo;s
auditors&rsquo; opinion date, so that the Company&rsquo;s auditors are able to perform the procedures they reasonably consider necessary
to take responsibility for the work of SRM&rsquo;s auditors as it relates to the Company&rsquo;s auditors&rsquo; report on SRM&rsquo;s
financial statements, all within sufficient time to enable the Company to meet its timetable for the filing of its annual financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.02. <U>Ownership of Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
information owned by one Party or any of its Subsidiaries that is provided to a requesting Party pursuant to this <U>Article V</U> shall
be deemed to remain the property of the providing Party. Unless specifically set forth herein, nothing contained in this Agreement shall
be construed as granting or conferring rights of license or otherwise in any such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.03. <U>Confidentiality</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
any termination of this Agreement, the Parties shall hold, and shall each cause its and their other respective officers, directors, accountants,
agents or attorneys (&ldquo;<U>Representatives</U>&rdquo;) to hold, in strict confidence, and not to disclose or release or use, without
the prior written consent of the other Party, any and all non-public information (&ldquo;<U>Confidential Information</U>&rdquo;) concerning
the other Party; <U>provided</U> that the Parties may disclose, or may permit disclosure of, Confidential Information (i) to their respective
auditors, attorneys, financial advisors, bankers and other appropriate consultants and advisors who have a need to know such information
and are informed of their obligation to hold such information confidential to the same extent as is applicable to the Parties and in
respect of whose failure to comply with such obligations, the applicable Party will be responsible, (ii) if the Parties are required
or compelled to disclose any such Confidential Information by judicial or administrative process or by other requirements of law or stock
exchange rule, (iii) as required in connection with any legal or other proceeding by one Party against the other Party, or (iv) as necessary
in order to permit a Party to prepare and disclose its financial statements, tax returns or other disclosures required by applicable
law, including the rules and regulations of any securities exchange such Party&rsquo;s securities are traded on. Notwithstanding the
foregoing, in the event that any demand or request for disclosure of Confidential Information is made pursuant to clause (ii) above,
each Party, shall promptly notify the other of the existence of such request or demand and shall provide the other a reasonable opportunity
to seek an appropriate protective order or other remedy, which such Parties will cooperate in obtaining. In the event that such appropriate
protective order or other remedy is not obtained, the Party whose Confidential Information is required to be disclosed shall or shall
cause the other Party to furnish, or cause to be furnished, only that portion of the Confidential Information that is legally required
to be disclosed and shall take commercially reasonable steps to ensure that confidential treatment is accorded such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.04. <U>Limitation of Liability</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
NO EVENT SHALL ANY PARTY BE LIABLE TO THE OTHER PARTY OR ANY OF ITS SUBSIDIARIES FOR PUNITIVE, CONSEQUENTIAL, SPECIAL OR INDIRECT DAMAGES,
INCLUDING LOSS OF FUTURE PROFITS, REVENUE OR INCOME, DIMINUTION IN VALUE OR LOSS OF BUSINESS REPUTATION OR OPPORTUNITY, HOWEVER CAUSED
AND ON ANY THEORY OF LIABILITY (INCLUDING NEGLIGENCE) ARISING IN ANY WAY OUT OF THIS AGREEMENT, REGARDLESS OF WHETHER SUCH DAMAGES WERE
FORESEEABLE OR SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES EXCEPT TO THE EXTENT AWARDED BY A COURT OF COMPETENT JURISDICTION
IN CONNECTION WITH A THIRD-PARTY CLAIM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.05 <U>Liability for Information Provided</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Party shall have any Liability to the other Party in the event that any information exchanged or provided pursuant to this <U>Article
V</U> is found to be inaccurate, in the absence of intentional misconduct by the Party providing such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTAIN
OTHER MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.01. <U>Insurance</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company and SRM agree that from and after the date of the IPO Closing they shall maintain their own insurance policies, except that
the Company&rsquo;s general liability policy shall cover SRM to the extent that they share premises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
SRM shall notify the Company, as promptly as practicable, of any claim made by SRM pursuant to this <U>Section 6.01</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Except as provided in <U>Section 6.01(a)</U>, from and after the date of the IPO Closing, SRM shall not have any rights to or under any
of the Policies of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This Agreement shall not be considered as an attempted assignment of any policy shared by and between the Company and SRM or SRM Ltd
or as a contract of insurance and shall not be construed to waive any right or remedy of the Company in respect of any policy shared
by and between the Company and SRM or SRM Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.02. <U>Bulk Sales Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party hereby waives compliance with the requirements and provisions of the &ldquo;bulk-sale&rdquo; or &ldquo;bulk-transfer&rdquo; Laws
of any jurisdiction that may otherwise be applicable with respect to any of the transactions contemplated in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.03. <U>Shared Employees and Premises</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Shared Employees</I>. Douglas McKinnon and Markita Russell are currently providing services to both the Company and SRM and shall
continue to do so during the one year period following this Agreement (the &ldquo;<U>Transition Period</U>&rdquo;). For providing these
services, Mr. McKinnon and Ms. Russell shall be paid $25,000 per annum directly from SRM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Office and Facilities</I>. Currently both the Company and SRM share the same office premises and related facilities. The Company agrees
that SRM may maintain its presence at the current office location until such time as it is mutually agreed that SRM requires its own
office and facilities, or the Parties agree on a monthly sub-lease arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
6.04. <U>Further Actions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as otherwise provided in this Agreement, the Parties shall use their commercially reasonable efforts to take, or cause to be taken,
all appropriate action, to do, or cause to be done, and to assist and cooperate with the other Party in doing, all things necessary,
proper or advisable under applicable Law to execute and deliver the Transaction Documents and such other documents and other papers as
may be required to carry out the provisions of this Agreement and to consummate and make effective the transactions contemplated by this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From time to time after the Effective Time, without additional consideration, each Party shall execute and deliver such further instruments
and take such other action as may be necessary or is reasonably requested by the other Party to make effective the transactions contemplated
by this Agreement and the other Transaction Documents. Without limiting the foregoing, upon reasonable request of a Party, the other
Party shall execute, acknowledge and deliver all such further assurances, deeds, assignments, consequences, powers of attorney and other
instruments and papers as may be required for the transfer of direct or indirect ownership of the applicable Transferred Assets, as contemplated
by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VII </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.01 <U>Mutual Representations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party hereto represents and warrants to the other that (i) it is duly authorized to enter into and perform this Agreement and has duly
executed and delivered this Agreement, (ii) the execution, delivery and performance of its obligations under this Agreement will not
conflict with or result in a breach of or default under or a violation of its or its subsidiaries&rsquo; organizational documents, any
material contract to which it is a party or by which any of its assets or subsidiaries are bound or any order, judgment, decree, permit,
statute, law, rule or regulation to which it or any of its subsidiaries is subject, and (iii) this Agreement constitutes its valid and
binding obligation, enforceable in accordance with its terms, subject to (A) bankruptcy, insolvency, reorganization, moratorium or other
similar laws affecting the enforcement generally of creditors&rsquo; rights and remedies, (B) general principles of equity (regardless
of whether considered in a proceeding at law or in equity), including the discretion of any court of competent jurisdiction in granting
specific performance or other equitable relief, and (C) an implied duty to take action and make determinations on a reasonable basis
and in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
7.02 <U>Company Representations and Warranties</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company represents and warrants to SRM that (i) the assets of SRM Ltd include all tangible and intangible assets currently used in and
necessary to conduct the SRM Business as conducted by the Company and SRM Ltd immediately prior to the Effective Time (the &ldquo;<U>SRM
Assets</U>&rdquo;), including those assets accounted for in SRM Ltd&rsquo;s audited balance sheet for the year ended December 31, 2022
(the &ldquo;<U>Balance Sheet</U>&rdquo;) as included in the IPO Registration Statement, and none of such SRM Assets are owned by any
other person, and (ii) the liabilities of SRM Ltd only consist of the liabilities exclusively related to the SRM Business (the &ldquo;<U>SRM
Liabilities</U>&rdquo;) and such liabilities are all accounted for in the Balance Sheet, including the promissory note dated September
1, 2022 in favor of the Company, which has a balance of $1,511,205.74, and $6,293 of expenses paid by the Company on behalf of SRM, totaling
$1,517,498.74 as of the date hereof and will be repaid using a portion of the net proceeds of the SRM IPO. From and after the date of
the Balance Sheet, SRM Ltd has not incurred any liabilities not in the ordinary course of the SRM Business or unrelated to the SRM Business.
The IPO Registration Statement shall include all material changes in the SRM Assets or SRM Liabilities since the date of the Balance
Sheet through the date of the prospectus included therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
VIII </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TAX
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.01. <U>Tax Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall be liable for, and shall indemnify and hold SRM harmless from and against, any liability for taxes on the Company or imposed
with respect to the income, receipts, property, profits, wages, capital, net worth, employees or operations of the Company attributable
to any period prior to the Effective Time (the &ldquo;<U>Pre-Separation Tax Period</U>&rdquo;) (including, for the avoidance of doubt,
any withholding taxes imposed on payments made by SRM to the Company) (the &ldquo;<U>Company Taxes</U>&rdquo;). SRM shall be liable for,
and shall indemnify and hold harmless the Company from and against, any liability for taxes imposed on SRM or imposed with respect to
the income, receipts, property, profits, wages, capital, net worth, employees or operations of SRM attributable to any period after the
Separation, inclusive of the date of the Effective Time (the &ldquo;<U>Post-Separation Tax Period</U>&rdquo;) (including, for the avoidance
of doubt, any withholding taxes) (the &ldquo;<U>SRM Taxes</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.02. <U>Tax Contests</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party shall promptly notify the other Party in writing upon receipt by such Party or any of its officers or directors of a written communication
from any governmental authority responsible for the collection of taxes (a &ldquo;<U>Taxing Authority</U>&rdquo;) with respect to any
pending or threatened audit, claim, dispute, suit, action, proposed assessment or other proceeding (a &ldquo;<U>Tax Contest</U>&rdquo;)
concerning any taxes for which the other Party may be liable pursuant to this Agreement. In the case of any Tax Contest relating to the
Company Taxes that is undertaken against SRM, SRM shall (i) use reasonable best efforts to keep the Company informed regarding the progress
and substantive aspects of such Tax Contest, (ii) offer the Company a reasonable opportunity to comment before submitting to any Taxing
Authority any written materials prepared or furnished in connection with such Tax Contest, and allow the Company to participate in any
related meeting or telephonic conference with the applicable Taxing Authority and (iii) not settle or otherwise dispose of any item subject
to such Tax Contest that could reasonably be expected to adversely affect the Company without obtaining the prior written consent of
the Company, which consent shall not be unreasonably withheld, conditioned or delayed. In the case of any Tax Contest relating to SRM
Taxes that is undertaken against the Company, the Company shall (i) use reasonable best efforts to keep SRM informed regarding the progress
and substantive aspects of such Tax Contest, (ii) offer SRM a reasonable opportunity to comment before submitting to any Taxing Authority
any written materials prepared or furnished in connection with such Tax Contest, and allow SRM to participate in any related meeting
or telephonic conference with the applicable Taxing Authority and (iii) not settle or otherwise dispose of any item subject to such Tax
Contest that could reasonably be expected to adversely affect SRM without obtaining the prior written consent of SRM, which consent shall
not be unreasonably withheld, conditioned or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8.03. <U>Cooperation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties shall cooperate (and cause their respective Affiliates to cooperate) with each other and with each other&rsquo;s agents, including
accounting firms and legal counsel, in connection with Tax matters relating to the Parties and their Affiliates, including (i) preparation
and filing of Tax returns, (ii) determining the liability for and amount of any Taxes due (including estimated Taxes) or the right to
and amount of any refund of Taxes, (iii) examinations of Tax returns, and (iv) any administrative or judicial proceeding in respect of
Taxes assessed or proposed to be assessed. Such cooperation shall include making all information and documents in their possession relating
to the other Party and its Affiliates reasonably available to such other Party. Each Party shall also make available to the other Party,
as reasonably requested and available, personnel (including officers, directors, employees and agents of the Parties or their respective
Affiliates) responsible for preparing, maintaining, and interpreting information and documents relevant to Taxes, and personnel reasonably
required as witnesses or for purposes of providing information or documents in connection with any administrative or judicial proceedings
relating to Taxes. Any information or documents provided under this <U>Section 8.03</U> shall be kept confidential by the Party receiving
the information or documents, except as may otherwise be necessary in connection with the filing of Tax returns or in connection with
any administrative or judicial proceedings relating to Taxes. In addition, in the event that a Party determines that the provision of
any information or documents to the other Party could be commercially detrimental, violates any law or agreement or waive any Privilege,
the Parties shall use commercially reasonable efforts to permit each other&rsquo;s compliance with its obligations under this <U>Section
8.03</U> in a manner that avoids any such harm or consequence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENERAL
PROVISIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.01. <U>Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be terminated and the Separation and the Distribution may be abandoned at any time prior to the Effective Time by and in
the sole discretion of the Company; provided, however, that this Agreement and the Separation and the Distribution may not be terminated
or abandoned following the entry into the Underwriting Agreement unless the closing of the SRM IPO does not occur following such entry
in accordance with the terms of the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.02. <U>Survival of Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as expressly set forth in this Agreement or any other Transaction Document, all covenants and agreements contained in this Agreement
and each of the other Transaction Documents shall survive the Distribution and remain in full force and effect in accordance with their
applicable terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.03. <U>Expenses</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise specified in this Agreement, all costs and expenses, including fees and disbursements of counsel, financial advisors and
accountants, incurred in connection with this Agreement and the transactions contemplated by this Agreement shall be borne by the Party
incurring such costs and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.04. <U>Notices</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and, in the case of delivery
in person or by overnight mail, shall be deemed to have been duly given upon receipt) by delivery in person or overnight mail to the
respective parties or delivery by electronic mail transmission (providing confirmation of transmission) to the respective Parties. Any
notice sent by electronic mail transmission shall be deemed to have been given and received at the time of confirmation of transmission.
However, if such electronic mail transmission is sent after 5:00 pm, Eastern Time, notice shall be deemed to have been given on the next
business day. All notices, requests, claims, demands and other communications hereunder shall be addressed as follows, or to such other
address or email address for a Party as shall be specified in a notice given in accordance with this <U>Section 9.04</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
if to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter
Wellness, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1061
E. Indiantown Rd., Suite 110</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter,
FL 33477</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>bjohn@jupiterwellness.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Brian S. John</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
if to SRM:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRM
Entertainment, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1061
E. Indiantown Rd., Suite 110</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter,
FL 33477</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>rmiller@jupiterwellness.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Richard Miller</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to (which shall not constitute notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
Ross Ference LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
Avenue of the Americas, 31<SUP>st</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10036 USA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
amarcus@srf.law</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Arthur Marcus</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.05. <U>Public Announcements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
and after the Effective Time, the Parties shall consult with each other before issuing, and give each other the opportunity to review
and comment upon, that portion of any press release or other public statements that relates to the transactions contemplated by this
Agreement, and shall not issue any such press release or make any such public statement prior to such consultation, except: (a) as may
be required by applicable law or applicable stock exchange regulation, in which case the Party that is so required shall, to the extent
legally permissible, consult with the other Party before issuing such press release or making such public statement; (b) for disclosures
made that are substantially consistent with disclosure contained in the IPO Registration Statement or related prospectus or any press
release or public statement previously issued with the prior written consent of the other Party; or (c) as may pertain to disputes between
SRM, on one hand, and the Company on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.06. <U>Severability</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any provision of this Agreement shall be held to be illegal, invalid or unenforceable under any applicable law, then such contravention
or invalidity shall not invalidate the entire Agreement. Such provision shall be deemed to be modified to the extent necessary to render
it legal, valid and enforceable, and if no such modification shall render it legal, valid and enforceable, then this Agreement shall
be construed as if not containing the provision held to be invalid, and the rights and obligations of the Parties shall be construed
and enforced accordingly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.07. <U>Entire Agreement; Construction</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement constitutes the entire agreement of the Parties and their Affiliates (as defined below) with respect to the subject matter
hereof and thereof and supersede all prior agreements and undertakings, both written and oral, among the Parties with respect to the
subject matter hereof and thereof, including, but not limited to, the Original Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.08. <U>Assignment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may not be assigned by a Party without the consent of the other Party; <U>provided</U> that a Party may assign this Agreement
or any of its rights and obligations hereunder to an entity that controls, is controlled by, or is under common control with such Party
(an &ldquo;<U>Affiliate</U>&rdquo;) without the consent of the other Party <U>provided</U> that (a) no such assignment shall relieve
the assignor of any of its obligations hereunder and (b) such rights shall be assigned back to the assigning Party if such Affiliate
ceases to be an Affiliate of the assigning Party; provided, however, that this Agreement may not be assigned following the pricing of
the SRM IPO unless the IPO Closing does not occur following such pricing in accordance with the terms of the Underwriting Agreement without
the prior written consent of the underwriter. Any attempted assignment that is not in accordance with this <U>Section 9.08</U> shall
be null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.09. <U>Amendment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may not be amended or modified except (a) by an instrument in writing signed by, or on behalf of, each Party that expressly
references the Section of this Agreement to be amended or (b) by a waiver in accordance with <U>Section 9.10</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.10. <U>Waiver</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
Party may (a) extend the time for the performance of any of the obligations or other acts of the other Party; (b) waive any inaccuracies
in the representations and warranties of the other Party contained herein or in any document delivered by the other Party pursuant to
this Agreement; or (c) waive compliance with any of the agreements of the other Party or conditions to such obligations contained herein.
Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the Party to be bound thereby. Notwithstanding
the foregoing, no failure or delay by any Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single
or partial exercise thereof preclude any other or future exercise of any other right hereunder. Any waiver of any term or condition hereof
shall not be construed as a waiver of any subsequent breach or as a subsequent waiver of the same term or condition, or a waiver of any
other term or condition of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.11. <U>Specific Performance</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not
performed in accordance with their specific terms or were otherwise breached. Each Party agrees that, in the event of any breach or threatened
breach by the other Party of any obligation contained in this Agreement, the non-breaching Party shall be entitled to (a) an order of
specific performance to enforce the observance and performance of such obligation and (b) an injunction restraining such breach or threatened
breach. Each Party further agrees that the non-breaching Party shall not be required to obtain, furnish or post any bond or similar instrument
in connection with or as a condition to obtaining any remedy referred to in this <U>Section 9.11</U>, and each Party irrevocably waives
any right it may have to require the obtaining, furnishing or posting of any such bond or similar instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.12. <U>Governing Law</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware without giving effect to any applicable
principles of conflict of laws that would cause the laws of another state to otherwise govern this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.13. <U>Waiver of Jury Trial</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
OF THE PARTIES HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION AMONG THE PARTIES DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH
THIS AGREEMENT. EACH OF THE PARTIES (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES
THAT IT AND THE OTHER PARTY HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS <U>SECTION 9.13</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.14. <U>No Duplication; No Double Recovery</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Agreement is intended to confer to or impose upon any Party a duplicative right, entitlement, obligation or recovery with respect
to any matter arising out of or resulting from the same facts and circumstances (including with respect to the rights, entitlements,
obligations and recoveries that may arise out of <U>Article IV</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.15. <U>Mutual Drafting</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Parties have participated jointly in the negotiation and drafting of this Agreement with the assistance of counsel and other advisors
and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by
the Parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision
of this Agreement or interim drafts of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
9.16. <U>Counterparts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be executed in any number of counterparts and by different Parties in separate counterparts, and delivered by means of
electronic mail transmission or otherwise, each of which when so executed and delivered shall be deemed to be an original and all of
which when taken together shall constitute one and the same agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the Parties has caused this Agreement to be executed as of the date first written above by its respective officers
thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JUPITER
    WELLNESS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian S. John</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian S. John</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRM
ENTERTAINMENT, INC</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt 0.25pt 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; width: 45%"><I>/s/
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Miller</FONT></I></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Richard Miller</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to Amended and Restated Stock Exchange Agreement]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
AND ASSUMPTION AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Assignment and Assumption Agreement (this &ldquo;<U>Agreement</U>&rdquo;), dated as of August 3, 2023 (the &ldquo;<U>Effective Date</U>&rdquo;),
is entered into by and between Jupiter Wellness, Inc. (the &ldquo;<U>Assignor</U>&rdquo;) and SRM Entertainment, Inc. (the &ldquo;<U>Assignee</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Assignor entered into an Employment Agreement, (together with the amendments thereto, the &ldquo;<U>Employment Agreement</U>&rdquo;)
with Douglas McKinnon (the &ldquo;<U>Executive</U>&rdquo;), who is an executive officer of the Assignee and an employee of the Assignor
and/or one of its affiliates, dated August 5, 2019;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Assignor will cause the Assignee to assume and agree to perform the Assignee&rsquo;s obligations under the Employment Agreement,
and that effective upon such assumption, the Assignor will have no further liability for the Employment Agreement, except as set forth
in Schedule A attached hereto (the &ldquo;<U>Retained Obligations</U>&rdquo;), and the Assignee will be expressly and unconditionally
responsible for its liabilities set forth in the Employment Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
effective as of the Effective Date, the Assignor desires to assign and the Assignee desires to assume and discharge or perform when due,
all of the Assignor&rsquo;s obligations under the Employment Agreement other than the Retained Obligations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the premises and the mutual covenants and agreements set forth herein, and in the Employment Agreement,
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Assignment of Employment Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Effective Date, the Assignor hereby irrevocably, absolutely and unconditionally assigns, transfers, conveys and delivers to
the Assignee and its successors and permitted assigns forever all of the Assignor&rsquo;s right, title and interest of every kind, nature
and description in, to and under the Employment Agreement, except as related to the Retained Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Acceptance of Assignment and Assumption of Employment Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Effective as of the Effective Date, the Assignee hereby accepts the assignment, transfer, conveyance and delivery of the Employment Agreement,
other than with respect to the Retained Obligations.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Effective as of the Effective Date, the Assignee hereby irrevocably, absolutely and unconditionally assumes, undertakes and agrees to
pay, perform and discharge in full, and release and discharge the Assignor and its affiliates, successors and assigns, irrevocably, completely,
unconditionally and forever from any and all obligations under the Employment Agreement, other than the Retained Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Acknowledgement that Employment Agreement Conditioned upon the IPO</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Assignor and the Assignee acknowledge and agree that, except as otherwise provided in Schedule A attached hereto with respect to the
Retained Obligations, if the proposed initial public offering of the Assignee is not consummated by December 31, 2023, this Agreement
will terminate and have no effect (including on the terms of the Executive&rsquo;s employment with the Assignor and its affiliates).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Next
page is a signature page.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, each of the undersigned has caused this Agreement to be duly executed on its behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JUPITER WELLNESS, INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian John</I></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian John</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/03/2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SRM
    ENTERTAINMENT, INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Richard Miller</I></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Miller</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/03/2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the undersigned has agreed to this Agreement between Jupiter Wellness, Inc. and SRM Entertainment, Inc., whereas
SRM Entertainment, Inc. has assumed the obligations under the Employment Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DOUGLAS O. MCKINNON</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Douglas McKinnon</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas McKinnon</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/03/2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RETAINED
OBLIGATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25,000
is payable to the Executive as a result of the cancellation of the Assignor&rsquo;s common stock issued in lieu of salary recorded in
the books and records of the Assignor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of all unexercised options of Assignor held by the Executive will continue through the full-term of the Executive&rsquo;s option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>jupw-20230814.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayDCbP9z5Z8GekhvWB0bYl67yciC3AePC5M96aWYX0G -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:jupw="http://jupiterwellness.com/20230814" elementFormDefault="qualified" targetNamespace="http://jupiterwellness.com/20230814">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://jupiterwellness.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="jupw-20230814_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="jupw-20230814_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="jupw-20230814_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" name="WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>jupw-20230814_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jupiterwellness.com/role/Cover" xlink:href="jupw-20230814.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://jupiterwellness.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="jupw-20230814.xsd#jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:label="loc_jupwWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_jupwWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>jupw-20230814_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="jupw-20230814.xsd#jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:label="jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:to="jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_lbl" xml:lang="en-US">Warrants, each exercisable for one share of Common Stock at $8.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>jupw-20230814_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jupiterwellness.com/role/Cover" xlink:href="jupw-20230814.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://jupiterwellness.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="jupw-20230814.xsd#jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:label="loc_jupwWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_jupwWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140330365698784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 14,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">JUPITER
WELLNESS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001760903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2455880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1061
E. Indiantown Rd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste. 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jupiter<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">462-2700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JUPW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember', window );">Warrants, each exercisable for one share of Common Stock at $8.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    each exercisable for one share of Common Stock at $8.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JUPWW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jupw="http://jupiterwellness.com/20230814"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="jupw-20230814.xsd" xlink:type="simple"/>
    <context id="AsOf2023-08-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
        </entity>
        <period>
            <startDate>2023-08-14</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="From2023-08-142023-08-14_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-14</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jupw:WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-14</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-08-14">0001760903</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-08-14">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-08-14">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-08-14">2023-08-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-08-14">JUPITER WELLNESS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-08-14">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-08-14">001-39569</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-08-14">83-2455880</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-08-14">1061 E. Indiantown Rd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-08-14">Ste. 110</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-08-14">Jupiter</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-08-14">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-08-14">33477</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-08-14">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-08-14">462-2700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-08-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-08-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-08-14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-08-14">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-08-142023-08-14_us-gaap_CommonStockMember">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-08-142023-08-14_us-gaap_CommonStockMember">JUPW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-08-142023-08-14_us-gaap_CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">Warrants,     each exercisable for one share of Common Stock at $8.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">JUPWW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-08-142023-08-14_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-08-14">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2023-08-14">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 4T 55ZK$(A8S 0  (@(   \
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M4$L! A0#%     @ 4T 55VQ^WZWN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 4T 55YE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !30!57'HW_8/ $  "7%   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 4T 55^#T.HFJ @  , P
M  T              ( !,PT  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !3
M0!57EXJ[',     3 @  "P              @ $($   7W)E;',O+G)E;'-0
M2P$"% ,4    " !30!57JL0B%C,!   B @  #P              @ 'Q$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 4T 55R0>FZ*M    ^ $  !H
M             ( !41(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ 4T 55V60>9(9 0  SP,  !,              ( !-A,  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  @!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jupiterwellness.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex10-3.htm</File>
    <File>ex10-4.htm</File>
    <File>jupw-20230814.xsd</File>
    <File>jupw-20230814_def.xml</File>
    <File>jupw-20230814_lab.xml</File>
    <File>jupw-20230814_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 27
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "jupw-20230814_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "jupw-20230814_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jupw-20230814_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "jupw-20230814.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "jupw",
   "nsuri": "http://jupiterwellness.com/20230814",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "AsOf2023-08-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://jupiterwellness.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "AsOf2023-08-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "jupw_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each exercisable for one share of Common Stock at $8.50 per share"
       }
      }
     },
     "localname": "WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember",
     "nsuri": "http://jupiterwellness.com/20230814",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-23-029511-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-029511-xbrl.zip
M4$L#!!0    ( %- %5=SQC@2@_0   ;$!P *    97@Q,"TQ+FAT;>Q]65/<
M6+;N.Q'\!]V.TQT0(2C 0Y7+=2L"V[C:][AL7["[;C\J4\I$9:64K0&<Y]??
M->U)0\).H&RP^J'+0*:TA[777L.WOO7+/S_^_O;7[:U?_GER_ K^&^#_?OGX
MYN/;DU]_^8'_"W_]0?[\RXOWK_X=G'W\]]N3__VW69'7/P>'!\LZ^)@NDBIX
MEUP&I\4BRD/^11B<)64Z^QM\$;[ZP?=[SX,Z^5+O15DZSW\.IDE>)^7S8!&5
M\S3?JXOESP$\0O]B4M1UL:#?_>W77UZ_?_?1?M_>+%JDV>KGJ]Y(GZW2_TEX
M@'_[]1_YI%H^_^4'?""LR(>-YW*-<>O?9<D,GGK@+D"9SL]O=6J_O/CUY,MY
M.DGK[:W#@_W#7WYX\>NW,%'>Z5N>J=K';V.*M[Z7)__OY.6GCV_>O]O>^M?)
MZ1G\XUN8YG>PDW<RQ4_O7IV<_G'ZYN.;=[]M;QW_=GIR\OO)NX^_O#B%B4Y6
M093'0;0H\CG_YNST]P#^?'+Z\?C-._Q@&+QY]W(_Y+_^GT\?WL#?@C].WKY]
M=W)VQG_DO\&#^!\GKX-_?OKX\?T[^5*<7J156N1!,0M>)/GT'-;@<_ FOTBJ
M>@%3AO&_??M2/AQ5P6FR+),*_A#5Z46"WZK/$YCB15)&6? ICY/RLDQAI:H'
MO7'?EFR2EI%?I; %^.*#_2=I?INSAD]N;_V[*#^']"7\UW<S]^-FWE1X>SX.
M@Z.#HT??S<2_IE5TJ]?FZ^TMI??N_624SM[>6JNT[_]$HVI[J__"J7HNG""/
M%DD<P%UV-CU/XB9+@L,@JNL(?PK.DS*IB_N_)D^>'6QO_1[%:043/;Y(\B8)
M@T?/ZO/@=584Y?V?8,\] W\Y.#JZ_U-[*-KT+8A?4I%5&?P&1S-+0.O\?/_G
M]>W$ /X$<R.=K>[Z>O]XGFQO-:A#*WAM$L,GT<5 @[F.TASO$O B\NE^&$3!
MM"B710EJ&!3/K"A1U])722%GT66EO0'0U:2IWR4741P%.],BRY(IZN]L%5RF
MH*O2N@JJ9E*E<1J56I:BV2S-4O@R##G-IUD3I_D\I&\431UDZ2*MZ?TPG"P+
M8'1I#5\.0!E.LZ)"Y5\&<5)-RW0"/Z0Y#><TF:=5+0.GL>&\@AWP9O!22/-H
M!O.%[\U26()=<G,F\.NY,T)\M!D?SFYPJ?"E_\CB_S3%<W 57A:+992OT%?X
M1TF_W WIQ>#?38M\EI:+BM8CFI>)#*T^3V%)S#..U9_LI_!*HD/7@%3!FES/
ME\.GV^-S+UAWF+ IVUOT&OQ. ?]7\IYWKMQ?/OUJ;MU??OCTJURX*"G!Y7DZ
M/9>]<&[S%&8-<@%+#6M>NG_;Z7Z>I:1JX&$]8^$]<V1M"F("XW,GW'929;JP
MP2AUN(AQ ]];X?3[OV8O$HE+E=0X45BG29(5E_O?D0KY/G6F'&H28!C4GP7(
MQ6JON 0%8K3&"@_B_VF6*#+!'TF6Y4E5&7WZ*@&E&96)HUAWC,!]@+^Y)WX_
M^%"F<)[@6-4XBACU+)ZS8L9:1PT+CPE_/:#H!RE#^!8(=/)E>A[E\\2H&U <
M\)P8QC--%A,8ZC-R<H]"/)1POF$A8WHBG,2:/@GC_#U:!4=/V1O>WFJIE!/U
MCEZ]%0;+IJR:" 8'0V+=L)/NNA/ +\;X][2JF@3_(?-Y&CXY. @/#@Z"ZAQ^
MHR\=^>8_R@I? MIS6BP6,-"J+J9@2BZC,KB(,GC4?QWLP[</@R7,E![15H@O
M^8MG^$5WW*FU?*C7\!*2U],P>9G@JH)URO'N @^MA/^B*)C1GNV?[O^^[UX=
MP5N\V^ !UO[C_2*_;FEEO@GATU-9+MR82996YT-W,GB_!2C'_\;_.ULFTQ1\
MI^-XD>9R,U[P-<EW!W[W0U(LLT2M)NKA!EXPQ3^_/(<9<6@2=@_4;;_@RW[5
MYU$=%+#8>&UN;]&SZ2_ZV9.F2O%D@!:=+_17IF5"%RUI?#@[<$?F>7'!8UV6
M1=Q,X<[$7<!'U@4+?>(L*N@ T ET>[?V&-9V>^N%O-A=79X+7,XR@?8W2624
MA+>^R@8'#&$A V\F?\)E) <6K_LXQ6-NW1C;6V*F= ]-&"2S&=]E 4>@ A6
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MC.'_$97 5Q))+\:QP<"JL1TVG9B$VAC#_8F#_!..9A6G$G6Y:$F8^&GB8(&
M)KPLZI; \[/#/79LZLS?[&&?T'#L0G'6\EG&*A.[\*S[JC2Z[J$0"WLXQ%"
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M=*PJ$+:H3!,G%D'DHU**;W;19I7I+V+P&<B--"C!$*E&TLQAM=%5HV&172:
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M&\9A^X4<?A#9J"UQ6I X.34MTDL',72O*&K,6A7&E#NW0D^Y!*43])(8]3R
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M#C,Y+A5(G)0$QN#Q*CB&Y!/?<ZP$40@29#YF>H"7' C?J*\LO?=5@K$<5>&
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M+V1.<!A0:-03T#(%K9_1-4)O+,7@-,RZ/^? ',+>9A.R$!9-KMLW%DL)4:G
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MPF9'$"A!Z65IR<(ZYCH+,!2WV]B1K9VV/=$76) $:_LMK<O5WJ%JJIERI&H
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M-:Q!H_YF^,\I7(&",I]&9;F2G@N!NU7=KWLC'N!N:*;RIA)[QJHW.8@.X8W
MDHTRA0$04% UY,.TBPPYT0/VAT2VIJ8@'Q9QCJP0#V:!^'EI3V;A0&Z86&.
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M4^+505+F&CXQJQ&\M'/X9!=499;D<>0).8VC5249&TDY614LURE*&4R [V[
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ML,";$OP'O<<A6!W$32U0<K:<7Z48U"''@H)&L^#HX/" #4/W^^KOA\^>/=V
M3.Y=Q$&PX%4RPP8<P;'$1-CDPH=C#=1KL"OA0__&=JLPDB-K)!_/X5I!ZI^X
MX9)>&+^GW[D"ERCX9P/'(SCEOH1FTD=JZTZ^@*%&+M][<G[L *G%P("7V[S
MW^_@=<]>8K;:H(,EB@4ZM8N(TH$4R%7$>>C2T.F __):&)/:W1^;YN.Y_]K8
M:3GES@QD2@-5'V=SA]CU<I1=Q. \>[(<9O(^1J;U,/F>!A>L.LKRNV57*MU(
M,@S^A&VIX=[)L?,8<>3G2)HOC_2LVV,=@04>TB.MA\F$3C6*PK6/->Z=I_"J
MC1X]AS'W^2#,I/O"_/?FH^\U@T1.5;OG/)?N2I0H!OT0-Y3TZ^WHW5=>Y4F
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M'TJ\Z.%^_B<(%G?B9#(JS2QH5R&DIF$WN4O@&Y52*A'@ -"H\32PEVH YS*
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MU5[L':H@.LY[I(1^D "YRHIO?,&?L4W%8/.>1VF@HI%D#5'X=P+Z*[LH?GE
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M'M1SGDXGQ!$)&Y K^CZ-1RC7^0WT"5SFD/4",%F-8*YG2XM( Z32W!<4\*Z
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M-EPC-CB!%Y48W" 9N S.%8$3%RTE8"2CED9*AKI1 0(W)D&'7D&:4K5YBBW
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MVY5Y;$55 A6U;PST.G@FP2B"O^+^^TSC^[7QY20Y=RGD-&M0'B^&T[4I3=!
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M7QX0D_?*=?/]J<=[F],V26U?F6M/P9\!9F&*>Z6*[YD]?']DU,'-+A>X>^\
M%OCEMQ.%'D41,A#RW;"J+Z3_\&C_V'MK*BE^_>G+;VJ*;>>(/<:IQ %[%DX5
M]FNP3XJ0WH.=)[_L[WOSO=F>[YT$6#62DA/KU\!CV]BK"M:9'Q5JO8K^+\)
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MM/J-?,M0/S8#() 'K=;GUN'O2K]/AQT_V'$Y>R^,U8E(4!V>6J5E7EDF/9*
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MT?2SU49'6 =C8FR8<PV<J<R1XA=&@3#8-N9Y*JY:AR.S"D;:'^TL&M$!)MV
MQ,J7S,,BN^2)U%2/6@^]N @MY-+3RE%;;JIXJ:3N%:[:R>PR,*9.@@A!VMJZ
MP0Y22:&:>IE:K6J_?4#=?8(+%5O6#2I,@#2SH:7;M7GY8*?-1*OVU*Y7"5 0
M%FAYM7C97[FYRSOYR,NB5CYM)_)AF2<HGY6WMN,5[4Z^/>]8-Z9U?-YNA&##
MD1C%W+XBBK[AYVN<C^XSNX;=S1<:=4#9^(UC#,#^5?TPUH%UO8N1;K*J'MA
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M.-V-D#.LVT_Y(E;E-,L1;PT(P5VPDXTO3#8CGK09I;X"M.]=T[+G67+.J;S
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MK/7#4*WTOPH1 TEPP2I_.U?^X,2[%<N1JK)>FV_Q@D\__3G8.<$*+"POY3Z
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MN1+6>:\)>TVX#9KPZ0I-V,E55Z7[ABE]&<LL&)<+?4)7M5,/\B6/4QP<@-&
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M=QR>[ (E':S:RO[Q&A.I,?H\-P']5"5VNM2HS3+/DCIH8P42:!Y0=H&#_5%
MT.*KUJ/G;BVHH_$N#V!3^_?0W-W?$6Q+7M8.:VK'=&ELE9[XM\*ZK-)_JW%=
MWE?!NMAG^95HKMY."YS+89!W -JJX;78>=<.V:)SG\;<GUA.5:5OVY:YWN]
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M98K9IF;CU#-Q$1U.Q)!KIEZM>(%B+=RE+3)+ &V2TA29$0"ISE0CQ)8S;%'
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ME)H'R(Z(VSX*[*RLX M.6_=)<[A.2\8GMI&54">^ 8OX1NB0)5>RS_4TL+U
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MWXKMM+O-VO48%A>E_Q,'0#(96(UO);'I\/!DBU?U].FO+WH[?3!I*UU[H+^
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M@MA+)U<W%SSV+ 1(<>%* #M#+@#A]WBPV8EQZX- (I'VI?'Q3U\;>TH&O?/
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MF[-2]GS!TX\5_:4GAC*7UL:E>TNRF#=CNU;E*2](.-=.-ZALK75]V:AV2>N
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M_?ALXY5[>12LV.[QS278W[75E;O*Z>EYI5Z/D^IY.?D>^_R?6A3!8&N5/E5
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MCL\E'E.<+LSS"UI!_@/N,;:W $ON>0>D1=H)A@);IO",&%=LS?*-0Y&LZ=\
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M?RZ.6NNU7B95;JO=E%U+%<SF^67'@#X/K6:^I-8?=/?JFURB_P=02P,$%
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MG*@+<SC4I<6F=()BBW'Y'U!+ P04    " !30!57T.1RBP )  #+:   %0
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M(N6=-)B*5V7<2J]]SI1N)4,:E:9;.IZ;#RFSF>#+4BD3V7AA#;+::B(MCXL
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M$4,9!$B]]N#WD-01J IQ3,VU8)@WK^.4"?DN/7"U0W^(*X*&FJ\XZM,'0=-
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M=*F7H68!:"Z?$2N+0%]D(4B58GM_>7/3I?@D-E>;Q%]SG!&QY7]02P,$%
M  @ 4T 55P9[$69*"   96,  !4   !J=7!W+3(P,C,P.#$T7W!R92YX;6S5
MG6]WVC84QM_OG'T'C[TF0-)N3=JL)Z6AA].T9"%MM[WI$;8 +4+B2'* ;S_)
M_ E@2[YL+=?KBY3 E7V?WR,+7UMR7KV>3WCT2)5F4ES66B?-6D1%+!,F1I>U
M3_WZ5;_=[=8B;8A(")>"7M:$K+W^[<<?(OOOU4_U>M1AE"<7T5L9U[MB*%]&
M'\F$7D3OJ*"*&*E>1I\)3]T[LL,X55%;3J:<&FH_6.[X(GI^TCH?1/4Z8+N?
MJ4BD^G37W6QW;,Q47S0:L]GL1,A',I/J09_$<@+;8-\0D^K-UIKSYNK?LODK
MSL3#A?LQ()I&EI?0%W/-+FMNOZO=SLY.I!HU3IO-5N./#S?]>$PGI,Z$XQ;3
MVKJ5VTI1N];Y^7DC^W0=FHN<#Q1?[^.LL4YGLV7[*0O$;V6BV87.TKN1,3&9
M[:6[B;P1[K?Z.JSNWJJW3NMGK9.Y3FIK^!E!)3F]H\/(_6_=V^SU[W3*#%4S
MRKF@.O.MX6(:;6G[I4TX:SU6='A9L[$SNY/3L^:+UC.WBY]W@LQB:ONG9JY[
MU:+&SNZGBFHJ3*;XQKZQTX3.C>U5-%EOR.W_P 0-,Z[-JNNTHKKK9^G$[M*^
M7$:N\EEGQ&6\DP1W?L@]Q>N^G5'7-#X9R<=&0EG#47 O,AP9"OO+UVQ'5P-M
M%(G->DN<#"C/MO_5QNR%-/YS5D.B!UF'2'5]1,ATF1KE1J_?><IQ]<97=\Q1
M!^>>#)Q7N417@?MQ^]ENNWJE=C,G*EYOV+[<L33?CU<1C2E1=GOU>,SXIC<,
ME9SX\*UV*(-92Y5094?79A.=M^WZM&M?:@#SK5AD[AZN8?A;Z:\,.*V  6U.
MM.X-^T;&#U=S!O$AW^3_:$=>Q>:PP#)E.Z6W<D*8\+M1%%LQ&WQ=:\^1(B4K
M*_"<D).)%%E*'^AD\/2U6F!$/K3,A\WA_YT<\/>C??0^F5M]Y%\9D#\Q<N]\
M_4*4(L+H:Q*/K^=4Q4R[0[4C54_0_MAJZPVW<KHR+TZ>-V^IRC[R&N$V_4VV
M#/3M#,^W;R;UV]A\X-G@^@STWFZQ^&1P-P+HQ_>RPW^2LK8CES$*UBN[_\3E
MT.%D5,QU+P0(MH5*ME 6%MJW5,>*31V@$L([D=C?!(>!+A")-$+<T1%S)8U+
M9:,A/&1XFF"/Z0<-(D'92%9<"9$2?D>G4I4XL!L)!/^L$N"+1"+Q_CTERE#%
M%Q#DN6 @]>>5H.Z1BG568L^J-'.@(.3ST4#TOU0"O4\L$OO^F'+NKL,3 >KW
M1?% _K]6@K]?< 4<N'YT)P-6#=R$K29 'UY4SH><;"0K;*W&9&)E*( )N6 @
M_O-*X/=(105_+1(H]DTHN*"J$/4]G4C,.TS'A"\SZMCWBBY ;Z5>$ YECUO-
MENI%Y?\G)0I,?RL8RAZWP"W1>F3R[52IG62" XX_&LH>M[0M4WMD^-?",+-P
M\SX^II[+R38L'P6%C5O.^M2A0%Y?S!#&S6L)@=Z/A,+&K6)#*E& MVW"BO"N
M2.C\/5V$B.="H<AQJ]>@3A3FMXI-B%KT65P^GN1CH=1Q:]:P4A3L]V3>36S:
M;,B6D\;*Z7N;0$W +5A!NE&\Z(I8JJG<NFK=EJD]0A=MF02'_9*&4%]P*]D#
M&*"X<Y4DEIM>_>>4M$*>%(:#[V)5P(F WHKP/SV,_RF</VZ%6ZJW(OS/#N-_
M!N>/6^66ZL7DW[8O>^I>SCRWS[W!4/:X56Z)5DSR6?X]=:OD(UO.N"_#GVL!
M]: *Q6]8->HAL#PC@/3_=204?!4*X6*5F,!OI3:$_\6F92>BQ?%0^%4HB4.*
MCWUY<]D!W'41WURIO1 H:-PJN%#7L=DZJQ4E_@Z]&P$EBUO:%JDZ,M@;Z6[*
MC*4(7A;.1T$!X]:H/G7''IS=JC;M'16V/@9/VL,=>O?U')GG%\6,S<#-]4[%
MZGJ0YP:>)Q3*&;>P#.H\,O.^Y"QFAHG1!YNY8H07 R^*@]+&+2/]"H^,^E91
M9SFUI^_9C#6W(E;UAD/?Z!R*AZ+'K2++%>-:T-4ZI>I0(PI:0>W +2BAZH\]
M!-$XM2/BHG4ZN'>+O#T#4"X*"AVWF/2I.S+DC_)>$??4B?YB,I#<O[*F,!"*
M&K=T#&@\,NV=/(HY[X5 ">/6C(6ZD(:+ZWD\)F)$_9,QBB.AI'%KR)!*M/%Y
M!!J?1P>.S[BUI$\=$N3EW'E[C/4&G(V(?WU>L %XK5(ET <T'WMY9+9LRCV\
M2$VR/#KV13%_3RB4//)2U)#.8S-/$V9HLDRIPP01L:W1-C(\%P#*6T&=0%ZK
M"E2/<M_A"^7\O9 ST:=$2T&39<D0NO7@;0*UHPKW/4MTHWCQ6?+4XE+9;%CE
M.2H\H5#V5;C?Z=&),P%U.==[\_VT?))="+VO!=2!*MSX#*M&FI)GJ'L>&'ND
M;XDAJPQ#1OA:0(VHPDW0L&JTA0:J;16,9/C._UX@%'L5)@87:D2AW9\0SM^D
MFKGG(H9H[P5":5=A!G"A1A3:UQ.J1G:\>Z?DS(Q7:VA#U#T-H/2K,,\WJ!G'
MA?G34O[EJL*@!071X$=&5(&_5RW6TU'BV,T+67[MBX0H#_Y0/-2 :BQ@]2L^
ML@4],Z9J^ZPK2\:E'YK#4=X*:@=N(0Q5C_-%O/54A>#W\$X<%'P52MXBA3@+
MT-(!9W&'2Q(\O]\)@X*N0GU;H ^%\QLB'E0Z-?'B5LF84G=?1V^./T"%!=P
MU)LJ5+X',<&Y(O'T',SL\9>ZEYKL;P?8_(+7)8+MH!Y5H2B&$$ Z=])/J^9H
M\F9Q1X=4N<D6]W1NWM@=/81/I0#-H495XYE08!X%?KUJY 3:73[83U>?N!_N
M;R+8=_X!4$L! A0#%     @ 4T 55W/&.!*#]   !L0'  H
M ( !     &5X,3 M,2YH=&U02P$"% ,4    " !30!57L:#2,_X0  "'>P
M"@              @ &K]   97@Q,"TR+FAT;5!+ 0(4 Q0    ( %- %5=
M1?#_ E8  +Q1 @ *              "  =$% 0!E>#$P+3,N:'1M4$L! A0#
M%     @ 4T 55Q;@+<CZ"0   EL   H              ( !^UL! &5X,3 M
M-"YH=&U02P$"% ,4    " !30!570I<:>Q$<  ! V   "P
M@ $=9@$ 9F]R;3@M:RYH=&U02P$"% ,4    " !30!574,^1$\8#   ]#@
M$0              @ %7@@$ :G5P=RTR,#(S,#@Q-"YX<V102P$"% ,4
M" !30!57T.1RBP )  #+:   %0              @ %,A@$ :G5P=RTR,#(S
M,#@Q-%]D968N>&UL4$L! A0#%     @ 4T 55S3F2-[U"P  8)   !4
M         ( !?X\! &IU<'<M,C R,S X,31?;&%B+GAM;%!+ 0(4 Q0    (
M %- %5<&>Q%F2@@  &5C   5              "  :>; 0!J=7!W+3(P,C,P
A.#$T7W!R92YX;6Q02P4&      D "0 A @  )*0!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
